Processing 00000000.tx.1: Adipose tissue gene expression profiling reveals distinct molecular pathways that define visceral adiposity in offspring of maternal protein-restricted rats Haiyan Guan,1 Edith Arany,2 Jonathan P. van Beek,1 Astrid Chamson-Reig,2 Sandra Thyssen,2 David J. 

Phrase: "Adipose tissue gene expression profiling"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   884   C0752248:Gene Expression Profiling [Laboratory Procedure,Molecular Biology Research Technique]
   884   C1449575:Gene Expression Profiling [Laboratory Procedure]
   867 E C1956267:Profile, Gene Expression [Quantitative Concept]
   840   C1513400:Expression Profiling [Molecular Biology Research Technique]
   771   C1979963:Profile [Laboratory Procedure]
   771   C2003903:Profile [Functional Concept]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "distinct molecular pathways"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C1704259:molecular pathway [Molecular Function]
           Pathways
   827   C1705987:Pathways [Conceptual Entity]

Phrase: "that"

Phrase: "define"

Phrase: "visceral adiposity in offspring of maternal protein-restricted rats Haiyan Guan,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0028754:Adiposity [Disease or Syndrome]
   738   C1563743:adiposity [Organism Attribute]

Phrase: "1 Edith Arany,"

Phrase: "2 Jonathan P. van Beek,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0557775:Van [Manufactured Object]

Phrase: "1 Astrid Chamson-Reig,"

Phrase: "2 Sandra Thyssen,"

Phrase: "2 David J."
Processing 00000000.tx.2: Hill,2,3 and Kaiping Yang1,3 Departments of 1Obstetrics and Gynaecology 2Medicine 3Physiology and Pharmacology, Canadian Institutes of Health Research Group in Fetal and Neonatal Health and Development, Children's Health Research Institute and Lawson Health Research Institute, University of Western Ontario, London, Ontario, Canada Submitted 30 September 2004 ; accepted in final form 19 November 2004  ABSTRACT TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION GRANTS REFERENCES  There is increasing evidence that poor early growth confers an increased risk of type 2 diabetes, hypertension, and other features of the metabolic syndrome in later life. 

Phrase: "Hill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442532:Hill [Spatial Concept]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "Kaiping Yang1,"

Phrase: "3 Departments of 1Obstetrics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Gynaecology 2Medicine 3Physiology"

Phrase: "and"

Phrase: "Pharmacology,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031330:Pharmacology [Biomedical Occupation or Discipline]
  1000   C1524059:pharmacology [Functional Concept]
   928 E C0205464:Pharmacologic [Functional Concept]

Phrase: "Canadian Institutes of Health Research Group"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C0035172:Research Institutes [Organization]
   753   C0021622:Institutes [Organization]
   719 E C1272753:Institute [Idea or Concept]

Phrase: "in Fetal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015965:Fetal [Embryonic Structure]
  1000   C0521457:Fetal [Functional Concept]

Phrase: "and"

Phrase: "Neonatal Health"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0018684:Health [Idea or Concept]
   761 E C0031206:healthiness [Finding]

Phrase: "and"

Phrase: "Development,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "Children's Health Research Institute"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   861   C0008078:Children's Health [Health Care Activity]
   861   C0035172:Research Institute [Organization]
   812   C0018684:Health [Idea or Concept]
   812   C0021622:institute [Organization]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: "and"

Phrase: "Lawson Health Research Institute,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0035172:Research Institute [Organization]
   812   C0018684:Health [Idea or Concept]
   812   C0021622:institute [Organization]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: "University of Western Ontario,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0029040:Ontario [Geographic Area]
   812   C0041740:University [Manufactured Object,Organization]
   812   C1705493:Western [Spatial Concept]

Phrase: "London,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023973:London [Geographic Area]

Phrase: "Ontario,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029040:Ontario [Geographic Area]

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: "Submitted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515023:Submitted [Functional Concept]

Phrase: "30 September 2004"

Phrase: ";"

Phrase: "accepted in final form 19 November 2004  ABSTRACT TOP ABSTRACT MATERIALS"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   738   C0000857:Abstract [Occupational Activity]
   738   C0205088:Final [Temporal Concept]
   738   C0348078:Form [Qualitative Concept]
   738   C0376315:Form [Manufactured Object]
   738   C0520510:Materials [Substance]
   738   C0600678:Abstract [Intellectual Product]
   738   C1272684:Accepted [Qualitative Concept]
   738   C1522492:Form [Functional Concept]
   738   C1546485:Final [Idea or Concept]
   738   C1548435:Accepted [Idea or Concept]
   738   C1552863:Abstract [Idea or Concept]
   738   C1704458:Top [Spatial Concept]
   704 E C1548601:Accept [Idea or Concept]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION GRANTS REFERENCES  There"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   766   C1514811:Reference [Idea or Concept]
   766   C1706462:Reference [Conceptual Entity]

Phrase: "is"

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that poor early growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C1837385:Poor growth [Finding]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2911660:Growth [Activity]

Phrase: "confers"

Phrase: "an increased risk of type 2 diabetes,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C1171304:diabetes risk [Quantitative Concept]
   748   C0035647:Risk [Qualitative Concept]
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]

Phrase: "hypertension,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020538:Hypertension [Disease or Syndrome]
  1000   C1963138:Hypertension [Finding]

Phrase: "and"

Phrase: "other features of the metabolic syndrome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C1864620:METABOLIC FEATURES [Clinical Attribute]
   719   C1521970:Feature [Qualitative Concept]
   719   C1706388:Feature [Conceptual Entity]
   719   C2346469:Feature [Qualitative Concept]
   719   C2348519:Feature [Qualitative Concept]

Phrase: "in later life."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0376558:Life [Idea or Concept]
   777 E C0595998:lives [Finding]
Processing 00000000.tx.3: We hypothesized that this may result from poor nutrition during early life exerting permanent effects on the structure and function of key metabolic organ systems. 

Phrase: "We"

Phrase: "hypothesized"

Phrase: "that"

Phrase: "this"

Phrase: "may"

Phrase: "result from poor nutrition"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0162429:POOR NUTRITION [Disease or Syndrome]
   770   C0028707:Nutrition [Biomedical Occupation or Discipline]
   770   C0032854:Poor [Group Attribute]
   770   C0392209:nutrition [Organism Attribute]
   770   C0542537:Poor [Qualitative Concept]
   770   C1274040:Result [Functional Concept]
   770   C1442959:Nutrition [Organism Function]
   770   C1546471:Result [Idea or Concept]
   770   C2700379:Poor [Qualitative Concept]
   770   C2825142:Result [Finding]

Phrase: "during early life"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0376558:Life [Idea or Concept]
   777 E C0595998:lives [Finding]

Phrase: "exerting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exerting [Organism Function]

Phrase: "permanent effects on the structure"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "function of key metabolic organ systems."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]
   731   C1180473:Functional system [Body System]
Processing 00000000.tx.4: To study the long-term impact of early-life undernutrition on susceptibility to visceral adiposity, we used a rat model of maternal protein restriction (MPR) in which dams were fed a low-protein diet (containing 8% instead of 20% protein in control diet) throughout pregnancy and lactation. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the long-term impact of early-life undernutrition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1825598:IMPACT [Gene or Genome]

Phrase: "on susceptibility"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0012655:Susceptibility [Clinical Attribute]
  1000   C0220898:Susceptibility [Organism Attribute]
  1000   C1264642:Susceptibility [Functional Concept]
  1000   C1547045:*Susceptibility [Quantitative Concept]
   928 E C0231204:Susceptible [Functional Concept]
   928 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "to visceral adiposity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0028754:Adiposity [Disease or Syndrome]
   861   C1563743:adiposity [Organism Attribute]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a rat model of maternal protein restriction (MPR)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3161035:Model [Intellectual Product]

Phrase: "in which dams"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2239937:DAMS [Gene or Genome]

Phrase: "were"

Phrase: "fed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0342895:FED [Disease or Syndrome]
   966 E C0204695:Feed [Health Care Activity]
   966 E C2987508:Feed [Activity]

Phrase: "a low-protein diet"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0242972:Low-Protein Diet [Therapeutic or Preventive Procedure]
           low protein
   901   C0452269:Protein diet [Therapeutic or Preventive Procedure]
   901   C0748025:low protein [Finding]
   827   C0012155:Diet [Food]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0205251:low [Qualitative Concept]
   827   C1299352:Low [Qualitative Concept]
   827   C1442959:Diet [Organism Function]
   827   C1519433:DIET [Therapeutic or Preventive Procedure]
   827   C1550472:low [Idea or Concept]
   827   C2983588:DIET [Food]
   755 E C2699635:DIETARY [Functional Concept]

Phrase: "("

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "8% instead of 20% protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in control diet"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0012155:Diet [Food]
   861   C1442959:Diet [Organism Function]
   861   C1519433:DIET [Therapeutic or Preventive Procedure]
   861   C2983588:DIET [Food]
   789 E C2699635:DIETARY [Functional Concept]

Phrase: ")"

Phrase: "throughout pregnancy"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0032961:Pregnancy [Organism Function]
  1000   C3484365:Pregnancy [Clinical Attribute]
   928 E C0549206:Pregnant [Finding]
   928 E C0553641:Pregnant [Functional Concept]
   928 E C0600457:PREGNANT [Finding]
   916 E C0552112:Pregnancies [Clinical Attribute]

Phrase: "and"

Phrase: "lactation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006147:Lactation [Organism Function]
  1000   C0022925:Lactation [Organ or Tissue Function]
Processing 00000000.tx.5: MPR offspring were born smaller than controls (offspring of dams on control diet) and in adulthood developed visceral adiposity. 

Phrase: "MPR offspring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]

Phrase: "were"

Phrase: "born"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0004897:Bear [Mammal]

Phrase: "smaller than controls"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0547044:Smaller [Qualitative Concept]
   790   C0700321:Smaller [Quantitative Concept]

Phrase: "(offspring of dams"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0680063:Offspring [Family Group]

Phrase: "on control diet"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0012155:Diet [Food]
   861   C1442959:Diet [Organism Function]
   861   C1519433:DIET [Therapeutic or Preventive Procedure]
   861   C2983588:DIET [Food]
   789 E C2699635:DIETARY [Functional Concept]

Phrase: ")"

Phrase: "and in adulthood"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0700597:Adulthood [Temporal Concept]
   790   C1515981:And [Idea or Concept]

Phrase: "developed"

Phrase: "visceral adiposity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0028754:Adiposity [Disease or Syndrome]
   861   C1563743:adiposity [Organism Attribute]
Processing 00000000.tx.6: We compared the pattern of gene expression in visceral adipose tissue (VAT) between MPR offspring and controls with Affymetrix rat expression arrays. 

Phrase: "We"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "the pattern of gene expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449774:Pattern [Spatial Concept]

Phrase: "in visceral adipose tissue (VAT)"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1563740:Visceral Adipose Tissue [Tissue]
   901   C0001527:Adipose tissue [Tissue]
   827   C0040300:Tissue [Tissue]
   827   C0442045:Visceral [Spatial Concept]
   827   C1547928:Tissue [Intellectual Product]
   755   C0028754:Adiposity [Disease or Syndrome]
   755   C1563743:adiposity [Organism Attribute]

Phrase: "between MPR offspring"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0205103:Between [Spatial Concept]
   795   C0443288:Restriction [Functional Concept]
   795   C0680063:Offspring [Family Group]
   795   C2347083:Maternal [Family Group]
   795   C3161035:Model [Intellectual Product]
   740 E C0026591:Mother [Family Group]
   712 E C1826438:MATER [Gene or Genome]

Phrase: "and"

Phrase: "controls with Affymetrix rat expression arrays."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0034693:Rat, NOS [Mammal]
   753   C0034721:Rat [Mammal]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   719   C1510941:Array [Spatial Concept]
Processing 00000000.tx.7: Of the total number of genes and expressed sequence tags analyzed (15,923 probe sets), 9,790 (61.5%) were expressed in VAT. 

Phrase: "Of the total number"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0237753:*Number [Quantitative Concept]
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "of genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "and"

Phrase: "expressed sequence tags"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0600510:Expressed Sequence Tags [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1139855:tags [Medical Device]
   827   C1519249:Sequence [Functional Concept]
   793 E C0037293:Tag [Neoplastic Process]
   793 E C0181496:Tag [Manufactured Object]
   793 E C1710492:TAG [Gene or Genome]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "(15,923 probe sets"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0036849:Set [Mental Process]
   812   C0182400:Probe [Medical Device]
   812   C1442518:Set [Functional Concept]
   812   C1704681:Probe [Gene or Genome]
   812   C1705195:Set [Conceptual Entity]
   812   C2347609:Probe [Chemical Viewed Functionally]
   812   C3536729:Probe [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "9,790"

Phrase: "(61.5%"

Phrase: ")"

Phrase: "were"

Phrase: "expressed in VAT."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C1563740:Visceral Adipose Tissue [Tissue]
   806   C0001527:Adipose tissue [Tissue]
   760   C0040300:Tissue [Tissue]
   760   C0442045:Visceral [Spatial Concept]
   760   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.8: We identified 650 transcripts as differentially expressed 1.5-fold in the VAT of MPR offspring. 

Phrase: "We"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "650 transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "as"

Phrase: "differentially"

Phrase: "expressed"

Phrase: "1.5-fold in the VAT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332462:Fold [Spatial Concept]
   744   C1880834:FOLD [Phenomenon or Process]

Phrase: "of MPR offspring."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0332285:Of [Spatial Concept]
   795   C0443288:Restriction [Functional Concept]
   795   C0680063:Offspring [Family Group]
   795   C2347083:Maternal [Family Group]
   795   C3161035:Model [Intellectual Product]
   740 E C0026591:Mother [Family Group]
   712 E C1826438:MATER [Gene or Genome]
Processing 00000000.tx.9: Gene ontology analysis revealed a global upregulation of genes involved in carbohydrate, lipid, and protein metabolism. 

Phrase: "Gene ontology analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C1138831:Gene Ontology [Intellectual Product]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a global upregulation of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0041904:Up-Regulation [Cell Function,Molecular Function]
   760   C0162493:Up-Regulation [Genetic Function]

Phrase: "involved in carbohydrate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0007004:Carbohydrate [Carbohydrate]
   790   C1314939:Involved [Functional Concept]

Phrase: "lipid,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023779:Lipid [Lipid]

Phrase: "and"

Phrase: "protein metabolism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0597299:Protein Metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.10: A number of genes involved in adipocyte differentiation, angiogenesis, and extracellular matrix remodeling were also upregulated. 

Phrase: "A number of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "involved in adipocyte differentiation,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1159884:adipocyte differentiation [Cell Function]
   770   C0007589:Differentiation [Cell Function]
   770   C0206131:Adipocyte [Cell]
   770   C1314939:Involved [Functional Concept]
   770   C1511938:Differentiation [Clinical Attribute]
   770   C2945687:Differentiation [Functional Concept]

Phrase: "angiogenesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0302600:Angiogenesis [Organ or Tissue Function]
  1000   C1519670:angiogenesis [Neoplastic Process]

Phrase: "and"

Phrase: "extracellular matrix remodeling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0015350:Extracellular Matrix [Tissue]

Phrase: "were"

Phrase: "also"

Phrase: "upregulated."
Processing 00000000.tx.11: However, in marked contrast to other rodent models of obesity, the expression of a large number of genes associated with inflammation was reduced in this rat model. 

Phrase: "However,"

Phrase: "in marked contrast"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1979874:Contrast [Qualitative Concept]

Phrase: "to other rodent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035804:Rodent [Mammal]

Phrase: "models of obesity,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0028754:Obesity [Disease or Syndrome]
   790   C1963185:Obesity [Finding]
   790   C3161035:Model [Intellectual Product]

Phrase: "the expression of a large number of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   750   C0017262:Gene Expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "associated with inflammation"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0021368:Inflammation [Pathologic Function]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "was"

Phrase: "reduced in this rat model."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C0392756:Reduced [Qualitative Concept]
   760   C3161035:Model [Intellectual Product]
Processing 00000000.tx.12: Thus visceral adiposity in this early-life programmed rat model is marked by dynamic changes in the transcriptional profile of VAT. 

Phrase: "Thus visceral adiposity in this early-life"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0028754:Adiposity [Disease or Syndrome]
   748   C1563743:adiposity [Organism Attribute]

Phrase: "programmed"

Phrase: "rat model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "is"

Phrase: "marked by dynamic changes"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   770   C0522501:Marked [Qualitative Concept]
   770   C0729333:Dynamic [Functional Concept]
   770   C1706089:Marked [Qualitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "in the transcriptional profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1979963:Profile [Laboratory Procedure]
   861   C2003903:Profile [Functional Concept]

Phrase: "of VAT."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1563740:Visceral Adipose Tissue [Tissue]
   901   C0001527:Adipose tissue [Tissue]
   827   C0040300:Tissue [Tissue]
   827   C0442045:Visceral [Spatial Concept]
   827   C1547928:Tissue [Intellectual Product]
   755   C0028754:Adiposity [Disease or Syndrome]
   755   C1563743:adiposity [Organism Attribute]
Processing 00000000.tx.13: Our data provide new insights into the molecular mechanisms that underlie the early-life programming of visceral adiposity. visceral adipose tissue; 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "new insights into the molecular mechanisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0233820:insights [Mental Process]

Phrase: "that"

Phrase: "underlie"

Phrase: "the early-life programming of visceral adiposity. visceral adipose tissue"

Phrase: ";"
Processing 00000000.tx.14: maternal protein restriction; 

Phrase: "maternal protein restriction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0443288:Restriction [Functional Concept]

Phrase: ";"
Processing 00000000.tx.15: DNA microarray OBESITY IS A SERIOUS MEDICAL PROBLEM not only because it substantially impairs quality of life but also because it increases the risk of hypertension, type 2 diabetes, coronary heart disease, sleeping disorders, and cancers (43). 

Phrase: "DNA microarray OBESITY"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0028754:Obesity [Disease or Syndrome]
   827   C1963185:Obesity [Finding]
   734   C0600596:DNA Microarray [Research Device]
   734   C1522053:DNA Microarray [Molecular Biology Research Technique]

Phrase: "IS"

Phrase: "A SERIOUS MEDICAL PROBLEM"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1254481:Medical Problem [Finding]
   901   C1715372:Medical problem [Clinical Attribute]
   827   C0033213:Problem [Finding]

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "because"

Phrase: "it substantially"

Phrase: "impairs"

Phrase: "quality of life"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0034380:Quality of life [Idea or Concept]
           Life Quality
  1000   C0518214:Quality of life [Finding]
           life quality
   790   C0332306:Quality [Qualitative Concept]

Phrase: "but"

Phrase: "also"

Phrase: "because"

Phrase: "it"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the risk of hypertension,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0559060:Hypertension risk [Finding]
   770   C0035647:Risk [Qualitative Concept]

Phrase: "type 2 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "coronary heart disease,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0010054:coronary heart disease [Disease or Syndrome]
  1000   C0010068:Coronary heart disease [Disease or Syndrome]
           Coronary Disease
   901   C0018799:Heart disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0018787:Heart [Body Part, Organ, or Organ Component]
           coronary
   827   C1281570:Heart [Body Part, Organ, or Organ Component]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "sleeping"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037313:Sleeping [Organism Function]
  1000   C0424522:Sleeping [Finding]

Phrase: "disorders,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012634:Disorders [Disease or Syndrome]

Phrase: "and"

Phrase: "cancers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006826:Cancer [Neoplastic Process]
  1000   C0998265:Cancer [Eukaryote]
  1000   C1306459:Cancer [Finding]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.16: There is strong evidence for a genetic component to human obesity (28). 

Phrase: "There"

Phrase: "is"

Phrase: "strong evidence for a genetic component"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332120:Evidence [Functional Concept]

Phrase: "to human obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0028754:Obesity [Disease or Syndrome]
   861   C1963185:Obesity [Finding]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.17: Multiple systems regulate energy homeostasis (35, 44), and a number of genes associated with human obesity have been identified (19), yet the genetic component of this condition cannot explain the dramatic increase in the prevalence of obesity in recent years. 

Phrase: "Multiple systems"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   777 E C0205373:Systemic [Functional Concept]

Phrase: "regulate"

Phrase: "energy homeostasis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3157043:energy homeostasis [Biologic Function]
   861   C0019868:Homeostasis [Biologic Function]

Phrase: "(35,"

Phrase: "44"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "a number of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "associated with human obesity"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0028754:Obesity [Disease or Syndrome]
   770   C0086418:Human [Human]
   770   C1963185:Obesity [Finding]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "have"

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "(19"

Phrase: ")"

Phrase: ","

Phrase: "yet"

Phrase: "the genetic component of this condition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449432:Component [Manufactured Object]
   753   C1705248:Component [Conceptual Entity]

Phrase: "cannot"

Phrase: "explain"

Phrase: "the dramatic increase in the prevalence of obesity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "in recent years."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.18: A large number of epidemiological studies have revealed a strong statistical association between poor fetal growth and the subsequent development of type 2 diabetes, hypertension, and obesity, visceral obesity in particular (54). 

Phrase: "A large number of epidemiological studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "have"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a strong statistical association between poor fetal growth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "the subsequent development of type 2 diabetes,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C1527148:Development [Functional Concept]

Phrase: "hypertension,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020538:Hypertension [Disease or Syndrome]
  1000   C1963138:Hypertension [Finding]

Phrase: "and"

Phrase: "obesity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "visceral obesity in particular"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C2936179:Obesity, Visceral [Sign or Symptom]
   770   C0028754:Obesity [Disease or Syndrome]
   770   C1963185:Obesity [Finding]

Phrase: "(54"

Phrase: ")."
Processing 00000000.tx.19: These observations were made initially by Barker et al. in England (3a) but have now been reproduced in a large number of populations worldwide. 

Phrase: "These observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "were"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "initially by Barker et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205265:Initially [Temporal Concept]

Phrase: "in England"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014282:England [Geographic Area]

Phrase: "(3a"

Phrase: ")"

Phrase: "but"

Phrase: "have"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "been"

Phrase: "reproduced in a large number of populations worldwide."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0032659:Population [Quantitative Concept]
   744   C0237753:*Number [Quantitative Concept]
   744   C0449788:Number [Quantitative Concept]
   744   C0549177:Large [Quantitative Concept]
   744   C1257890:Population [Population Group]
Processing 00000000.tx.20: These findings have led to the "fetal origins" hypothesis, which states that an adverse intrauterine environment programs or imprints the development of fetal tissues, permanently determining physiological responses and ultimately producing dysfunction and disease (60). 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "have"

Phrase: "led to the ""fetal origins"" hypothesis,"
Meta Candidates (Total=12; Excluded=6; Pruned=0; Remaining=6)
   753   C0015965:Fetal [Embryonic Structure]
   753   C0079946:origins [Classification]
   753   C0439659:Origins [Temporal Concept]
   753   C0521457:Fetal [Functional Concept]
   753   C1512571:Hypothesis [Idea or Concept]
   753   C1708698:LED [Manufactured Object]
   719 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   719 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   719 E C1522538:Lead [Functional Concept]
   719 E C1550512:origin [Intellectual Product]
   719 E C2348269:Lead [Element, Ion, or Isotope]
   719 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "which"

Phrase: "states"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1301808:State [Geographic Area]
  1000   C1442792:State [Functional Concept]
  1000   C3148680:State [Geographic Area]

Phrase: "that"

Phrase: "an adverse intrauterine environment programs"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0376691:Programs [Intellectual Product]
   812   C3484370:Programs [Functional Concept]
   779 E C1709697:Program [Conceptual Entity]
   779 E C2728259:Program [Pharmacologic Substance]

Phrase: "or"

Phrase: "imprints"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021118:imprint [Mental Process]
  1000   C1699173:imprint [Intellectual Product]

Phrase: "the development of fetal tissues,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0015928:Fetal Development [Physiologic Function]
   797   C0220829:fetal development [Functional Concept]
   781   C0178679:tissue development [Organ or Tissue Function]
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]

Phrase: "permanently"

Phrase: "determining"

Phrase: "physiological responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0871261:responses [Organism Attribute]
   827 E C1704632:Response [Finding]
   827 E C1706817:Response [Intellectual Product]
   827 E C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "ultimately"

Phrase: "producing"

Phrase: "dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0031847:dysfunction [Functional Concept]
  1000   C0277785:Dysfunction, NOS [Qualitative Concept]
   944 E C0231174:Malfunction [Functional Concept]
   944 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "and"

Phrase: "disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "(60"

Phrase: ")."
Processing 00000000.tx.21: However, the molecular mechanisms that underpin this relationship remain elusive. 

Phrase: "However,"

Phrase: "the molecular mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "underpin"

Phrase: "this relationship"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439849:Relationship [Qualitative Concept]
  1000   C1705630:Relationship [Idea or Concept]
  1000   C1706279:Relationship [Idea or Concept]
  1000   C3540605:Relationship [Intellectual Product]

Phrase: "remain"

Phrase: "elusive."
Processing 00000000.tx.22: In an attempt to provide a conceptual framework to begin to explain these observations, the thrifty-phenotype hypothesis has been proposed (24), which postulates that fetal development is sensitive to the nutritional environment. 

Phrase: "In an attempt to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516084:Attempt [Event]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a conceptual framework to"

Phrase: "begin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Begin [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "explain"

Phrase: "these observations,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "the thrifty-phenotype hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512571:Hypothesis [Idea or Concept]

Phrase: "has"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "(24"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "postulates"

Phrase: "that fetal development"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0015928:Fetal Development [Physiologic Function]
  1000   C0220829:fetal development [Functional Concept]
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "is"

Phrase: "sensitive to the nutritional environment."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332324:Sensitive to [Functional Concept]
           Sensitive
   760   C1550474:sensitive [Idea or Concept]
Processing 00000000.tx.23: When it is poor, an adaptive response is initiated to optimize the growth of certain organs, such as the brain, at the expense of others, such as peripheral organs. 

Phrase: "When"

Phrase: "it"

Phrase: "is"

Phrase: "poor,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032854:Poor [Group Attribute]
  1000   C0542537:Poor [Qualitative Concept]
  1000   C2700379:Poor [Qualitative Concept]

Phrase: "an adaptive response"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0231193:Adaptive [Functional Concept]
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "is"

Phrase: "initiated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1548602:Initiate [Idea or Concept]
   966   C1704686:Initiate [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "optimize"

Phrase: "the growth of certain organs,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   781   C1523713:organ growth [Organism Function]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0220844:growth [Physiologic Function]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2911660:Growth [Activity]

Phrase: "such as the brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "at the expense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680864:expense [Quantitative Concept]

Phrase: "of others,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "such as peripheral organs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0178784:organs [Body Part, Organ, or Organ Component]
Processing 00000000.tx.24: These adaptations serve to improve chances of fetal survival. 

Phrase: "These adaptations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0000934:adaptations [Organism Function]
  1000   C0392673:ADAPTATIONS [Biologic Function]

Phrase: "serve"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "improve"

Phrase: "chances of fetal survival."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0237506:Chance [Qualitative Concept]
Processing 00000000.tx.25: They also lead to an altered postnatal metabolism, which enhances postnatal survival under conditions of intermittent and poor nutrition. 

Phrase: "They also"

Phrase: "lead to an altered postnatal metabolism,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0025519:Metabolism [Organism Function]
   753   C0025520:metabolism [Functional Concept]
   753   C0392747:Altered [Functional Concept]
   753   C0443281:Postnatal [Temporal Concept]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1522538:Lead [Functional Concept]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "which"

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "postnatal survival under conditions of intermittent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0038952:Survival [Activity]
   753   C0220921:survival [Functional Concept]

Phrase: "and"

Phrase: "poor nutrition."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0162429:POOR NUTRITION [Disease or Syndrome]
   861   C0028707:Nutrition [Biomedical Occupation or Discipline]
   861   C0392209:nutrition [Organism Attribute]
   861   C1442959:Nutrition [Organism Function]
   789 E C1521739:Nutritional [Qualitative Concept]
   789 E C2707262:Nutritional [Clinical Attribute]
Processing 00000000.tx.26: However, these adaptations would become detrimental if postnatal nutrition were adequate or overabundant. 

Phrase: "However,"

Phrase: "these adaptations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0000934:adaptations [Organism Function]
  1000   C0392673:ADAPTATIONS [Biologic Function]

Phrase: "would"

Phrase: "become"

Phrase: "detrimental"

Phrase: "if"

Phrase: "postnatal nutrition"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0028707:Nutrition [Biomedical Occupation or Discipline]
   861   C0392209:nutrition [Organism Attribute]
   861   C1442959:Nutrition [Organism Function]
   789 E C1521739:Nutritional [Qualitative Concept]
   789 E C2707262:Nutritional [Clinical Attribute]

Phrase: "were"

Phrase: "adequate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205410:Adequate [Qualitative Concept]
  1000   C0205411:Adequate [Qualitative Concept]

Phrase: "or"

Phrase: "overabundant."
Processing 00000000.tx.27: The detrimental consequences may include increased risk of developing obesity and the associated metabolic diseases. 

Phrase: "The detrimental consequences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0686907:consequences [Functional Concept]

Phrase: "may"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "increased risk of developing obesity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0035647:Risk [Qualitative Concept]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]

Phrase: "and"

Phrase: "the associated metabolic diseases."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   901   C0025517:Metabolic Diseases [Disease or Syndrome]
   896   C0243083:associated disease [Pathologic Function]
   827   C0012634:Diseases [Disease or Syndrome]
   827   C0311400:Metabolic [Functional Concept]
   827   C1524026:Metabolic [Cell Function]
   827   C2707259:Metabolic [Clinical Attribute]
   755 E C1836721:MALS [Finding]
   755 E C3538764:MALS [Gene or Genome]
   755 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.28: Indeed, epidemiological studies in the human have suggested that adults who were growth restricted in utero (occurs in 510% pregnancies) have increased body fat and in particular increased visceral fat (52, 61). 

Phrase: "Indeed,"

Phrase: "epidemiological studies in the human"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0002783:Epidemiological Studies [Research Activity]
   797   C0178693:human studies [Research Activity]
   760   C0014507:Epidemiological [Biomedical Occupation or Discipline]
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that adults"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001675:Adults [Age Group]
   966 E C1706450:Adult [Human]

Phrase: "who"

Phrase: "were"

Phrase: "growth restricted in utero"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708480:In Utero [Age Group]
   812   C0042149:Utero- [Body Part, Organ, or Organ Component]

Phrase: "("

Phrase: "occurs in 510% pregnancies"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0032961:Pregnancies [Organism Function]
   770   C0552112:Pregnancies [Clinical Attribute]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]
   737 E C3484365:Pregnancy [Clinical Attribute]

Phrase: ")"

Phrase: "have"

Phrase: "increased body fat"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   901   C0001527:Body Fat [Tissue]
   901   C0015665:body fat [Body Part, Organ, or Organ Component]
   901   C0344335:Body Fat [Clinical Attribute]
   827   C0242821:body [Human]
   827   C0424612:FAT [Organism Attribute]
   827   C0460148:Body [Anatomical Structure]
   827   C1268086:Body [Anatomical Structure]
   743 E C1995017:Bodies [Cell Component]

Phrase: "and in particular increased visceral fat"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1563740:Visceral Fat [Tissue]
   753   C0205217:Increased [Quantitative Concept]
   753   C0424612:FAT [Organism Attribute]
   753   C0442045:Visceral [Spatial Concept]
   753   C0442805:Increased [Functional Concept]
   753   C1515981:And [Idea or Concept]

Phrase: "(52,"

Phrase: "61"

Phrase: ")."
Processing 00000000.tx.29: A wide variety of animal models have been established to test the fetal origins hypothesis (55). 

Phrase: "A wide variety of animal models"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1883525:Variety [Conceptual Entity]
   753   C2346866:Variety [Conceptual Entity]

Phrase: "have"

Phrase: "been"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "the fetal origins hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512571:Hypothesis [Idea or Concept]

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.30: Among them, the maternal protein restriction (MPR) rat model has been used extensively to study the long-term impact of an adverse intrauterine environment on susceptibility to hypertension, insulin resistance, type 2 diabetes, and other metabolic diseases (55). 

Phrase: "Among them,"

Phrase: "the maternal protein restriction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0443288:Restriction [Functional Concept]

Phrase: "(MPR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]

Phrase: ")"

Phrase: "rat model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "extensively to"

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the long-term impact of an adverse intrauterine environment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1825598:IMPACT [Gene or Genome]
   726   C0282165:Impact, Environmental [Phenomenon or Process]

Phrase: "on susceptibility"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0012655:Susceptibility [Clinical Attribute]
  1000   C0220898:Susceptibility [Organism Attribute]
  1000   C1264642:Susceptibility [Functional Concept]
  1000   C1547045:*Susceptibility [Quantitative Concept]
   928 E C0231204:Susceptible [Functional Concept]
   928 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "to hypertension,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020538:Hypertension [Disease or Syndrome]
  1000   C1963138:Hypertension [Finding]

Phrase: "insulin resistance,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "type 2 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "other metabolic diseases"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0025517:Metabolic Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   861   C0311400:Metabolic [Functional Concept]
   861   C1524026:Metabolic [Cell Function]
   861   C2707259:Metabolic [Clinical Attribute]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.31: In this model, rat dams are subjected to a low-protein diet containing 8% instead of 20% protein (control diet) throughout pregnancy and lactation. 

Phrase: "In this model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "rat dams"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2239937:DAMS [Gene or Genome]

Phrase: "are"

Phrase: "subjected to a low-protein diet"
Meta Candidates (Total=19; Excluded=1; Pruned=0; Remaining=18)
   833   C0242972:Low-Protein Diet [Therapeutic or Preventive Procedure]
           low protein
   790   C0452269:Protein diet [Therapeutic or Preventive Procedure]
   790   C0748025:low protein [Finding]
   783   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   753   C0012155:Diet [Food]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205251:low [Qualitative Concept]
   753   C1299352:Low [Qualitative Concept]
   753   C1442959:Diet [Organism Function]
   753   C1519433:DIET [Therapeutic or Preventive Procedure]
   753   C1550472:low [Idea or Concept]
   753   C2983588:DIET [Food]
   748 E C0012177:Dietary Protein [Amino Acid, Peptide, or Protein]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "8% instead of 20% protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(control diet"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0012155:Diet [Food]
   861   C1442959:Diet [Organism Function]
   861   C1519433:DIET [Therapeutic or Preventive Procedure]
   861   C2983588:DIET [Food]
   789 E C2699635:DIETARY [Functional Concept]

Phrase: ")"

Phrase: "throughout pregnancy"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0032961:Pregnancy [Organism Function]
  1000   C3484365:Pregnancy [Clinical Attribute]
   928 E C0549206:Pregnant [Finding]
   928 E C0553641:Pregnant [Functional Concept]
   928 E C0600457:PREGNANT [Finding]
   916 E C0552112:Pregnancies [Clinical Attribute]

Phrase: "and"

Phrase: "lactation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006147:Lactation [Organism Function]
  1000   C0022925:Lactation [Organ or Tissue Function]
Processing 00000000.tx.32: The MPR offspring are known to exhibit low birth weight, the characteristic feature of intrauterine growth restriction, and become diabetic, insulin resistant, and hypertensive in adulthood (56). 

Phrase: "The MPR offspring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3161035:Model [Intellectual Product]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "low birth weight,"
Meta Candidates (Total=27; Excluded=13; Pruned=0; Remaining=14)
  1000   C0021288:Low birth weight [Patient or Disabled Group]
  1000   C0024032:Low Birth Weight [Finding]
   913   C0041667:Low weight [Finding]
   901   C0005612:Birth Weight [Organism Attribute]
   827   C0005615:Birth [Organism Function]
   827   C0005910:weight [Organism Attribute]
   827   C0043100:Weight [Quantitative Concept]
   827   C0205251:low [Qualitative Concept]
   827   C1299352:Low [Qualitative Concept]
   827   C1305866:weight [Diagnostic Procedure]
   827   C1550472:low [Idea or Concept]
   827   C1550722:birth [Idea or Concept]
   827   C1705104:Weight [Idea or Concept]
   827   C3245487:birth [Intellectual Product]
   771 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   771 E C0314603:Genetic [Functional Concept]
   771 E C0454729:Natal [Geographic Area]
   743 E C0035150:Reproduction [Organism Function]
   743 E C0079946:origin [Classification]
   743 E C0439659:Origin [Temporal Concept]
   743 E C1550512:origin [Intellectual Product]
   727 E C0559522:Genital [Body System]
   727 E C1546649:Genital [Intellectual Product]
   727 E C1550642:Genital [Body Substance]
   721 E C0205313:Original [Idea or Concept]
   721 E C2347409:Original [Occupational Activity]
   708 E C0598240:originality [Mental Process]

Phrase: "the characteristic feature of intrauterine growth restriction,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C1521970:Feature [Qualitative Concept]
   748   C1706388:Feature [Conceptual Entity]
   748   C2346469:Feature [Qualitative Concept]
   748   C2348519:Feature [Qualitative Concept]

Phrase: "and"

Phrase: "become"

Phrase: "diabetic, insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0421248:diabetic insulin [Finding]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "resistant,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332325:Resistant [Functional Concept]
  1000   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "and"

Phrase: "hypertensive in adulthood"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0857121:hypertensive [Finding]

Phrase: "(56"

Phrase: ")."
Processing 00000000.tx.33: Other models of fetal programming also predispose to the development of these metabolic disorders, including maternal caloric restriction, uterine artery ligation, and excessive fetal glucocorticoid exposure (55). 

Phrase: "Other models of fetal programming also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Models [Intellectual Product]

Phrase: "predispose to the development of these metabolic disorders,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0025517:METABOLIC DISORDERS [Disease or Syndrome]
   744   C0012634:Disorders [Disease or Syndrome]
   744   C0243107:development [Physiologic Function]
   744   C0311400:Metabolic [Functional Concept]
   744   C0678723:Development [Organism Function]
   744   C1524026:Metabolic [Cell Function]
   744   C1527148:Development [Functional Concept]
   744   C2707259:Metabolic [Clinical Attribute]
   731   C0008073:DEVELOPMENTAL DISORDERS [Mental or Behavioral Dysfunction]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "maternal caloric restriction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1135809:Caloric Restriction [Therapeutic or Preventive Procedure]
   827   C0443288:Restriction [Functional Concept]

Phrase: "uterine artery ligation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0189722:artery ligation [Therapeutic or Preventive Procedure]
   827   C0023690:Ligation [Therapeutic or Preventive Procedure]
   734   C0226378:Uterine Artery [Body Part, Organ, or Organ Component]
   734   C1280153:Uterine artery [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "excessive fetal glucocorticoid exposure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0871747:fetal exposure [Finding]
   812   C0274281:Exposure, NOS [Injury or Poisoning]
   812   C0332157:Exposure [Clinical Attribute]

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.34: It is remarkable that these different insults in fetal life produce the same detrimental consequences that occur in adulthood, suggesting that a common mechanism may underlie the early-life programming of the adult diseases. 

Phrase: "It"

Phrase: "is"

Phrase: "remarkable"

Phrase: "that"

Phrase: "these different insults in fetal life"

Phrase: "produce"

Phrase: "the same detrimental consequences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0686907:consequences [Functional Concept]

Phrase: "that"

Phrase: "occur in adulthood,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0700597:Adulthood [Temporal Concept]
   790   C1709305:Occur [Activity]
   790   C2745955:OCCUR [Temporal Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a common mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "may"

Phrase: "underlie"

Phrase: "the early-life programming of the adult diseases."
Processing 00000000.tx.35: However, few studies have focused on the long-term impact of an adverse intrauterine environment on the susceptibility to obesity (57) and none on the early-life programming of adipose tissue gene expression. 

Phrase: "However,"

Phrase: "few studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "focused on the long-term impact of an adverse intrauterine environment"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   756   C0443252:Long-term [Temporal Concept]
   738   C0014406:Environment [Spatial Concept]
   738   C0205166:Long [Qualitative Concept]
   738   C0205234:Focused [Spatial Concept]
   738   C0694756:Intrauterine [Body Space or Junction]
   738   C1285542:focused [Functional Concept]
   738   C1515273:Term [Temporal Concept]
   738   C1705313:Term [Idea or Concept]
   738   C1706317:Long [Qualitative Concept]
   738   C1825598:IMPACT [Gene or Genome]
   738   C2826302:TERM [Intellectual Product]
   718   C0282165:Impact, Environmental [Phenomenon or Process]

Phrase: "on the susceptibility"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0012655:Susceptibility [Clinical Attribute]
  1000   C0220898:Susceptibility [Organism Attribute]
  1000   C1264642:Susceptibility [Functional Concept]
  1000   C1547045:*Susceptibility [Quantitative Concept]
   928 E C0231204:Susceptible [Functional Concept]
   928 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "to obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "(57"

Phrase: ")"

Phrase: "and"

Phrase: "none on the early-life programming of adipose tissue gene expression."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   756   C0001527:Adipose tissue [Tissue]
   756   C0017262:Gene Expression [Genetic Function]
   738   C0017337:Gene [Gene or Genome]
   738   C0040300:Tissue [Tissue]
   738   C0185117:Expression [Therapeutic or Preventive Procedure]
   738   C0376558:Life [Idea or Concept]
   738   C0456148:None [Quantitative Concept]
   738   C0549184:None [Quantitative Concept]
   738   C1279919:Early [Temporal Concept]
   738   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.36: Therefore, the aims of the present study were to determine, using the MPR rat model, 1) whether poor early nutrition led to the development of visceral adiposity and 2) whether the phenotypic changes in fat mass were associated with alterations in the transcriptional profile of visceral adipose tissue (VAT).  

Phrase: "Therefore,"

Phrase: "the aims of the present study"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C1947946:Aims [Idea or Concept]
   753   C3540473:AIMS [Intellectual Product]
   719 E C2948600:Aim [Pharmacologic Substance]
   719 E C3540471:AIM [Gene or Genome]
   719 E C3540472:AIM [Functional Concept]

Phrase: "were"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: ","

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the MPR rat model,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "whether"

Phrase: "poor early nutrition"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   913   C0162429:POOR NUTRITION [Disease or Syndrome]
   827   C0028707:Nutrition [Biomedical Occupation or Discipline]
   827   C0392209:nutrition [Organism Attribute]
   827   C1442959:Nutrition [Organism Function]
   755 E C1521739:Nutritional [Qualitative Concept]
   755 E C2707262:Nutritional [Clinical Attribute]

Phrase: "led to the development of visceral adiposity"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   748   C0028754:Adiposity [Disease or Syndrome]
   748   C0243107:development [Physiologic Function]
   748   C0442045:Visceral [Spatial Concept]
   748   C0678723:Development [Organism Function]
   748   C1527148:Development [Functional Concept]
   748   C1563743:adiposity [Organism Attribute]
   748   C1708698:LED [Manufactured Object]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C1522538:Lead [Functional Concept]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "whether"

Phrase: "the phenotypic changes in fat mass"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   767   C0025320:The change [Physiologic Function]
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "were"

Phrase: "associated with alterations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756   C1515926:Alteration [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in the transcriptional profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1979963:Profile [Laboratory Procedure]
   861   C2003903:Profile [Functional Concept]

Phrase: "of visceral adipose tissue"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1563740:Visceral Adipose Tissue [Tissue]
   901   C0001527:Adipose tissue [Tissue]
   827   C0040300:Tissue [Tissue]
   827   C0442045:Visceral [Spatial Concept]
   827   C1547928:Tissue [Intellectual Product]
   755   C0028754:Adiposity [Disease or Syndrome]
   755   C1563743:adiposity [Organism Attribute]

Phrase: "(VAT"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1563740:Visceral Adipose Tissue [Tissue]
   901   C0001527:Adipose tissue [Tissue]
   827   C0040300:Tissue [Tissue]
   827   C0442045:Visceral [Spatial Concept]
   827   C1547928:Tissue [Intellectual Product]
   755   C0028754:Adiposity [Disease or Syndrome]
   755   C1563743:adiposity [Organism Attribute]

Phrase: ")."
Processing 00000000.tx.37: MATERIALS AND METHODS TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION GRANTS REFERENCES  Animals and dietary manipulations. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION GRANTS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0018173:Grants [Quantitative Concept]
   779 E C1548284:Grant [Idea or Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "and"

Phrase: "dietary manipulations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0185111:MANIPULATIONS [Therapeutic or Preventive Procedure]
   861   C0947647:Manipulations NOS [Therapeutic or Preventive Procedure]
Processing 00000000.tx.38: Virgin female Wistar rats (initial weight 240260 g) were purchased from Charles River Laboratories (Wilmington, MA) and bred in our animal care facility (Lawson Health Research Institute). 

Phrase: "Virgin female Wistar rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0034716:Rats, Wistar [Mammal]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]
   812   C2700262:Wistar [Mammal]

Phrase: "(initial weight 240260 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "purchased from Charles River Laboratories"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0022877:Laboratories [Manufactured Object,Organization]
   760   C0337050:River [Natural Phenomenon or Process]
   760   C0869011:purchased [Activity]
   760   C1619828:Laboratories [Intellectual Product]
   726 E C3244292:laboratory [Functional Concept]

Phrase: "(Wilmington,"

Phrase: "MA)"

Phrase: "and"

Phrase: "bred in our animal care facility"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0178478:animal care [Occupation or Discipline]
   783   C0872329:animal facility [Manufactured Object]
   753   C0003062:Animal [Animal]
   753   C1547538:Facility [Idea or Concept]
   753   C1947933:Care [Activity]
   719   C0006159:breed [Organism Function]
   719   C1704650:Breed [Classification]

Phrase: "(Lawson Health Research Institute"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0035172:Research Institute [Organization]
   812   C0018684:Health [Idea or Concept]
   812   C0021622:institute [Organization]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: ")."
Processing 00000000.tx.39: They were housed individually and maintained at 22C on a 12:12-h light-dark cycle. 

Phrase: "They"

Phrase: "were"

Phrase: "housed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0020056:Housed [Manufactured Object]
   966 E C0442519:house [Conceptual Entity]
   966 E C2003847:House [Manufactured Object]

Phrase: "individually"

Phrase: "and"

Phrase: "maintained at 22C"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1314677:Maintained [Functional Concept]
   756 E C0024501:Maintain [Activity]

Phrase: "on a 12"

Phrase: ":"

Phrase: "12-h light-dark cycle."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C2718082:Light-Dark Cycle [Temporal Concept]
           Light Cycle
   804   C0023693:Light [Natural Phenomenon or Process]
   804   C0332582:Dark [Qualitative Concept]
   804   C1306462:Light [Functional Concept]
   804   C1511572:Cycle [Temporal Concept]
   804   C1881376:Light [Qualitative Concept]
Processing 00000000.tx.40: They were mated, and day 0 of gestation was set as the day on which vaginal plugs were expelled. 

Phrase: "They"

Phrase: "were"

Phrase: "mated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1254211:mated [Pharmacologic Substance]
  1000   C1260875:Mated [Organism Function]
   966 E C0682323:mate [Family Group]

Phrase: ","

Phrase: "and"

Phrase: "day 0 of gestation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0032961:Gestation [Organism Function]
   770   C0332173:/day [Temporal Concept]
   770   C0439228:day [Temporal Concept]
   770   C0439505:/day [Temporal Concept]

Phrase: "was"

Phrase: "set as the day"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0036849:Set [Mental Process]
   770   C0332173:/day [Temporal Concept]
   770   C0439228:day [Temporal Concept]
   770   C0439505:/day [Temporal Concept]
   770   C1442518:Set [Functional Concept]
   770   C1705195:Set [Conceptual Entity]

Phrase: "on which vaginal plugs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0182324:plugs [Manufactured Object]
   827 E C1705909:Plug [Medical Device]

Phrase: "were"

Phrase: "expelled."
Processing 00000000.tx.41: Pregnant rats were fed a diet containing 20% protein (control) or an isocaloric diet containing 8% protein (low protein) throughout pregnancy and lactation. 

Phrase: "Pregnant rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "fed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0342895:FED [Disease or Syndrome]
   966 E C0204695:Feed [Health Care Activity]
   966 E C2987508:Feed [Activity]

Phrase: "a diet"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0012155:Diet [Food]
  1000   C1442959:Diet [Organism Function]
  1000   C1519433:DIET [Therapeutic or Preventive Procedure]
  1000   C2983588:DIET [Food]
   928 E C2699635:DIETARY [Functional Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "20% protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "or"

Phrase: "an isocaloric diet"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0012155:Diet [Food]
   861   C1442959:Diet [Organism Function]
   861   C1519433:DIET [Therapeutic or Preventive Procedure]
   861   C2983588:DIET [Food]
   789 E C2699635:DIETARY [Functional Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "8% protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(low protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0242972:low protein [Therapeutic or Preventive Procedure]
  1000   C0748025:low protein [Finding]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0205251:low [Qualitative Concept]
   861   C1299352:Low [Qualitative Concept]
   861   C1550472:low [Idea or Concept]

Phrase: ")"

Phrase: "throughout pregnancy"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0032961:Pregnancy [Organism Function]
  1000   C3484365:Pregnancy [Clinical Attribute]
   928 E C0549206:Pregnant [Finding]
   928 E C0553641:Pregnant [Functional Concept]
   928 E C0600457:PREGNANT [Finding]
   916 E C0552112:Pregnancies [Clinical Attribute]

Phrase: "and"

Phrase: "lactation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006147:Lactation [Organism Function]
  1000   C0022925:Lactation [Organ or Tissue Function]
Processing 00000000.tx.42: The composition and source of the diets are described in detail in Table 1. 

Phrase: "The composition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0486616:Composition [Clinical Attribute]
  1000   C1555710:composition [Idea or Concept]

Phrase: "and"

Phrase: "source of the diets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0449416:Source [Finding]
   770   C1705919:Source [Idea or Concept]

Phrase: "are"

Phrase: "described in detail"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1522508:Detail [Qualitative Concept]
   790   C1552738:described [Idea or Concept]
   790   C1561567:detail [Functional Concept]

Phrase: "in Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.43: There were no differences in litter size or sex ratio between the control and protein-restricted groups. 

Phrase: "There"

Phrase: "were"

Phrase: "no differences in litter size"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1268722:Difference in size [Finding]
           differences size
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "or"

Phrase: "sex ratio between the control"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0036893:Sex Ratio [Quantitative Concept]
   760   C0009253:Sex [Organism Function]
   760   C0036864:Sex [Behavior]
   760   C0079399:sex [Organism Attribute]
   760   C0456603:Ratio [Quantitative Concept]
   760   C1314687:Sex [Finding]
   760   C1522384:sex [Organism Attribute]
   760   C1547037:Ratio [Intellectual Product]

Phrase: "and"

Phrase: "protein-restricted groups."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1552839:groups [Idea or Concept]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
Processing 00000000.tx.44: Litters from four control and four protein-restricted dams were followed in this study. 

Phrase: "Litters from four control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1299950:Litter [Manufactured Object]

Phrase: "and"

Phrase: "four protein-restricted dams"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2239937:DAMS [Gene or Genome]

Phrase: "were"

Phrase: "followed in this study."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0332283:followed [Temporal Concept]
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
   737 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.45: At 3 days of age, litters were randomly reduced to eight pups, thus ensuring a standard litter size per dam. 

Phrase: "At 3 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442459:3 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "of age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "litters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1299950:Litter [Manufactured Object]

Phrase: "were"

Phrase: "randomly"

Phrase: "reduced to eight pups,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205454:Eight [Quantitative Concept]
   770   C0392756:Reduced [Qualitative Concept]

Phrase: "thus"

Phrase: "ensuring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0218063:Ensure [Food]

Phrase: "a standard litter size per dam."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0023881:Litter Size [Quantitative Concept]
   753   C0456389:size [Spatial Concept]
Processing 00000000.tx.46: At 21 days of age, all pups were weaned onto a 20% protein diet. 

Phrase: "At 21 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "of age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "all pups"

Phrase: "were"

Phrase: "weaned onto a 20% protein diet."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0452269:Protein diet [Therapeutic or Preventive Procedure]
   783   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   753   C0012155:Diet [Food]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0043084:weaned [Organism Function]
   753   C1442959:Diet [Organism Function]
   753   C1519433:DIET [Therapeutic or Preventive Procedure]
   753   C2983588:DIET [Food]
   748 E C0012177:Dietary Protein [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.47: For simplicity, the two groups of offspring will be termed control and MPR rats. 

Phrase: "For simplicity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0205352:Simple [Qualitative Concept]

Phrase: "the two groups of offspring"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1552839:groups [Idea or Concept]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "will"

Phrase: "be"

Phrase: "termed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1515273:Term [Temporal Concept]
   966   C1705313:Term [Idea or Concept]
   966   C2826302:TERM [Intellectual Product]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "MPR rats."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]
Processing 00000000.tx.48: For consistency, only male offspring were used for the study because early-life programming is known to occur in a sexually dimorphic manner (41), which was not the focus of this study. 

Phrase: "For consistency,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332529:Consistency [Qualitative Concept]
  1000   C1547017:Consistency [Quantitative Concept]
   928 E C0332290:Consistent [Idea or Concept]

Phrase: "only male offspring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0680063:Offspring [Family Group]

Phrase: "were"

Phrase: "used for the study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "because"

Phrase: "early-life programming"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "occur in a sexually dimorphic manner"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0036864:Sexually [Behavior]
   753   C0205220:Dimorphic [Spatial Concept]
   753   C1709305:Occur [Activity]
   753   C2745955:OCCUR [Temporal Concept]

Phrase: "(41"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the focus of this study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205234:Focus [Spatial Concept]
   760   C1285542:focus [Functional Concept]
Processing 00000000.tx.49: At 130 days of age, male offspring were killed and their visceral fat pads (composed of mesenteric, omental, and retroperitoneal fat masses) isolated, weighed, frozen on dry ice, and stored at 80C until use. 

Phrase: "At 130 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "of age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "male offspring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0680063:Offspring [Family Group]

Phrase: "were"

Phrase: "killed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:killed [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]

Phrase: "and"

Phrase: "their visceral fat pads"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0154270:fat pads [Finding]
   901   C0935625:Fat pads [Tissue]
   827   C0182158:Pads [Medical Device]
   827   C0332568:Pad [Neoplastic Process]
   827   C1706529:Pads [Biomedical or Dental Material]
   827   C3540603:PAD [Gene or Genome]
   734   C1563740:Visceral Fat [Tissue]

Phrase: "("

Phrase: "composed of mesenteric, omental,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0025474:Mesenteric [Body Location or Region]
   770   C0028977:Omental [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "retroperitoneal fat masses"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   896   C0267771:Retroperitoneal mass [Disease or Syndrome]
   793   C0577559:Mass [Finding]
   793   C1306372:*Mass [Quantitative Concept]
   793   C3152252:Mass [Quantitative Concept]
   734   C0738677:Retroperitoneal Fat [Tissue]

Phrase: ")"

Phrase: "isolated,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   928 E C0204727:Isolation [Therapeutic or Preventive Procedure]
   928 E C0220862:isolation [Laboratory Procedure]

Phrase: "weighed"

Phrase: ","

Phrase: "frozen on dry ice,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0013239:Dry Ice [Inorganic Chemical]
   770   C0011682:Dry [Natural Phenomenon or Process]
   770   C0016701:Frozen [Natural Phenomenon or Process]
   770   C0020746:Ice [Inorganic Chemical]
   770   C0205222:Dry [Qualitative Concept]
   770   C0677542:Frozen [Functional Concept]
   770   C1512080:Dry [Qualitative Concept]

Phrase: "and"

Phrase: "stored at 80C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1698986:Store [Functional Concept]

Phrase: "until use."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]
Processing 00000000.tx.50: This age was chosen because these animals were monitored for a separate study, after weaning, for their status of insulin homeostasis and found to exhibit insulin resistance for the first time (data not shown). 

Phrase: "This age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "was"

Phrase: "chosen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Chosen [Activity]

Phrase: "because"

Phrase: "these animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "monitored for a separate study,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   781   C1521743:Study Monitor [Professional or Occupational Group]
           Monitor
   760   C0443299:Separate [Spatial Concept]
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]
   726   C0030695:monitor [Health Care Activity]
   726   C0150369:monitor [Health Care Activity]
   726   C0181904:Monitor [Medical Device]
   726   C0596972:Monitor [Medical Device]
   726   C1704646:Monitor [Manufactured Object]

Phrase: "after"

Phrase: "weaning,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043084:Weaning [Organism Function]

Phrase: "for their status"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449438:Status [Qualitative Concept]

Phrase: "of insulin homeostasis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019868:Homeostasis [Biologic Function]

Phrase: "and"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "insulin resistance for the first time"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0021655:Insulin Resistance [Pathologic Function]
   790   C2700570:INSULIN RESISTANCE [Gene or Genome]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0237834:Resistance [Mental Process]
   753   C1514892:Resistance [Physiologic Function]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.51: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.52: Composition of the diets  Histology. 

Phrase: "Composition of the diets  Histology."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0486616:Composition [Clinical Attribute]
   760   C1555710:composition [Idea or Concept]
Processing 00000000.tx.53: Paraffin-embedded sections (5 m) of fat pad from control and MPR rats were stained with Oil red O. 

Phrase: "Paraffin-embedded sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0205155:Section [Spatial Concept]
   793   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   793   C1522472:Section [Substance]
   793   C1552923:Section [Quantitative Concept]
   793   C1705191:Section [Physical Object]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "m) of fat pad"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0154270:fat pad [Finding]
   833   C0935625:Fat pad [Tissue]
   770   C0182158:pad [Medical Device]
   770   C0332568:Pad [Neoplastic Process]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0424612:FAT [Organism Attribute]
   770   C0441923:M+ [Intellectual Product]
   770   C3540603:PAD [Gene or Genome]

Phrase: "from control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "MPR rats"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]

Phrase: "were"

Phrase: "stained with Oil red O."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   883   C0069388:Oil red O stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           oil red O
   883   C1294000:Oil red-O stain [Laboratory Procedure]
   760   C0028908:Oil [Lipid]
   760   C0332575:Red [Finding]
   760   C1260956:Red [Qualitative Concept]
   760   C1517288:Oil [Food,Lipid]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   704 E C0996956:Olea [Plant]
Processing 00000000.tx.54: Sections were examined under a standard microscope, and the photomicrographs were captured at x20 magnification. 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "examined under a standard microscope,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0181839:Microscope [Medical Device]
   760   C0332128:Examined [Finding]
   760   C1442989:Standard [Qualitative Concept]
   760   C1706379:Microscope [Medical Device]
   760   C2828392:Standard [Intellectual Product]

Phrase: "and"

Phrase: "the photomicrographs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   893   C0031753:Photomicrographies [Laboratory Procedure]

Phrase: "were"

Phrase: "captured at x20 magnification."
Processing 00000000.tx.55: RNA extraction. 

Phrase: "RNA extraction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0185115:Extraction [Therapeutic or Preventive Procedure]
   861   C0684295:extraction [Laboratory Procedure]
Processing 00000000.tx.56: Total RNA was extracted from homogenized adipose tissues with TRIzol (Invitrogen Life Technologies, Burlington, ON, Canada) and subsequently purified by RNeasy Mini Kit (Qiagen, Mississauga, ON, Canada) coupled with on-column DNase digestion with the RNase-Free DNase Set (Qiagen) according to the manufacturer's instructions. 

Phrase: "Total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "extracted from homogenized adipose tissues"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0001527:Adipose tissues [Tissue]
   760   C0040300:Tissues [Tissue]
   760   C0185115:Extracted [Therapeutic or Preventive Procedure]
   760   C3541890:EXTRACTED [Finding]
   726 E C1547928:Tissue [Intellectual Product]
   726 E C2828366:Extract [Substance]

Phrase: "with TRIzol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0916178:trizol [Organic Chemical]

Phrase: "(Invitrogen Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0039421:technologies [Occupation or Discipline]

Phrase: "Burlington,"

Phrase: "ON,"

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "subsequently"

Phrase: "purified by RNeasy Mini Kit (Qiagen,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0445542:Mini [Organism Attribute]
   753   C0812225:KIT [Medical Device]
   753   C1150635:KIT [Molecular Function]
   753   C1705212:Kit [Medical Device]
   753   C1705213:KIT [Medical Device]
   753   C1998793:Purified [Functional Concept]
   753   C3273202:Kit [Manufactured Object]

Phrase: "Mississauga,"

Phrase: "ON,"

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")"

Phrase: "coupled with on-column DNase digestion"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0011519:DNase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0011522:DNAase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   753   C0012238:Digestion [Organism Function]
   753   C1185738:Column [Body Part, Organ, or Organ Component]
   753   C1706132:Column [Idea or Concept]
   753   C1948027:Coupled [Functional Concept]
   753   C2349986:Digestion [Research Activity]
   719 E C0010222:couple [Family Group]

Phrase: "with the RNase-Free DNase Set (Qiagen"

Phrase: ")"

Phrase: "according to the manufacturer's instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.57: DNA microarray and data analysis. 

Phrase: "DNA microarray"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0600596:DNA Microarray [Research Device]
  1000   C1522053:DNA Microarray [Molecular Biology Research Technique]
   861   C1709016:Microarray [Manufactured Object]

Phrase: "and"

Phrase: "data analysis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0010992:Data Analysis [Occupational Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1511726:Data [Idea or Concept]
   861   C1524024:analysis [Functional Concept]
   861   C3245479:data [Medical Device]
Processing 00000000.tx.58: A total of four arrays (Affymetrix Rat Expression Array RAE230A; Affymetrix, Santa Clara, CA) were conducted using total RNA samples from two control and two MPR rats. 

Phrase: "A total of four arrays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]

Phrase: "(Affymetrix Rat Expression Array RAE230A"

Phrase: "; Affymetrix,"

Phrase: "Santa Clara,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551532:Santa Clara [Population Group]

Phrase: "CA)"

Phrase: "were"

Phrase: "conducted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0004927:Conduct [Individual Behavior]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "total RNA samples from two control"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0370003:Sample [Substance]
   719   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "two MPR rats."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3161035:Model [Intellectual Product]
Processing 00000000.tx.59: Microarrays were performed at the London Regional Genomics Centre (London, ON, Canada) following the standard procedures as outlined in the Affymetrix GeneChip Expression Analysis Technical Manual. 

Phrase: "Microarrays"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1709016:Microarray [Manufactured Object]

Phrase: "were"

Phrase: "performed at the London Regional Genomics Centre"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   774   C0558281:Regional center [Manufactured Object]
   748   C0023973:London [Geographic Area]
   748   C0205099:Center [Spatial Concept]
   748   C0205147:regional [Spatial Concept]
   748   C0205276:Regional [Spatial Concept]
   748   C0884358:Performed [Functional Concept]
   748   C0887950:Genomics [Biomedical Occupation or Discipline]
   748   C1947913:Regional [Spatial Concept]
   714 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(London,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023973:London [Geographic Area]

Phrase: "ON,"

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the standard procedures"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0025664:procedures [Intellectual Product]
   861   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C2700391:procedures [Activity]
   827 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   827 E C3274430:PROCEDURE [Health Care Activity]
   827 E C3538935:Procedure [Idea or Concept]
   827 E C3539779:Procedure [Intellectual Product]

Phrase: "as"

Phrase: "outlined in the Affymetrix GeneChip Expression Analysis Technical Manual."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   762   C0441544:Manual expression [Therapeutic or Preventive Procedure]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0024763:Manual [Intellectual Product,Manufactured Object]
   742   C0175674:Manual [Functional Concept]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   742   C0449851:Technical [Functional Concept]
   742   C0872345:Gene Chip [Medical Device,Research Device]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]
   742   C1955272:Genechip [Manufactured Object]
Processing 00000000.tx.60: The complete data set was submitted to the National Center for Biotechnology Information's Gene Expression Omnibus (GEO; 

Phrase: "The complete data set"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0150098:Data Set [Intellectual Product]
   901   C1706233:Dataset [Intellectual Product]
   827   C0036849:Set [Mental Process]
   827   C1442518:Set [Functional Concept]
   827   C1511726:Data [Idea or Concept]
   827   C1705195:Set [Conceptual Entity]
   827   C3245479:data [Medical Device]

Phrase: "was"

Phrase: "submitted to the National Center for Biotechnology Information's Gene Expression Omnibus"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   820   C1705803:National Center for Biotechnology Information [Organization]
   756   C0017262:Gene Expression [Genetic Function]
   754   C0021415:center information [Manufactured Object,Organization]
   738   C0005574:Biotechnology [Biomedical Occupation or Discipline]
   738   C0017337:Gene [Gene or Genome]
   738   C0185117:Expression [Therapeutic or Preventive Procedure]
   738   C0205099:Center [Spatial Concept]
   738   C1515023:Submitted [Functional Concept]
   738   C1533716:Information [Idea or Concept]
   738   C3245503:national [Intellectual Product]

Phrase: "(GEO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017454:GEO [Geographic Area]

Phrase: ";"
Processing 00000000.tx.61: http://www.ncbi.nlm.nih.gov/geo/) database (acc. no. GSE1813 [NCBI GEO] ). 

Phrase: "http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//www.ncbi.nlm.nih.gov/geo/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0017454:GEO [Geographic Area]

Phrase: ")"

Phrase: "database"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242356:Database [Intellectual Product]
  1000   C0993637:Data Base [Intellectual Product]

Phrase: "(acc."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0175754:ACC [Congenital Abnormality,Disease or Syndrome]
  1000   C0282160:ACC [Congenital Abnormality]
  1000   C3541413:ACC [Gene or Genome]

Phrase: "no. GSE1813"

Phrase: "[NCBI GEO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017454:GEO [Geographic Area]

Phrase: "]"

Phrase: ")."
Processing 00000000.tx.62: Expression values for the Affymetrix GeneChip data were globally normalized to a preset value and analyzed using GeneSpring version 5.0 software (Silicon Genetics, Redwood City, CA). 

Phrase: "Expression values for the Affymetrix GeneChip data"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   757   C1704610:Data Value [Intellectual Product]
   748   C0042295:Values [Qualitative Concept]
   714 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "globally"

Phrase: "normalized to a preset value"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1522609:Value [Quantitative Concept]
   760   C1882115:Normalized [Research Activity]

Phrase: "and"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "GeneSpring version 5.0 software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(Silicon Genetics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017398:Genetics [Biomedical Occupation or Discipline]
   861   C0017399:genetics [Biologic Function]

Phrase: "Redwood City,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0008848:City [Geographic Area]
   861   C1002377:Redwood [Plant]
   861   C3262831:City [Clinical Attribute]

Phrase: "CA)."
Processing 00000000.tx.63: Values for the mean expression level for each gene were calculated for the control and MPR microarray data sets. 

Phrase: "Values for the mean expression level"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0042295:Values [Qualitative Concept]
   719 E C1522609:Value [Quantitative Concept]

Phrase: "for each gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "were"

Phrase: "calculated for the control"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0243148:control [Qualitative Concept]
   770   C0444686:Calculated [Functional Concept]
   770   C1441506:Calculated [Activity]
   770   C1443182:Calculated [Laboratory Procedure]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "MPR microarray data sets."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C3161035:Model [Intellectual Product]
Processing 00000000.tx.64: Candidate genes were selected by a combination of absolute analysis (the absolute call was present on one of the two control arrays and on one of the two MPR arrays for genes considered to exhibit decreased and increased expression, respectively) and comparison analysis (displayed >1.5-fold increase or decrease from the control to MPR animals). 

Phrase: "Candidate genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1332838:Candidate Genes [Gene or Genome]
   861   C0017337:Genes [Gene or Genome]

Phrase: "were"

Phrase: "selected by a combination of absolute analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0205195:Combination [Qualitative Concept]
   748   C0205344:Absolute [Qualitative Concept]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   748   C1947911:Combination [Physical Object]
   714   C1707391:Select [Activity]

Phrase: "("

Phrase: "the absolute call"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0679006:Call [Mental Process]
   861   C1292769:c-ALL [Neoplastic Process]
   861   C1947967:Call [Functional Concept]

Phrase: "was"

Phrase: "present on one of the two control arrays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0150312:Present [Quantitative Concept]
   744   C0449450:Present [Idea or Concept]

Phrase: "and on one of the two MPR arrays"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   751   C1136346:Protein Arrays [Medical Device,Research Device]
   736   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0205447:One [Quantitative Concept]
   736   C0205448:Two [Quantitative Concept]
   736   C0443288:Restriction [Functional Concept]
   736   C1515981:And [Idea or Concept]
   736   C2347083:Maternal [Family Group]
   736   C3161035:Model [Intellectual Product]
   703   C1510941:Array [Spatial Concept]

Phrase: "for genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "increased expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "respectively"

Phrase: ")"

Phrase: "and"

Phrase: "comparison analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "("

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: ">1.5-fold increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0442805:Increase [Functional Concept]

Phrase: "or"

Phrase: "decrease from the control"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]

Phrase: "to MPR animals"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   813   C0440447:protein animal [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0003062:Animals [Animal]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0443288:Restriction [Functional Concept]
   795   C1883351:To [Qualitative Concept]
   795   C2347083:Maternal [Family Group]
   795   C3161035:Model [Intellectual Product]
   740 E C0026591:Mother [Family Group]
   712 E C1826438:MATER [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.65: A total of 15,923 data sets were sorted according to the following stringent criteria. 

Phrase: "A total of 15,923 data sets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439175:% total [Quantitative Concept]
   748   C0439810:Total [Qualitative Concept]

Phrase: "were"

Phrase: "sorted according to the following stringent criteria."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0237886:sorted [Mental Process]
   748   C0243161:criteria [Intellectual Product]
   748   C0680240:according [Social Behavior]
   748   C0700314:sorted [Cell Function]
   748   C1947906:Sorted [Activity]
   714   C0332283:follow [Temporal Concept]
   714   C1719822:Follow [Intellectual Product]
Processing 00000000.tx.66: To reduce false positives, data sets were excluded if 1) the raw values displayed >10-fold difference between the two data sets in either group (17 datasets were excluded); 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reduce"

Phrase: "false positives,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0205557:false positives [Laboratory or Test Result]
   861   C0205237:False [Qualitative Concept]
   827   C0439178:% Positive [Quantitative Concept]
   827   C1446409:Positive [Qualitative Concept]
   827   C1514241:Positive [Finding]
   827   C2825490:Positive [Qualitative Concept]

Phrase: "data sets"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0150098:data sets [Intellectual Product]
   861   C0036849:Set [Mental Process]
   861   C1442518:Set [Functional Concept]
   861   C1511726:Data [Idea or Concept]
   861   C1705195:Set [Conceptual Entity]
   861   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "excluded"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]

Phrase: "if 1)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0750557:If [Qualitative Concept]

Phrase: "the raw values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: ">10-fold difference between the two data sets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1705241:*Difference [Quantitative Concept]
   744   C1705242:Difference [Qualitative Concept]

Phrase: "in either group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "(17 datasets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0150098:Dataset [Intellectual Product]
   827   C1706233:Dataset [Intellectual Product]

Phrase: "were"

Phrase: "excluded"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.67: 2) one of the raw values in the two MPR datasets was less than the mean raw value of the two control data sets for genes exhibiting increased expression (15 data sets were excluded); 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "one of the raw values"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "in the two MPR datasets"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   791   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0150312:In [Quantitative Concept]
   791   C0205448:Two [Quantitative Concept]
   791   C0332285:In [Spatial Concept]
   791   C0443288:Restriction [Functional Concept]
   791   C2347083:Maternal [Family Group]
   791   C3161035:Model [Intellectual Product]
   758   C0150098:Dataset [Intellectual Product]
   758   C1706233:Dataset [Intellectual Product]
   735 E C0026591:Mother [Family Group]
   708 E C1826438:MATER [Gene or Genome]

Phrase: "was"

Phrase: "less than the mean raw value of the two control data sets"
Meta Candidates (Total=22; Excluded=0; Pruned=0; Remaining=22)
   753   C0150098:data sets [Intellectual Product]
   753   C0439092:Less Than [Intellectual Product]
           less
   751   C1704610:Data Value [Intellectual Product]
   736   C0001884:R AW [Organ or Tissue Function]
   736   C0036849:Set [Mental Process]
   736   C0205448:Two [Quantitative Concept]
   736   C0243148:control [Qualitative Concept]
   736   C0444504:Mean [Quantitative Concept]
   736   C0547044:Less [Qualitative Concept]
   736   C1442518:Set [Functional Concept]
   736   C1511726:Data [Idea or Concept]
   736   C1522609:Value [Quantitative Concept]
   736   C1550141:Control [Substance]
   736   C1705195:Set [Conceptual Entity]
   736   C1709843:Raw [Qualitative Concept]
   736   C1882979:Control [Conceptual Entity]
   736   C2347634:Mean [Quantitative Concept]
   736   C2348143:Mean [Quantitative Concept]
   736   C2587213:Control [Functional Concept]
   736   C3245479:data [Medical Device]
   736   C3274648:Control [Qualitative Concept]

Phrase: "for genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "exhibiting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:exhibiting [Intellectual Product]

Phrase: "increased expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(15 data sets"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0150098:data sets [Intellectual Product]
   827   C0036849:Set [Mental Process]
   827   C1442518:Set [Functional Concept]
   827   C1511726:Data [Idea or Concept]
   827   C1705195:Set [Conceptual Entity]
   827   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "excluded"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.68: and 3) one of the raw values in the two control data sets was less than the mean raw value of the MPR data sets for genes exhibiting decreased expression (14 data sets were excluded). 

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "one of the raw values"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "in the two control data sets"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0150098:data sets [Intellectual Product]
   812   C0036849:Set [Mental Process]
   812   C1442518:Set [Functional Concept]
   812   C1511726:Data [Idea or Concept]
   812   C1705195:Set [Conceptual Entity]
   812   C3245479:data [Medical Device]

Phrase: "was"

Phrase: "less than the mean raw value"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0439092:Less Than [Intellectual Product]
           less
   753   C0001884:R AW [Organ or Tissue Function]
   753   C0444504:Mean [Quantitative Concept]
   753   C0547044:Less [Qualitative Concept]
   753   C1522609:Value [Quantitative Concept]
   753   C1709843:Raw [Qualitative Concept]
   753   C2347634:Mean [Quantitative Concept]
   753   C2348143:Mean [Quantitative Concept]

Phrase: "of the MPR data sets"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   829   C1137947:Protein SET [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   807   C0150098:data sets [Intellectual Product]
   791   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0036849:Set [Mental Process]
   791   C0332285:Of [Spatial Concept]
   791   C0443288:Restriction [Functional Concept]
   791   C1442518:Set [Functional Concept]
   791   C1511726:Data [Idea or Concept]
   791   C1705195:Set [Conceptual Entity]
   791   C2347083:Maternal [Family Group]
   791   C3161035:Model [Intellectual Product]
   791   C3245479:data [Medical Device]
   735 E C0026591:Mother [Family Group]
   708 E C1826438:MATER [Gene or Genome]

Phrase: "for genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "exhibiting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:exhibiting [Intellectual Product]

Phrase: "decreased expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(14 data sets"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0150098:data sets [Intellectual Product]
   827   C0036849:Set [Mental Process]
   827   C1442518:Set [Functional Concept]
   827   C1511726:Data [Idea or Concept]
   827   C1705195:Set [Conceptual Entity]
   827   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "excluded"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]

Phrase: ")."
Processing 00000000.tx.69: This resulted in 650 genes being identified as differentially expressed in MPR offspring compared with the controls. 

Phrase: "This"

Phrase: "resulted in 650 genes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0017337:Genes [Gene or Genome]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "being"

Phrase: "identified as differentially"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]

Phrase: "expressed in MPR offspring"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0443288:Restriction [Functional Concept]
   744   C0680063:Offspring [Family Group]
   744   C2347083:Maternal [Family Group]
   744   C3161035:Model [Intellectual Product]

Phrase: "compared with the controls."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1707455:Compared [Activity]
   737   C0243148:control [Qualitative Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.70: Real-time quantitative RT-PCR. 

Phrase: "Real-time quantitative RT-PCR."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   911   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   884   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   840   C0599161:RT-PCR [Molecular Biology Research Technique]
   840   C1550177:Real Time [Idea or Concept]
   804   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   804   C0040223:Time [Temporal Concept]
   804   C0237400:Real [Qualitative Concept]
   804   C0392762:Quantitative [Quantitative Concept]
   804   C0677874:pCR [Finding]
   804   C3272377:REAL [Intellectual Product]
   804   C3541383:Time [Temporal Concept]
   748 E C0442043:Temporal [Spatial Concept]
   748 E C2362314:Temporal [Temporal Concept]
   721 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.71: Real-time quantitative RT-PCR (qRT-PCR) was used to study the expression of seven representative genes identified as differentially expressed (displayed variable degrees of change ranging from 4.7- to +3.3-fold) by the DNA microarray. 

Phrase: "Real-time quantitative RT-PCR (qRT-PCR)"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   911   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   884   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   840   C0599161:RT-PCR [Molecular Biology Research Technique]
   840   C1550177:Real Time [Idea or Concept]
   804   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   804   C0040223:Time [Temporal Concept]
   804   C0237400:Real [Qualitative Concept]
   804   C0392762:Quantitative [Quantitative Concept]
   804   C0677874:pCR [Finding]
   804   C3272377:REAL [Intellectual Product]
   804   C3541383:Time [Temporal Concept]
   748 E C0442043:Temporal [Spatial Concept]
   748 E C2362314:Temporal [Temporal Concept]
   721 E C1632851:Times [Quantitative Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the expression of seven representative genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0017262:Gene Expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "as"

Phrase: "differentially"

Phrase: "expressed"

Phrase: "(displayed variable degrees of change ranging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0449286:degrees [Quantitative Concept]
   753   C0542560:degrees [Intellectual Product]
   719 E C0441889:Degree [Qualitative Concept]
   719 E C1561545:degree [Quantitative Concept]
   719 E C2348088:Degree [Quantitative Concept]

Phrase: "from 4.7- to +3.3-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0332462:Fold [Spatial Concept]
   799   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: "by the DNA microarray."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0600596:DNA Microarray [Research Device]
  1000   C1522053:DNA Microarray [Molecular Biology Research Technique]
   861   C1709016:Microarray [Manufactured Object]
Processing 00000000.tx.72: In addition, transcript levels of two genes that displayed no change in expression with DNA microarray were also determined. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "transcript levels of two genes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0441889:Levels [Qualitative Concept]
   760   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "that"

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "no change in expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0442739:No change [Finding]
   833   C1548568:No change [Intellectual Product]
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]

Phrase: "with DNA microarray"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0600596:DNA Microarray [Research Device]
  1000   C1522053:DNA Microarray [Molecular Biology Research Technique]
   861   C1709016:Microarray [Manufactured Object]

Phrase: "were"

Phrase: "also"

Phrase: "determined."
Processing 00000000.tx.73: Another important consideration for choosing these genes for qRT-PCR was their established role in adipogenesis, angiogenesis, or obesity. 

Phrase: "Another important consideration for choosing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0518609:consideration [Finding]

Phrase: "these genes for qRT-PCR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017337:Genes [Gene or Genome]

Phrase: "was"

Phrase: "their established role in adipogenesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "angiogenesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0302600:Angiogenesis [Organ or Tissue Function]
  1000   C1519670:angiogenesis [Neoplastic Process]

Phrase: "or"

Phrase: "obesity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]
Processing 00000000.tx.74: qRT-PCR was performed on the same total RNA samples as those used in the DNA microarray study and on additional RNA samples from four control and four MPR rats. 

Phrase: "qRT-PCR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   901   C0599161:RT-PCR [Molecular Biology Research Technique]
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0392762:Quantitative [Quantitative Concept]
   827   C0677874:pCR [Finding]

Phrase: "was"

Phrase: "performed on the same total RNA samples"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0439175:% total [Quantitative Concept]
   748   C0439810:Total [Qualitative Concept]
   748   C0445247:Same [Qualitative Concept]
   748   C0884358:Performed [Functional Concept]
   714   C0370003:Sample [Substance]
   714   C2347026:Sample [Conceptual Entity]
   714 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as those"

Phrase: "used in the DNA microarray study"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   790   C0600596:DNA Microarray [Research Device]
   790   C1522053:DNA Microarray [Molecular Biology Research Technique]
   767   C0869040:study use [Research Activity]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0557651:Study [Manufactured Object]
   753   C1273517:used [Finding]
   753   C1709016:Microarray [Manufactured Object]
   753   C2603343:Study [Research Activity]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "and on additional RNA samples"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C1515981:And [Idea or Concept]
   760   C1524062:Additional [Functional Concept]
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]

Phrase: "from four control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "four MPR rats."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3161035:Model [Intellectual Product]
Processing 00000000.tx.75: Thus a total of six RNA samples per group were subjected to a two-step customer-designed SYBR Green I chemistry-based qRT-PCR, as described previously (71). 

Phrase: "Thus"

Phrase: "a total of six RNA samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]

Phrase: "per group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "subjected"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "to a two-step customer-designed SYBR Green I chemistry-based qRT-PCR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   799   C0599161:RT-PCR [Molecular Biology Research Technique]
   787   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   787   C0392762:Quantitative [Quantitative Concept]
   787   C0677874:pCR [Finding]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(71"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.76: Briefly, 1 g of total RNA was reverse transcribed in a total volume of 20 l with the High Capacity Complementary Deoxyribonucleic Acid (cDNA) Archive Kit (Applied Biosystems), following the manufacturer's instructions. 

Phrase: "Briefly,"

Phrase: "1 g of total RNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   760   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "transcribed in a total volume of 20 l"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0449468:Total Volume [Quantitative Concept]
           *Volume
   744   C0439175:% total [Quantitative Concept]
   744   C0439810:Total [Qualitative Concept]
   744   C1690016:% volume [Qualitative Concept]
   744   C1705102:Volume [Intellectual Product]
   744   C2700258:Volume [Laboratory Procedure]

Phrase: "with the High Capacity Complementary Deoxyribonucleic Acid (cDNA) Archive Kit (Applied Biosystems"

Phrase: ")"

Phrase: ","

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the manufacturer's instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.77: For every RT reaction set, one RNA sample was set up without reverse transcriptase enzyme to provide a negative control. 

Phrase: "For every RT reaction set,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0036849:Set [Mental Process]
   827   C1442518:Set [Functional Concept]
   827   C1705195:Set [Conceptual Entity]

Phrase: "one RNA sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "set up without reverse transcriptase enzyme to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0036849:Set [Mental Process]
   748   C1442518:Set [Functional Concept]
   748   C1705195:Set [Conceptual Entity]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a negative control."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C1639518:% negative control [Quantitative Concept]
  1000   C1947986:Negative Control [Conceptual Entity]
   861   C0205160:Negative [Qualitative Concept]
   861   C0243148:control [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.78: Gene-specific primers (detailed in Table 2) were designed using Primer Express Software (Applied Biosystems, Foster City, CA), and the optimal concentrations for each gene were determined empirically. 

Phrase: "Gene-specific primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "("

Phrase: "detailed in Table 2"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1522508:Detailed [Qualitative Concept]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737 E C1561567:detail [Functional Concept]

Phrase: ")"

Phrase: "were"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "Express"

Phrase: "Software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(Applied Biosystems,"

Phrase: "Foster City,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0008848:City [Geographic Area]
   861   C0242298:foster [Daily or Recreational Activity]
   861   C0344349:foster [Family Group]
   861   C3262831:City [Clinical Attribute]

Phrase: "CA),"

Phrase: "and"

Phrase: "the optimal concentrations for each gene"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "were"

Phrase: "determined"

Phrase: "empirically."
Processing 00000000.tx.79: All primers were purchased from Sigma Genosys (Oakville, ON, Canada). 

Phrase: "All primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "purchased from Sigma Genosys"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0869011:purchased [Activity]
   770   C1719918:Sigma [Intellectual Product]

Phrase: "(Oakville,"

Phrase: "ON,"

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")."
Processing 00000000.tx.80: The SYBR Green I assay was performed with the SYBR Green PCR Master Mix (Applied Biosystems) and a modified universal thermal cycling condition (2 min at 50C and 10 min at 95C, followed by 40 cycles of 10 s each at 95, 60, and 72C) with the standard disassociation/melting parameters (15 s each at 95, 60, and 95C) on the ABI Prism 7900HT Sequence Detection System (Applied Biosystems). 

Phrase: "The SYBR Green I assay"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
   756   C0386577:SYBR Green I [Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "performed with the SYBR Green PCR Master Mix"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   744   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0205430:Mix [Functional Concept]
   744   C0332583:Green [Qualitative Concept]
   744   C0444649:Master [Qualitative Concept]
   744   C0677874:pCR [Finding]
   744   C0884358:Performed [Functional Concept]
   744   C1421951:MIX [Gene or Genome]
   744   C1720722:Mix [Qualitative Concept]
   711 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Applied Biosystems"

Phrase: ")"

Phrase: "and"

Phrase: "a modified universal thermal cycling condition"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   804   C0012634:condition [Disease or Syndrome]
   804   C0348080:Condition [Qualitative Concept]
   804   C1705253:Condition [Conceptual Entity]
   733 E C0009647:Conditioned [Mental Process]
   733 E C1701901:Conditional [Qualitative Concept]
   733 E C1963686:Conditional [Functional Concept]
   704 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(2 min at 50C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "10 min at 95C,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0456692:/10 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "followed by 40 cycles of 10 s"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   778   C0332283:Followed by [Temporal Concept]
           followed
   748   C0439509:/40 [Temporal Concept]
   714   C1511572:Cycle [Temporal Concept]
   714 E C1719822:Follow [Intellectual Product]

Phrase: "each at 95,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1457900:Each [Quantitative Concept]

Phrase: "60,"

Phrase: "and"

Phrase: "72C"

Phrase: ")"

Phrase: "with the standard disassociation/melting parameters"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0449381:Parameters [Finding]
   779 E C0549193:Parameter [Spatial Concept]
   779 E C1704769:Parameter [Conceptual Entity]
   779 E C2350001:Parameter [Quantitative Concept]

Phrase: "(15 s"

Phrase: "each at 95,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1457900:Each [Quantitative Concept]

Phrase: "60,"

Phrase: "and"

Phrase: "95C"

Phrase: ")"

Phrase: "on the ABI Prism 7900HT Sequence Detection System"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C0449913:System [Functional Concept]
   799   C1553451:System [Manufactured Object]
   799   C1704459:System [Medical Device]
   727 E C0205373:Systemic [Functional Concept]

Phrase: "(Applied Biosystems"

Phrase: ")."
Processing 00000000.tx.81: The specificity of the SYBR Green I assay was verified by performing a melting curve analysis and by subsequent sequencing of the PCR products. 

Phrase: "The specificity of the SYBR Green I assay"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0037791:Specificity [Quantitative Concept]
   744   C1511884:Specificity [Quantitative Concept]

Phrase: "was"

Phrase: "verified by performing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1711411:Verified [Functional Concept]
   756   C0884358:Perform [Functional Concept]
   756   C2947996:Perform [Pharmacologic Substance]

Phrase: "a melting curve analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "and by subsequent sequencing of the PCR products."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   744   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0332282:Subsequent [Temporal Concept]
   744   C0677874:pCR [Finding]
   744   C1514468:Products [Entity]
   744   C1515981:And [Idea or Concept]
   744   C1553778:Sequencing [Intellectual Product]
   744   C1561491:Sequencing [Functional Concept]
   711 E C1704444:Product [Quantitative Concept]
Processing 00000000.tx.82: View this table: [in this window] [in a new window]  Table 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.83: Primer sequences for quantitative RT-PCR  Levels of 28S rRNA (housekeeping gene) and target mRNAs in each RNA sample were quantified by the relative standard curve method (Applied Biosystems). 

Phrase: "Primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "sequences for quantitative RT-PCR  Levels of 28S rRNA (housekeeping gene"
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   775   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   756   C0599161:RT-PCR [Molecular Biology Research Technique]
   756   C1334046:House-keeping Gene [Gene or Genome]
   754   C0035899:rRNA Gene [Gene or Genome]
   738   C0004793:Sequence [Nucleotide Sequence]
   738   C0017337:Gene [Gene or Genome]
   738   C0020053:Housekeeping [Occupational Activity]
   738   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   738   C0035701:RRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0162326:Sequence [Nucleotide Sequence]
   738   C0162327:Sequence [Nucleotide Sequence]
   738   C0392762:Quantitative [Quantitative Concept]
   738   C0441889:Levels [Qualitative Concept]
   738   C0677874:pCR [Finding]
   738   C1519249:Sequence [Functional Concept]
   738   C1552142:28s [Body Part, Organ, or Organ Component]
   704 E C0456079:Level [Classification]
   704 E C1547707:Level [Geographic Area]
   704 E C2946261:Level [Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "target mRNAs in each RNA sample"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "quantified by the relative standard curve method"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   748   C0025663:Method [Intellectual Product]
   748   C0080103:Relative [Family Group]
   748   C0205134:Curve [Spatial Concept]
   748   C0205345:Relative [Qualitative Concept]
   748   C0449851:Method [Functional Concept]
   748   C0871511:METHOD [Intellectual Product]
   748   C1442989:Standard [Qualitative Concept]
   748   C1547039:*Relative [Quantitative Concept]
   748   C2828392:Standard [Intellectual Product]
   714   C1709793:Quantify [Quantitative Concept]

Phrase: "(Applied Biosystems"

Phrase: ")."
Processing 00000000.tx.84: Briefly, standard curves for 28S rRNA and each target gene were generated by performing a dilution series of a mixed cDNA pool. 

Phrase: "Briefly,"

Phrase: "standard curves for 28S rRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0205134:Curve [Spatial Concept]

Phrase: "and"

Phrase: "each target gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1332838:Target Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "were"

Phrase: "generated by performing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C3146294:Generated [Activity]
   756   C0884358:Perform [Functional Concept]
   756   C2947996:Perform [Pharmacologic Substance]

Phrase: "a dilution series of a mixed cDNA pool."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0205549:Series [Quantitative Concept]
   738   C2348044:Series [Intellectual Product]
Processing 00000000.tx.85: For each RNA sample, the amount of target mRNA relative to that of 28S rRNA was obtained. 

Phrase: "For each RNA sample,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "the amount of target mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "relative to that of 28S rRNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: "was"

Phrase: "obtained."
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]
Processing 00000000.tx.86: For each target gene, fold changes in the MPR group compared with the control were then calculated and expressed as means  SE. 

Phrase: "For each target gene,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1332838:Target Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332462:Fold [Spatial Concept]
  1000   C1880834:FOLD [Phenomenon or Process]

Phrase: "changes in the MPR group"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0392747:Change [Functional Concept]
   742   C0441833:Group [Idea or Concept]
   742   C0443172:change [Quantitative Concept]
   742   C0443288:Restriction [Functional Concept]
   742   C0687744:group [Population Group]
   742   C1257890:Group [Population Group]
   742   C1552516:Group [Health Care Related Organization]
   742   C1705241:Change [Quantitative Concept]
   742   C1705428:Group [Conceptual Entity]
   742   C1705429:Group [Population Group]
   742   C2347083:Maternal [Family Group]
   742   C3161035:Model [Intellectual Product]

Phrase: "compared with the control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "and"

Phrase: "expressed as means  SE."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1704970:Means [Conceptual Entity]
   737 E C0444504:Mean [Quantitative Concept]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.87: Data were analyzed by a standard t-test, and significance was set at P < 0.05. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "analyzed by a standard t-test,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0022885:Test [Laboratory Procedure]
   753   C0039593:Test [Functional Concept]
   753   C0392366:test [Intellectual Product]
   753   C0936012:Analyzed [Research Activity]
   753   C1442989:Standard [Qualitative Concept]
   753   C2828392:Standard [Intellectual Product]

Phrase: "and"

Phrase: "significance"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0237881:Significance [Quantitative Concept]
  1000   C0750502:Significance [Idea or Concept]
   928 E C1546944:Significant [Qualitative Concept]

Phrase: "was"

Phrase: "set at P < 0.05."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0036849:Set [Mental Process]
   760   C1442518:Set [Functional Concept]
   760   C1705195:Set [Conceptual Entity]
Processing 00000000.tx.88: All calculations were performed using SPSS software version 9.0 (Chicago, IL).  

Phrase: "All calculations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1441506:Calculation [Activity]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "SPSS software version 9.0"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0037585:Software [Intellectual Product,Manufactured Object]
   804   C0333052:Version [Functional Concept]
   804   C2607870:Version [Spatial Concept]

Phrase: "(Chicago,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008044:Chicago [Geographic Area]

Phrase: "IL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: ")."
Processing 00000000.tx.89: RESULTS TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION GRANTS REFERENCES  MPR leads to growth restriction and visceral adiposity. 

Phrase: "RESULTS TOP ABSTRACT MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION GRANTS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0018173:Grants [Quantitative Concept]
   779 E C1548284:Grant [Idea or Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "MPR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]

Phrase: "leads to growth restriction"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0018270:'growth' NOS [Organism Function]
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0181586:leads [Medical Device]
   770   C0220844:growth [Physiologic Function]
   770   C0443288:Restriction [Functional Concept]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C1621966:Growth [Organ or Tissue Function]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C2911660:Growth [Activity]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "visceral adiposity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0028754:Adiposity [Disease or Syndrome]
   861   C1563743:adiposity [Organism Attribute]
Processing 00000000.tx.90: The male offspring of dams fed a low-protein (8%) diet were significantly smaller at birth than offspring of control dams fed a diet containing 20% protein (5.01  0.15 vs. 6.40  0.15 g, P < 0.01). 

Phrase: "The male offspring of dams"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680063:Offspring [Family Group]

Phrase: "fed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0342895:FED [Disease or Syndrome]
   966 E C0204695:Feed [Health Care Activity]
   966 E C2987508:Feed [Activity]

Phrase: "a low-protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0242972:low protein [Therapeutic or Preventive Procedure]
  1000   C0748025:low protein [Finding]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0205251:low [Qualitative Concept]
   861   C1299352:Low [Qualitative Concept]
   861   C1550472:low [Idea or Concept]

Phrase: "(8%"

Phrase: ")"

Phrase: "diet"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0012155:Diet [Food]
  1000   C1442959:Diet [Organism Function]
  1000   C1519433:DIET [Therapeutic or Preventive Procedure]
  1000   C2983588:DIET [Food]
   928 E C2699635:DIETARY [Functional Concept]

Phrase: "were"

Phrase: "significantly smaller at birth"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0547044:Smaller [Qualitative Concept]
   770   C0700321:Smaller [Quantitative Concept]

Phrase: "than offspring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680063:Offspring [Family Group]

Phrase: "of control dams"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2239937:DAMS [Gene or Genome]

Phrase: "fed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0342895:FED [Disease or Syndrome]
   966 E C0204695:Feed [Health Care Activity]
   966 E C2987508:Feed [Activity]

Phrase: "a diet"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0012155:Diet [Food]
  1000   C1442959:Diet [Organism Function]
  1000   C1519433:DIET [Therapeutic or Preventive Procedure]
  1000   C2983588:DIET [Food]
   928 E C2699635:DIETARY [Functional Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "20% protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(5.01  0.15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439084:>5 [Quantitative Concept]
   812   C0728893:+5 [Quantitative Concept]

Phrase: "vs. 6.40  0.15 g,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C1955160:40 g [Quantitative Concept]
   804   C0439267:g% [Quantitative Concept]

Phrase: "P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.91: At 130 days of age, the mean body weight of MPR male offspring was slightly lower than that of the controls, but the weight of visceral fat mass as well as the ratio of visceral fat to body weight were significantly higher (Fig. 1), indicative of visceral adiposity. 

Phrase: "At 130 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "of age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "the mean body weight of MPR male offspring"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   753   C0005910:Body Weight [Organism Attribute]
           weight
   753   C1305866:body weight [Diagnostic Procedure]
           weight
   751   C1180279:Male body [Fully Formed Anatomical Structure]
   751   C1325683:protein body [Cell Component]
   736   C0043100:Weight [Quantitative Concept]
   736   C0242821:body [Human]
   736   C0444504:Mean [Quantitative Concept]
   736   C0460148:Body [Anatomical Structure]
   736   C1268086:Body [Anatomical Structure]
   736   C1705104:Weight [Idea or Concept]
   736   C2347634:Mean [Quantitative Concept]
   736   C2348143:Mean [Quantitative Concept]

Phrase: "was"

Phrase: "slightly lower than that of the controls,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0441994:Lower [Spatial Concept]
   748   C1548802:Lower [Body Location or Region]
   748   C2003888:Lower [Activity]

Phrase: "but"

Phrase: "the weight of visceral fat mass"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0005910:weight [Organism Attribute]
   753   C0043100:Weight [Quantitative Concept]
   753   C1305866:weight [Diagnostic Procedure]
   753   C1705104:Weight [Idea or Concept]

Phrase: "as well as"

Phrase: "the ratio of visceral fat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: "to body weight"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0005910:Body Weight [Organism Attribute]
           weight
  1000   C1305866:body weight [Diagnostic Procedure]
           weight
   861   C0043100:Weight [Quantitative Concept]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   861   C1705104:Weight [Idea or Concept]
   777 E C1995017:Bodies [Cell Component]

Phrase: "were"

Phrase: "significantly higher"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0205250:High [Qualitative Concept]
   827   C1299351:High [Qualitative Concept]
   827   C2700149:HIGH [Intellectual Product]
   777 E C0489786:Height [Organism Attribute]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "indicative of visceral adiposity."
Processing 00000000.tx.92: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.93: 2, the sizes of adipocytes were similar between control and MPR rats, suggesting that visceral adiposity in this rat model was primarily a result of hyperplasia. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "the sizes of adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0456389:SIZES [Spatial Concept]

Phrase: "were"

Phrase: "similar between control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "MPR rats,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that visceral adiposity in this rat model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0028754:Adiposity [Disease or Syndrome]
   748   C1563743:adiposity [Organism Attribute]

Phrase: "was"

Phrase: "primarily"

Phrase: "a result of hyperplasia."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]
Processing 00000000.tx.94: View larger version (10K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(10K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.95: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.96: Effects of maternal protein restriction (MPR) on body weight (A), visceral fat weight (B), and the ratio of visceral fat to body weight (C) of male offspring rats at 130 days of age. 

Phrase: "Effects of maternal protein restriction"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "(MPR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]

Phrase: ")"

Phrase: "on body weight"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0005910:Body Weight [Organism Attribute]
           weight
  1000   C1305866:body weight [Diagnostic Procedure]
           weight
   861   C0043100:Weight [Quantitative Concept]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   861   C1705104:Weight [Idea or Concept]
   777 E C1995017:Bodies [Cell Component]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "visceral fat weight"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0005910:weight [Organism Attribute]
   827   C0043100:Weight [Quantitative Concept]
   827   C1305866:weight [Diagnostic Procedure]
   827   C1705104:Weight [Idea or Concept]
   734   C1563740:Visceral Fat [Tissue]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the ratio of visceral fat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: "to body weight"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0005910:Body Weight [Organism Attribute]
           weight
  1000   C1305866:body weight [Diagnostic Procedure]
           weight
   861   C0043100:Weight [Quantitative Concept]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   861   C1705104:Weight [Idea or Concept]
   777 E C1995017:Bodies [Cell Component]

Phrase: "(C) of male offspring rats"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1553033:[c] [Quantitative Concept]

Phrase: "at 130 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "of age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]
Processing 00000000.tx.97: Data are expressed as means  SE; 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as means  SE"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1704970:Means [Conceptual Entity]
   737 E C0444504:Mean [Quantitative Concept]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.98: n = 69 rats. 

Phrase: "n = 69 rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
Processing 00000000.tx.99: *P < 0.05 and **P < 0.01 compared with controls (male offspring of rat dams on control diet).  

Phrase: "*P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "and **"

Phrase: "P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared with controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "(male offspring of rat dams"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680063:Offspring [Family Group]

Phrase: "on control diet"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0012155:Diet [Food]
   861   C1442959:Diet [Organism Function]
   861   C1519433:DIET [Therapeutic or Preventive Procedure]
   861   C2983588:DIET [Food]
   789 E C2699635:DIETARY [Functional Concept]

Phrase: ")."
Processing 00000000.tx.100: View larger version (119K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(119K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.101: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.102: Fat pad histology. 

Phrase: "Fat pad histology."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0019638:Histology [Biomedical Occupation or Discipline]
   827   C0205462:histology [Functional Concept]
   827   C0344441:Histology [Laboratory Procedure]
   734   C0154270:fat pad [Finding]
   734   C0935625:Fat pad [Tissue]
Processing 00000000.tx.103: Paraffin-embedded sections of fat pad from control and MPR rats at 130 days of age were stained with Oil red O. 

Phrase: "Paraffin-embedded sections of fat pad"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   719   C0205155:Section [Spatial Concept]
   719   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   719   C1522472:Section [Substance]
   719   C1552923:Section [Quantitative Concept]
   719   C1705191:Section [Physical Object]

Phrase: "from control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "MPR rats"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]

Phrase: "at 130 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "of age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "were"

Phrase: "stained with Oil red O."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   883   C0069388:Oil red O stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           oil red O
   883   C1294000:Oil red-O stain [Laboratory Procedure]
   760   C0028908:Oil [Lipid]
   760   C0332575:Red [Finding]
   760   C1260956:Red [Qualitative Concept]
   760   C1517288:Oil [Food,Lipid]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   704 E C0996956:Olea [Plant]
Processing 00000000.tx.104: Representative photomicrographs are shown.  

Phrase: "Representative photomicrographs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   755   C0031753:Photomicrographies [Laboratory Procedure]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.105: Overview of changes in VAT gene expression. 

Phrase: "Overview of changes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0814812:overview [Intellectual Product]

Phrase: "in VAT gene expression."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0017262:Gene Expression [Genetic Function]
   804   C0017337:Gene [Gene or Genome]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   717   C1563740:Visceral Adipose Tissue [Tissue]
Processing 00000000.tx.106: To determine whether MPR alters the transcriptional profile of VAT and to gain insight into the identity of genes and molecular pathways involved in the pathogenesis of visceral adiposity, DNA microarray experiments were conducted on VAT derived from MPR and control rats. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "MPR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the transcriptional profile of VAT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1979963:Profile [Laboratory Procedure]
   748   C2003903:Profile [Functional Concept]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "gain"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1517378:Gain [Quantitative Concept]
   944 E C0205217:Increased [Quantitative Concept]
   944 E C0439661:Acquired [Temporal Concept]
   944 E C0442805:Increase [Functional Concept]
   944 E C0442808:Increasing [Functional Concept]
   944 E C1301820:Obtain [Functional Concept]
   944 E C1706701:Acquire [Activity]
   944 E C3245488:acquired [Intellectual Product]

Phrase: "insight into the identity of genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0233820:Insight [Mental Process]

Phrase: "and"

Phrase: "molecular pathways"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C1704259:molecular pathway [Molecular Function]
           Pathways
   861   C1705987:Pathways [Conceptual Entity]

Phrase: "involved in the pathogenesis of visceral adiposity,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0028754:Adiposity [Disease or Syndrome]
   748   C0442045:Visceral [Spatial Concept]
   748   C0543483:pathogenesis [Functional Concept]
   748   C0699748:Pathogenesis [Pathologic Function]
   748   C1314939:Involved [Functional Concept]
   748   C1563743:adiposity [Organism Attribute]

Phrase: "DNA microarray experiments"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C0600596:DNA Microarray [Research Device]
   734   C1522053:DNA Microarray [Molecular Biology Research Technique]

Phrase: "were"

Phrase: "conducted on VAT"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C1563740:Visceral Adipose Tissue [Tissue]
   806   C0001527:Adipose tissue [Tissue]
   760   C0040300:Tissue [Tissue]
   760   C0442045:Visceral [Spatial Concept]
   760   C1547928:Tissue [Intellectual Product]
   726   C0004927:Conduct [Individual Behavior]

Phrase: "derived from MPR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0443288:Restriction [Functional Concept]
   748   C1441547:Derived [Qualitative Concept]
   748   C2347083:Maternal [Family Group]
   748   C3161035:Model [Intellectual Product]
   748   C3245521:derived [Idea or Concept]

Phrase: "and"

Phrase: "control rats."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.107: Of the 15,923 genes and expressed sequence tags (ESTs) analyzed (hereafter referred to as genes), 9,790 (61.5%) were expressed at sufficient levels for detection in VAT. 

Phrase: "Of the 15,923 genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "and"

Phrase: "expressed sequence tags (ESTs)"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0600510:Expressed Sequence Tags [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1139855:tags [Medical Device]
   827   C1519249:Sequence [Functional Concept]
   793 E C0037293:Tag [Neoplastic Process]
   793 E C0181496:Tag [Manufactured Object]
   793 E C1710492:TAG [Gene or Genome]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "(hereafter"

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to as genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017337:Genes [Gene or Genome]
   790   C1883351:To [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "9,790"

Phrase: "(61.5%"

Phrase: ")"

Phrase: "were"

Phrase: "expressed at sufficient levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0205410:Sufficient [Qualitative Concept]
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "for detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "in VAT."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1563740:Visceral Adipose Tissue [Tissue]
   901   C0001527:Adipose tissue [Tissue]
   827   C0040300:Tissue [Tissue]
   827   C0442045:Visceral [Spatial Concept]
   827   C1547928:Tissue [Intellectual Product]
   755   C0028754:Adiposity [Disease or Syndrome]
   755   C1563743:adiposity [Organism Attribute]
Processing 00000000.tx.108: MPR altered the expression of 650 genes (>1.5-fold induction or repression) in VAT. 

Phrase: "MPR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]

Phrase: "altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "the expression of 650 genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0017262:Gene Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "("

Phrase: ">1.5-fold induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205263:Induction [Functional Concept]
   812   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "repression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035143:Repression [Mental Process]

Phrase: ")"

Phrase: "in VAT."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1563740:Visceral Adipose Tissue [Tissue]
   901   C0001527:Adipose tissue [Tissue]
   827   C0040300:Tissue [Tissue]
   827   C0442045:Visceral [Spatial Concept]
   827   C1547928:Tissue [Intellectual Product]
   755   C0028754:Adiposity [Disease or Syndrome]
   755   C1563743:adiposity [Organism Attribute]
Processing 00000000.tx.109: Of these, 376 are known genes, including ESTs displaying sequence homology to known genes (Table 3). 

Phrase: "Of these,"

Phrase: "376"

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "genes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "ESTs"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0600510:Expressed Sequence Tags [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1139855:tags [Medical Device]
   827   C1519249:Sequence [Functional Concept]
   793 E C0037293:Tag [Neoplastic Process]
   793 E C0181496:Tag [Manufactured Object]
   793 E C1710492:TAG [Gene or Genome]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "displaying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displaying [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "sequence homology to known genes"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0162775:Sequence Homology [Quantitative Concept]
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1334043:Homology [Gene or Genome]
           Gene Homolog
   760   C1519249:Sequence [Functional Concept]
   760   C2697616:Homology [Qualitative Concept]
   756 E C0162774:Sequence Homolog [Molecular Sequence]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.110: Among these 376 genes, 57 are of unknown function. 

Phrase: "Among these 376 genes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "57"

Phrase: "are of unknown function."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0031843:function [Physiologic Function]
   770   C0439673:Unknown [Qualitative Concept]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1551058:Are [Quantitative Concept]
   770   C1705273:Function [Intellectual Product]
Processing 00000000.tx.111: However, 87 genes were associated with metabolism, including carbohydrate, lipid, protein, and other metabolic processes. 

Phrase: "However,"

Phrase: "87 genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "were"

Phrase: "associated with metabolism,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0025519:Metabolism [Organism Function]
   790   C0025520:metabolism [Functional Concept]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "carbohydrate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007004:Carbohydrate [Carbohydrate]

Phrase: "lipid,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023779:Lipid [Lipid]

Phrase: "protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "other metabolic processes."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025519:Metabolic Processes [Organism Function]
   983 E C1524026:Metabolic Process [Cell Function]
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.112: Importantly, 78% (68 of 87 genes) were upregulated by MPR (Table 3). 

Phrase: "Importantly,"

Phrase: "78%"

Phrase: "(68 of 87 genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017337:Genes [Gene or Genome]
   770   C0450387:68 [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "upregulated by MPR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0443288:Restriction [Functional Concept]
   748   C2347083:Maternal [Family Group]
   748   C3161035:Model [Intellectual Product]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.113: Moreover, 50 genes were classified as involved in inflammation, all but two of which (96%) were downregulated by MPR. 

Phrase: "Moreover,"

Phrase: "50 genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "were"

Phrase: "classified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008902:Classified [Classification]

Phrase: "as"

Phrase: "involved in inflammation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0021368:Inflammation [Pathologic Function]
   790   C1314939:Involved [Functional Concept]

Phrase: "all"

Phrase: "but"

Phrase: "two of which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205448:Two [Quantitative Concept]

Phrase: "(96%"

Phrase: ")"

Phrase: "were"

Phrase: "downregulated by MPR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0443288:Restriction [Functional Concept]
   748   C2347083:Maternal [Family Group]
   748   C3161035:Model [Intellectual Product]
Processing 00000000.tx.114: In addition, 9 of 10 genes involved in cell cycle regulation were also suppressed. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "9 of 10 genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017337:Genes [Gene or Genome]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "in cell cycle regulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C1155872:Cell Cycle Regulation [Cell Function]
   812   C0851285:Regulation [Governmental or Regulatory Activity]
   812   C1327622:Regulation [Biologic Function]

Phrase: "were"

Phrase: "also"

Phrase: "suppressed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:Suppressed [Functional Concept]
Processing 00000000.tx.115: A total of 120 genes were differentially expressed twofold or more in the MPR group (Tables 4 and 5). 

Phrase: "A total of 120 genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]

Phrase: "were"

Phrase: "differentially expressed twofold"

Phrase: "or"

Phrase: "more in the MPR group"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205172:More [Functional Concept]
   742   C0441833:Group [Idea or Concept]
   742   C0443288:Restriction [Functional Concept]
   742   C0687744:group [Population Group]
   742   C1257890:Group [Population Group]
   742   C1552516:Group [Health Care Related Organization]
   742   C1705428:Group [Conceptual Entity]
   742   C1705429:Group [Population Group]
   742   C2347083:Maternal [Family Group]
   742   C3161035:Model [Intellectual Product]

Phrase: "(Tables 4"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0039224:tables [Manufactured Object]
   861   C1706074:Tables [Intellectual Product]
   827 E C1706073:Table [Medical Device]

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.116: View this table: [in this window] [in a new window]  Table 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.117: Overview of MPR-induced changes in VAT gene expression as determined by DNA microarray  View this table: [in this window] [in a new window]  Table 4. 

Phrase: "Overview of MPR-induced changes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0814812:overview [Intellectual Product]

Phrase: "in VAT gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0017262:Gene Expression [Genetic Function]
   804   C0017337:Gene [Gene or Genome]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   717   C1563740:Visceral Adipose Tissue [Tissue]

Phrase: "as"

Phrase: "determined by DNA microarray"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0600596:DNA Microarray [Research Device]
   833   C1522053:DNA Microarray [Molecular Biology Research Technique]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1709016:Microarray [Manufactured Object]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 4."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.118: Genes with increased expression in MPR rat VAT  View this table: [in this window] [in a new window]  Table 5. 

Phrase: "Genes with increased expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0017262:Gene Expression [Genetic Function]
   770   C0017337:Genes [Gene or Genome]

Phrase: "in MPR rat VAT"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   821   C1563740:Visceral Adipose Tissue [Tissue]
   804   C0001527:Adipose tissue [Tissue]
   790   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0034693:Rat, NOS [Mammal]
   790   C0034721:Rat [Mammal]
   790   C0040300:Tissue [Tissue]
   790   C0150312:In [Quantitative Concept]
   790   C0332285:In [Spatial Concept]
   790   C0442045:Visceral [Spatial Concept]
   790   C0443288:Restriction [Functional Concept]
   790   C1547928:Tissue [Intellectual Product]
   790   C2347083:Maternal [Family Group]
   790   C3161035:Model [Intellectual Product]
   734 E C0026591:Mother [Family Group]
   718   C0028754:Adiposity [Disease or Syndrome]
   718   C1563743:adiposity [Organism Attribute]
   706 E C1826438:MATER [Gene or Genome]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 5."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.119: Genes with decreased expression in MPR rat VAT  MPR increases expression of genes associated with carbohydrate metabolism. 

Phrase: "Genes with decreased expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0017262:Gene Expression [Genetic Function]
   770   C0017337:Genes [Gene or Genome]

Phrase: "in MPR rat VAT  MPR"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   816   C1563740:Visceral Adipose Tissue [Tissue]
   801   C0001527:Adipose tissue [Tissue]
   788   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   788   C0034693:Rat, NOS [Mammal]
   788   C0034721:Rat [Mammal]
   788   C0040300:Tissue [Tissue]
   788   C0150312:In [Quantitative Concept]
   788   C0332285:In [Spatial Concept]
   788   C0442045:Visceral [Spatial Concept]
   788   C0443288:Restriction [Functional Concept]
   788   C1547928:Tissue [Intellectual Product]
   788   C2347083:Maternal [Family Group]
   788   C3161035:Model [Intellectual Product]
   733 E C0026591:Mother [Family Group]
   717   C0028754:Adiposity [Disease or Syndrome]
   717   C1563743:adiposity [Organism Attribute]
   705 E C1826438:MATER [Gene or Genome]

Phrase: "MPR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0443288:Restriction [Functional Concept]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "expression of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   841   C0017262:Gene Expression [Genetic Function]
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "associated with carbohydrate metabolism."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0302820:Carbohydrate Metabolism [Molecular Function]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0007004:Carbohydrate [Carbohydrate]
   770   C0025519:Metabolism [Organism Function]
   770   C0025520:metabolism [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.120: The expression of several genes involved in carbohydrate metabolism was upregulated by MPR (Table 3). 

Phrase: "The expression of several genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0017262:Gene Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "involved in carbohydrate metabolism"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0302820:Carbohydrate Metabolism [Molecular Function]
   770   C0007004:Carbohydrate [Carbohydrate]
   770   C0025519:Metabolism [Organism Function]
   770   C0025520:metabolism [Functional Concept]
   770   C1314939:Involved [Functional Concept]

Phrase: "was"

Phrase: "upregulated by MPR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0443288:Restriction [Functional Concept]
   748   C2347083:Maternal [Family Group]
   748   C3161035:Model [Intellectual Product]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.121: Expression of the gene encoding glucose transporter-4 (GLUT4, +1.6-fold), which plays a key role in glucose uptake by adipocytes (12), was upregulated. 

Phrase: "Expression of the gene encoding glucose transporter-4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0017262:Gene Expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(GLUT4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420175:GLUT4 [Gene or Genome]
  1000   C2982484:GLUT4 [Gene or Genome]

Phrase: "+1.6-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a key role in glucose uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "by adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206131:Adipocytes [Cell]

Phrase: "(12"

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "upregulated."
Processing 00000000.tx.122: MPR also increased the expression of glucose-6-phosphate isomerase (+1.6-fold) and phosphofructokinase (+1.5-fold), two important regulators of the glycolytic pathway (65). 

Phrase: "MPR also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the expression of glucose-6-phosphate isomerase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(+1.6-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: "and"

Phrase: "phosphofructokinase (+1.5-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332462:Fold [Spatial Concept]
   812   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "two important regulators of the glycolytic pathway"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0182953:regulators [Medical Device]
   714 E C1704734:Regulator [Medical Device]
   714 E C1704735:Regulator [Conceptual Entity]

Phrase: "(65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.123: The expression of both malic enzyme (+1.8-fold) and malate dehydrogenase (+1.6-fold), two critical enzymes responsible for linking glycolysis with the tricarboxylic acid (TCA) cycle (65), was upregulated by MPR. 

Phrase: "The expression of both malic enzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(+1.8-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: "and"

Phrase: "malate dehydrogenase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024544:Malate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0220873:malate [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(+1.6-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "two critical enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014442:Enzymes [Enzyme,Organic Chemical]
   827   C0014445:enzymes [Functional Concept]

Phrase: "responsible for linking glycolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "with the tricarboxylic acid (TCA) cycle"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0008858:Tricarboxylic Acid Cycle [Molecular Function]
   901   C0040887:tricarboxylic acid [Organic Chemical]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]
   827   C1511572:Cycle [Temporal Concept]

Phrase: "(65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "upregulated by MPR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0443288:Restriction [Functional Concept]
   748   C2347083:Maternal [Family Group]
   748   C3161035:Model [Intellectual Product]
Processing 00000000.tx.124: MPR increases expression of genes associated with lipid metabolism. 

Phrase: "MPR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "expression of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   841   C0017262:Gene Expression [Genetic Function]
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "associated with lipid metabolism."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C0598783:Lipid Metabolism [Molecular Function]
   833   C1517898:Lipid Metabolism [Molecular Function]
   770   C0023779:Lipid [Lipid]
   770   C0025519:Metabolism [Organism Function]
   770   C0025520:metabolism [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.125: Several genes involved in lipogenesis or adipocyte differentiation were upregulated by MPR (Table 4). 

Phrase: "Several genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "involved in lipogenesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0596843:lipogenesis [Molecular Function]
   790   C1314939:Involved [Functional Concept]
   790   C1563744:Lipogenesis [Organism Function]

Phrase: "or"

Phrase: "adipocyte differentiation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1159884:adipocyte differentiation [Cell Function]
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "were"

Phrase: "upregulated by MPR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0443288:Restriction [Functional Concept]
   748   C2347083:Maternal [Family Group]
   748   C3161035:Model [Intellectual Product]

Phrase: "(Table 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.126: Expression of fatty acid synthase (FAS, +3.3-fold), a key lipogenic enzyme (40), was upregulated by MPR. 

Phrase: "Expression of fatty acid synthase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(FAS,"

Phrase: "+3.3-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "a key lipogenic enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "upregulated by MPR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0443288:Restriction [Functional Concept]
   748   C2347083:Maternal [Family Group]
   748   C3161035:Model [Intellectual Product]
Processing 00000000.tx.127: Moreover, MPR also increased the expression of other lipogenic enzymes, including glycerol-3-phosphate dehydrogenase [G3PDH, +1.9-fold (65)], acetyl-CoA carboxylase [ACC, +1.7-fold (65)], and the enzyme that catalyzes the rate-limiting step in lipogenesis, stearoyl-CoA desaturase [SCD, +2.6-fold (50)]. 

Phrase: "Moreover,"

Phrase: "MPR also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the expression of other lipogenic enzymes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "glycerol-3-phosphate dehydrogenase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0017875:Glycerol-3-Phosphate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0051369:glycerol 3-phosphate [Biologically Active Substance,Organophosphorus Compound]
   902   C0061557:Glycerol dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "[G3PDH,"

Phrase: "+1.9-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "(65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: ")"

Phrase: "],"

Phrase: "acetyl-CoA carboxylase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001022:Acetyl-CoA Carboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0001026:Acetyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0007064:Carboxylase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "[ACC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0175754:ACC [Congenital Abnormality,Disease or Syndrome]
  1000   C0282160:ACC [Congenital Abnormality]
  1000   C3541413:ACC [Gene or Genome]

Phrase: "+1.7-fold"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]
   734   C3541329:1-7 [Gene or Genome]

Phrase: "(65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: ")"

Phrase: "],"

Phrase: "and"

Phrase: "the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "that"

Phrase: "catalyzes"

Phrase: "the rate-limiting step in lipogenesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0596843:lipogenesis [Molecular Function]
   804   C1563744:Lipogenesis [Organism Function]

Phrase: "stearoyl-CoA desaturase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0038233:Stearoyl-CoA Desaturase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1419846:STEAROYL-CoA DESATURASE [Gene or Genome]
   901   C0075202:stearoyl-CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0599871:desaturase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "[SCD,"

Phrase: "+2.6-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "(50"

Phrase: ")"

Phrase: "]."
Processing 00000000.tx.128: In addition to linking glycolysis with the TCA cycle, malic enzyme (+1.8-fold) also plays an important role in generating NADPH necessary for lipogenesis (65). 

Phrase: "In addition to linking glycolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017952:Glycolysis [Molecular Function]

Phrase: "with the TCA cycle,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0008858:Tricarboxylic Acid Cycle [Molecular Function]
   901   C0040887:tricarboxylic acid [Organic Chemical]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]
   827   C1511572:Cycle [Temporal Concept]

Phrase: "malic enzyme"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0065558:'Malic' enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1151164:'malic' enzyme [Molecular Function]
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "(+1.8-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: "also"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "an important role in generating NADPH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "necessary for lipogenesis"

Phrase: "(65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.129: It is well known that ANG (ANG) II is involved in lipogenesis (2), and the intracellular level of ANG II can be augmented either by the increased conversion of ANG I to ANG II or by the decreased inactivation of ANG II. 

Phrase: "It"

Phrase: "is"

Phrase: "well known"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205170:Well [Qualitative Concept]
   861   C0205309:Known [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "that ANG (ANG) II"

Phrase: "is"

Phrase: "involved in lipogenesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0596843:lipogenesis [Molecular Function]
   790   C1314939:Involved [Functional Concept]
   790   C1563744:Lipogenesis [Organism Function]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the intracellular level of ANG II"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0441926:Level II [Intellectual Product]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "can"

Phrase: "be"

Phrase: "augmented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:Augmented [Quantitative Concept]

Phrase: "either by the increased conversion of ANG I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0021966:I- [Inorganic Chemical]
   744   C0205217:Increased [Quantitative Concept]
   744   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0439836:Conversion [Functional Concept]
   744   C0442805:Increased [Functional Concept]

Phrase: "to ANG II"

Phrase: "or by the decreased inactivation of ANG II."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   744   C0205216:Decreased [Quantitative Concept]
   744   C0392756:Decreased [Qualitative Concept]
   744   C0442797:decreased [Qualitative Concept]
   744   C0544461:Inactivation [Cell or Molecular Dysfunction]
   711 E C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.130: It was remarkable that MPR not only upregulated the expression of chymase-1 (+2.0-fold), an enzyme involved in the conversion of ANG I to ANG II (15), but also downregulated the expression of leucyl-specific aminopeptidase (1.8-fold), an enzyme that inactivates ANG II (73). 

Phrase: "It"

Phrase: "was"

Phrase: "remarkable"

Phrase: "that MPR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "upregulated"

Phrase: "the expression of chymase-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(+2.0-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "an enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "involved in the conversion of ANG I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021966:I- [Inorganic Chemical]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0439836:Conversion [Functional Concept]
   748   C1314939:Involved [Functional Concept]

Phrase: "to ANG II"

Phrase: "(15"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "also"

Phrase: "downregulated"

Phrase: "the expression of leucyl-specific aminopeptidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(1.8-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "an enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "that"

Phrase: "inactivates"

Phrase: "ANG II"

Phrase: "(73"

Phrase: ")."
Processing 00000000.tx.131: Thus the expression of genes altered by MPR suggested the promotion of lipogenesis. 

Phrase: "Thus"

Phrase: "the expression of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0017262:Gene Expression [Genetic Function]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "altered by MPR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0392747:Altered [Functional Concept]
   748   C0443288:Restriction [Functional Concept]
   748   C2347083:Maternal [Family Group]
   748   C3161035:Model [Intellectual Product]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the promotion of lipogenesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033414:Promotion [Activity]
Processing 00000000.tx.132: However, the expression of sterol regulatory element-binding protein-1c/adipocyte determination differentiation-dependent factor 1 (SREBP-1c/ADD1), a critical transcription factor involved in positively regulating a number of lipogenic enzymes (30), was not altered by MPR, suggesting that factors other than SREBP-1c may be responsible for the increased expression of lipogenic enzymes in the MPR adipose tissue. 

Phrase: "However,"

Phrase: "the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of sterol regulatory element-binding protein-1c/adipocyte determination differentiation-dependent factor 1"
Meta Candidates (Total=28; Excluded=1; Pruned=0; Remaining=27)
   908   C0217529:Sterol Regulatory Element Binding Protein 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   908   C1420398:STEROL REGULATORY ELEMENT-BINDING PROTEIN 1 [Gene or Genome]
   861   C0537474:Sterol Regulatory Element Binding Protein 1c [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   816   C0815047:Regulatory Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   816   C2246292:sterol binding [Molecular Function]
   807   C1159884:adipocyte differentiation [Cell Function]
   799   C0034987:Regulatory Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   787   C0007589:Differentiation [Cell Function]
   787   C0013879:Element [Element, Ion, or Isotope]
   787   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   787   C0038323:Sterol [Steroid]
   787   C0206131:Adipocyte [Cell]
   787   C0220905:regulatory [Regulation or Law]
   787   C0243122:binding [Functional Concept]
   787   C0851827:Dependent [Qualitative Concept]
   787   C1145667:Binding [Activity]
   787   C1148554:determination [Laboratory Procedure]
   787   C1167622:Binding [Molecular Function]
   787   C1511938:Differentiation [Clinical Attribute]
   787   C1521761:Factor [Functional Concept]
   787   C1701901:Dependent [Qualitative Concept]
   787   C1704735:Regulatory [Conceptual Entity]
   787   C1705248:Element [Conceptual Entity]
   787   C2827422:Factor [Conceptual Entity]
   787   C2945687:Differentiation [Functional Concept]
   787   C3244310:dependent [Functional Concept]
   716 E C0205615:Differentiated [Qualitative Concept]

Phrase: "(SREBP-1c/ADD1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1412230:ADD1 [Gene or Genome]
   734   C0537474:SREBP-1c [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420398:SREBP-1c [Gene or Genome]
   734   C3538602:SREBP-1c [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "a critical transcription factor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040649:Transcription [Genetic Function]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "involved in positively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1314939:Involved [Functional Concept]

Phrase: "regulating"

Phrase: "a number of lipogenic enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "(30"

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "altered by MPR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0392747:Altered [Functional Concept]
   748   C0443288:Restriction [Functional Concept]
   748   C2347083:Maternal [Family Group]
   748   C3161035:Model [Intellectual Product]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that factors other than SREBP-1c"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1521761:Factor [Functional Concept]
   719   C2827422:Factor [Conceptual Entity]

Phrase: "may"

Phrase: "be"

Phrase: "responsible for the increased expression of lipogenic enzymes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1273518:Responsible [Finding]

Phrase: "in the MPR adipose tissue."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   807   C0001527:Adipose tissue [Tissue]
   791   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0040300:Tissue [Tissue]
   791   C0150312:In [Quantitative Concept]
   791   C0332285:In [Spatial Concept]
   791   C0443288:Restriction [Functional Concept]
   791   C1547928:Tissue [Intellectual Product]
   791   C2347083:Maternal [Family Group]
   791   C3161035:Model [Intellectual Product]
   735 E C0026591:Mother [Family Group]
   720   C0028754:Adiposity [Disease or Syndrome]
   720   C1563743:adiposity [Organism Attribute]
   708 E C1826438:MATER [Gene or Genome]
Processing 00000000.tx.133: One such factor may be Spot-14, a gene known to activate the expression of lipogenic enzymes (14) and the expression of which (+1.6-fold) was upregulated by MPR. 

Phrase: "One"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "such factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521761:Factor [Functional Concept]
  1000   C2827422:Factor [Conceptual Entity]

Phrase: "may"

Phrase: "be"

Phrase: "Spot-14,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0329155:Spot [Fish]
   861   C1427618:SPOT [Gene or Genome]
   861   C1705203:Spot [Conceptual Entity]

Phrase: "a gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the expression of lipogenic enzymes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(14"

Phrase: ")"

Phrase: "and"

Phrase: "the expression of which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(+1.6-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: "was"

Phrase: "upregulated by MPR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0443288:Restriction [Functional Concept]
   748   C2347083:Maternal [Family Group]
   748   C3161035:Model [Intellectual Product]
Processing 00000000.tx.134: In addition to upregulating genes associated with lipogenesis, MPR also enhanced the expression of genes involved in the uptake of free fatty acids (FFA) from circulation, including very low-density lipoprotein (VLDL) receptor [+1.6-fold (21)] and LDL-related protein-1 [+1.6-fold (6)]. 

Phrase: "In addition to upregulating genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "associated with lipogenesis,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0596843:lipogenesis [Molecular Function]
   790   C1563744:Lipogenesis [Organism Function]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "MPR also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "the expression of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0017262:Gene Expression [Genetic Function]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "involved in the uptake of free fatty acids (FFA)"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   800   C0015688:Free Fatty Acids [Lipid]
   770   C0015684:Fatty Acids [Lipid]
   767 E C2698488:Free Fatty Acid [Laboratory Procedure]
   744   C0001128:Acids [Chemical]
   744   C0243144:Uptake [Physiologic Function]
   744   C0332296:free [Functional Concept]
   744   C0347980:% uptake [Quantitative Concept]
   744   C1314939:Involved [Functional Concept]
   744   C1880497:Free [Qualitative Concept]
   744   C1996904:Free [Qualitative Concept]
   711 E C0202406:Acid [Laboratory Procedure]

Phrase: "from circulation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005775:Circulation [Physiologic Function]
  1000   C1516559:Circulation [Organism Function]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "very low-density lipoprotein (VLDL) receptor"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
  1000   C1421455:VERY LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   937   C0023825:Very low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   937   C0034821:Low Density Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   937   C1366529:LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   884   C0023823:Low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   840   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   840   C0442811:Very low [Finding]
   804   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0178587:density [Quantitative Concept]
   804   C0205251:low [Qualitative Concept]
   804   C0442824:Very [Qualitative Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1299352:Low [Qualitative Concept]
   804   C1550472:low [Idea or Concept]
   733 E C0439794:Dense [Qualitative Concept]

Phrase: "[+1.6-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "(21"

Phrase: ")"

Phrase: "]"

Phrase: "and"

Phrase: "LDL-related protein-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0023169:LDL-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   861   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "[+1.6-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "(6"

Phrase: ")"

Phrase: "]."
Processing 00000000.tx.135: Lipoprotein lipase, an enzyme responsible for hydrolyzing circulating lipids to produce FFA available for cellular uptake (74), and hormone-sensitive lipase, which plays a vital role in the mobilization of FFA from adipose tissue by controlling the rate of lipolysis of the stored triglycerides (23), were expressed abundantly in VAT, but MPR did not influence their expression. 

Phrase: "Lipoprotein lipase,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023816:LIPOPROTEIN LIPASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1416902:LIPOPROTEIN LIPASE [Gene or Genome]
   861   C0023764:Lipase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "an enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "responsible for hydrolyzing circulating lipids to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1273518:Responsible to [Finding]
           Responsible

Phrase: "produce"

Phrase: "FFA"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0015688:Free Fatty Acids [Lipid]
   966 E C2698488:Free Fatty Acid [Laboratory Procedure]
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "available for cellular uptake"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0470187:Available [Functional Concept]

Phrase: "(74"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "hormone-sensitive lipase,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0008385:Hormone-Sensitive Lipase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1416868:LIPASE, HORMONE-SENSITIVE [Gene or Genome]
   901   C1512498:Hormone-sensitive [Functional Concept]
   827   C0019932:Hormone [Hormone]
   827   C0023764:Lipase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0332324:Sensitive [Functional Concept]
   827   C1550474:sensitive [Idea or Concept]
   755 E C0458083:Hormonal [Qualitative Concept]

Phrase: "which"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a vital role in the mobilization of FFA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0035820:Role [Social Behavior]
   739   C1705810:Role [Conceptual Entity]

Phrase: "from adipose tissue"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001527:Adipose tissue [Tissue]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
   789   C0028754:Adiposity [Disease or Syndrome]
   789   C1563743:adiposity [Organism Attribute]

Phrase: "by controlling"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0332298:controlling [Functional Concept]
  1000   C2587213:Controlling [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]

Phrase: "the rate of lipolysis of the stored triglycerides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0871208:Rate [Activity]
   744   C1521828:Rate [Quantitative Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "expressed"

Phrase: "abundantly in VAT,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C1563740:Visceral Adipose Tissue [Tissue]
   806   C0001527:Adipose tissue [Tissue]
   760   C0040300:Tissue [Tissue]
   760   C0442045:Visceral [Spatial Concept]
   760   C1547928:Tissue [Intellectual Product]

Phrase: "but"

Phrase: "MPR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "influence"

Phrase: "their expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.136: Digestion of dietary fat occurs through the activation of two enzymes: gastric lipases, secreted in the stomach, and pancreatic lipases, secreted in the duodenum. 

Phrase: "Digestion of dietary fat"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0012238:Digestion [Organism Function]
   770   C2349986:Digestion [Research Activity]
   715 E C0443277:Peptic [Functional Concept]

Phrase: "occurs through the activation of two enzymes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   757   C0014429:Enzyme Activation [Molecular Function]
   748   C0014442:Enzymes [Enzyme,Organic Chemical]
   748   C0014445:enzymes [Functional Concept]
   748   C0205448:Two [Quantitative Concept]
   748   C1709305:Occur [Activity]
   748   C1879547:Activation [Activity]
   748   C2745955:OCCUR [Temporal Concept]

Phrase: ":"

Phrase: "gastric lipases,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1416869:LIPASE, GASTRIC [Gene or Genome]
   861   C0023764:lipases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "secreted in the stomach,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0038351:Stomach [Body Part, Organ, or Organ Component]
   770   C1278920:Stomach [Body Part, Organ, or Organ Component]
   770   C1327616:Secreted [Cell Function]
   770   C1517454:STOMACH [Tissue]
   715 E C1704242:Gastric [Qualitative Concept]

Phrase: "and"

Phrase: "pancreatic lipases,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0443469:Pancreatic lipase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   966   C1418708:PANCREATIC LIPASE [Gene or Genome]
   861   C0023764:lipases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "secreted in the duodenum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0013303:Duodenum [Body Part, Organ, or Organ Component]
   770   C1278921:Duodenum [Body Part, Organ, or Organ Component]
   770   C1327616:Secreted [Cell Function]
Processing 00000000.tx.137: Interestingly, expression of pancreatic lipase [+4.6-fold (16)] and its activating cofactor, colipase [+7.0-fold (72)], was markedly upregulated by MPR. 

Phrase: "Interestingly,"

Phrase: "expression of pancreatic lipase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "[+4.6-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "(16"

Phrase: ")"

Phrase: "]"

Phrase: "and"

Phrase: "its activating cofactor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0178555:Cofactor [Biologically Active Substance]

Phrase: "colipase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009304:colipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "[+7.0-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "(72"

Phrase: ")"

Phrase: "],"

Phrase: "was"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "upregulated by MPR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0443288:Restriction [Functional Concept]
   748   C2347083:Maternal [Family Group]
   748   C3161035:Model [Intellectual Product]
Processing 00000000.tx.138: The expression of these two genes is novel to VAT, where they may play a role in facilitating the uptake of lipids from circulation and/or in cellular lipolysis. 

Phrase: "The expression of these two genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0017262:Gene Expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "novel to VAT,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205314:Novel [Temporal Concept]
   760   C0679622:novel [Intellectual Product]

Phrase: "where"

Phrase: "they"

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in facilitating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "the uptake of lipids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243144:Uptake [Physiologic Function]
   770   C0347980:% uptake [Quantitative Concept]

Phrase: "from circulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005775:Circulation [Physiologic Function]
  1000   C1516559:Circulation [Organism Function]

Phrase: "and/or in cellular lipolysis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1706528:And/Or [Conceptual Entity]
   760   C0007634:Cellular [Cell]
   760   C0023796:Lipolysis [Organism Function]
   760   C0178539:Cellular [Functional Concept]
   760   C1515981:And [Idea or Concept]
Processing 00000000.tx.139: MPR also increased the expression of enzymes involved in cholesterol synthesis, sterol C5-desaturase [+1.6-fold (49)] and isopentenyl-diphosphate -isomerase [+1.5-fold (5)]. 

Phrase: "MPR also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the expression of enzymes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "involved in cholesterol synthesis,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0599474:cholesterol synthesis [Molecular Function]
   770   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   770   C0220781:synthesis [Biologic Function]
   770   C1314939:Involved [Functional Concept]
   770   C1883254:Synthesis [Activity]

Phrase: "sterol C5-desaturase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419827:STEROL C5-DESATURASE [Gene or Genome]
   827   C0599871:desaturase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "[+1.6-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "(49"

Phrase: ")"

Phrase: "]"

Phrase: "and"

Phrase: "isopentenyl-diphosphate -isomerase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0064030:isopentenyl diphosphate [Organophosphorus Compound]
   827   C0022202:Isomerase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0034320:diphosphate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "[+1.5-fold"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]
   734   C0450316:1/5 [Quantitative Concept]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "]."
Processing 00000000.tx.140: Thus both cholesterol uptake and synthesis appeared to be enhanced by MPR. 

Phrase: "Thus"

Phrase: "both cholesterol uptake"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2611279:cholesterol uptake [Cell Function]
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220781:synthesis [Biologic Function]
  1000   C1883254:Synthesis [Activity]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "enhanced by MPR."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0443288:Restriction [Functional Concept]
   748   C2347083:Maternal [Family Group]
   748   C2349975:Enhanced [Activity]
   748   C3161035:Model [Intellectual Product]
Processing 00000000.tx.141: MPR alters expression of genes associated with protein metabolism and other metabolic processes. 

Phrase: "MPR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "expression of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   841   C0017262:Gene Expression [Genetic Function]
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "associated with protein metabolism"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C0597299:Protein Metabolism [Molecular Function]
   770   C0025519:Metabolism [Organism Function]
   770   C0025520:metabolism [Functional Concept]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "other metabolic processes."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025519:Metabolic Processes [Organism Function]
   983 E C1524026:Metabolic Process [Cell Function]
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.142: Numerous pancreatic protein metabolizing enzymes, whose expression is novel to adipose tissue, including pancreatic cationic trypsinogen, pancreatic trypsin-1 (70), chymotrypsin-like chymotrypsin B (4), and carboxypeptidase B (13), were upregulated by MPR (Table 4). 

Phrase: "Numerous pancreatic protein metabolizing enzymes,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0920330:pancreatic enzymes [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   804   C0014442:Enzymes [Enzyme,Organic Chemical]
   804   C0014445:enzymes [Functional Concept]

Phrase: "whose expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "novel to adipose tissue,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205314:Novel [Temporal Concept]
   770   C0679622:novel [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "pancreatic cationic trypsinogen,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1418965:TRYPSINOGEN, CATIONIC [Gene or Genome]
   827   C0041243:Trypsinogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "pancreatic trypsin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1418965:TRYPSIN 1 [Gene or Genome]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   827   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(70"

Phrase: ")"

Phrase: ","

Phrase: "chymotrypsin-like chymotrypsin B (4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0008744:chymotrypsin B [Amino Acid, Peptide, or Protein,Enzyme]
   840   C1413809:chymotrypsin-like [Gene or Genome]
   804   C0008742:CHYMOTRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "carboxypeptidase B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0054756:Carboxypeptidase B [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0007075:Carboxypeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3265462:Carboxypeptidase [Pharmacologic Substance]

Phrase: "(13"

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "upregulated by MPR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0443288:Restriction [Functional Concept]
   748   C2347083:Maternal [Family Group]
   748   C3161035:Model [Intellectual Product]

Phrase: "(Table 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.143: These pancreatic secreted enzymes normally function to digest proteins in the small intestine. 

Phrase: "These pancreatic secreted enzymes normally"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0920330:pancreatic enzymes [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C0014442:Enzymes [Enzyme,Organic Chemical]
   812   C0014445:enzymes [Functional Concept]

Phrase: "function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "digest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0868946:digest [Physiologic Function]

Phrase: "proteins in the small intestine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.144: In adipose tissue they may be involved in extracellular matrix (ECM) remodeling, as demonstrated in various carcinomas (59). 

Phrase: "In adipose tissue"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001527:Adipose tissue [Tissue]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
   789   C0028754:Adiposity [Disease or Syndrome]
   789   C1563743:adiposity [Organism Attribute]

Phrase: "they"

Phrase: "may"

Phrase: "be"

Phrase: "involved in extracellular matrix (ECM) remodeling,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0015350:Extracellular Matrix [Tissue]
   760   C0521119:Extracellular [Cell Component]
   760   C1314939:Involved [Functional Concept]
   760   C1704640:Matrix [Spatial Concept]
   760   C1706515:Matrix [Body Substance]

Phrase: "as"

Phrase: "demonstrated in various carcinomas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0007097:Carcinomas [Neoplastic Process]
   770   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(59"

Phrase: ")."
Processing 00000000.tx.145: MPR also altered the expression of enzymes involved in a variety of other metabolic processes, including nucleic acid metabolism, steroid hormone metabolism, and drug detoxification (Table 3). 

Phrase: "MPR also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]

Phrase: "altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "the expression of enzymes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "involved in a variety of other metabolic processes,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C0025519:Metabolic Processes [Organism Function]
   754 E C1524026:Metabolic Process [Cell Function]
           Metabolic
   744   C0311400:Metabolic [Functional Concept]
   744   C1314939:Involved [Functional Concept]
   744   C1883525:Variety [Conceptual Entity]
   744   C2346866:Variety [Conceptual Entity]
   744   C2707259:Metabolic [Clinical Attribute]
   711   C1184743:Process [Body Part, Organ, or Organ Component]
   711   C1522240:Process [Phenomenon or Process]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "nucleic acid metabolism,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597098:nucleic acid metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]
   734   C0028606:Nucleic acid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "steroid hormone metabolism,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0597518:steroid hormone metabolism [Molecular Function]
   913   C0597520:Steroid Metabolism [Molecular Function]
   901   C0596716:hormone metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]
   734   C0301818:Steroid hormone [Hormone,Steroid]

Phrase: "and"

Phrase: "drug detoxification"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0025516:drug detoxification [Organism Function]
           Detoxification
  1000   C0204600:Drug detoxification [Therapeutic or Preventive Procedure]
   861   C0150543:Detoxification [Therapeutic or Preventive Procedure]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.146: MPR increases expression of genes associated with cellular proliferation and differentiation. 

Phrase: "MPR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "expression of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   841   C0017262:Gene Expression [Genetic Function]
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "associated with cellular proliferation"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C0020507:Cellular proliferation [Pathologic Function]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C0596290:Cellular Proliferation [Cell Function]
   770   C0007634:Cellular [Cell]
   770   C0178539:Cellular [Functional Concept]
   770   C0334094:Proliferation [Pathologic Function]
   770   C1514485:Proliferation [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "differentiation."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.147: MPR increased the expression of a number of growth factors, which are known to influence cellular proliferation and differentiation. 

Phrase: "MPR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the expression of a number of growth factors,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "which"

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "influence"

Phrase: "cellular proliferation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020507:Cellular proliferation [Pathologic Function]
  1000   C0596290:Cellular Proliferation [Cell Function]
   861   C0334094:Proliferation [Pathologic Function]
   861   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "differentiation."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.148: These included transforming growth factor- [TGF-, +2.3-fold (66)], bone morphogenetic protein-3 [BMP3, +1.9-fold (3)], connective tissue growth factor [CTGF, +1.8-fold (48)], insulin-like growth factor II [IGF-II, +1.5-fold (39)], and fibroblast growth factors 7 and 21 [+1.8- and +1.5-fold, respectively (53)]. 

Phrase: "These included transforming growth factor-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1510411:Transforming [Pathologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "[TGF-,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "+2.3-fold"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]
   734   C1519042:2-3 [Research Activity]

Phrase: "(66"

Phrase: ")"

Phrase: "],"

Phrase: "bone morphogenetic protein-3"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0069675:Bone Morphogenetic Protein 3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332425:BONE MORPHOGENETIC PROTEIN 3 [Gene or Genome]
   923   C0053932:Bone Morphogenetic Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   825   C2610491:bone morphogenesis [Organism Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   812   C0391978:Bone [Tissue]
   812   C1266908:Bone [Body Part, Organ, or Organ Component]
   812   C1266909:Bone [Body System]
   741   C0026559:Morphogenesis [Organism Function]
   741 E C0443157:Bony [Functional Concept]

Phrase: "[BMP3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0069675:BMP3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332425:BMP3 [Gene or Genome]

Phrase: "+1.9-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "],"

Phrase: "connective tissue growth factor"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
  1000   C0110610:connective tissue growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413791:CONNECTIVE TISSUE GROWTH FACTOR [Gene or Genome]
   875   C0040048:Tissue Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C1333522:TISSUE FACTOR [Gene or Genome]
   861   C0009780:Connective Tissue [Tissue]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1621966:Tissue Growth [Organ or Tissue Function]
           Growth
   812   C0018270:'growth' NOS [Organism Function]
   812   C0040300:Tissue [Tissue]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1547928:Tissue [Intellectual Product]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "[CTGF,"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
  1000   C0110610:connective tissue growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413791:CONNECTIVE TISSUE GROWTH FACTOR [Gene or Genome]
   875   C0040048:Tissue Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C1333522:TISSUE FACTOR [Gene or Genome]
   861   C0009780:Connective Tissue [Tissue]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1621966:Tissue Growth [Organ or Tissue Function]
           Growth
   812   C0018270:'growth' NOS [Organism Function]
   812   C0040300:Tissue [Tissue]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1547928:Tissue [Intellectual Product]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "+1.8-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "(48"

Phrase: ")"

Phrase: "],"

Phrase: "insulin-like growth factor II"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "[IGF-II,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021666:IGF-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:IGF2 [Gene or Genome]
  1000   C2697754:IGF2 [Laboratory Procedure]
   861   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]

Phrase: "+1.5-fold"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]
   734   C0450316:1/5 [Quantitative Concept]

Phrase: "(39"

Phrase: ")"

Phrase: "],"

Phrase: "and"

Phrase: "fibroblast growth factors 7"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   983   C0064294:Fibroblast Growth Factor 7 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   983   C0919507:FIBROBLAST GROWTH FACTOR 7 [Gene or Genome]
   983   C1565802:Fibroblast Growth Factor 7 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0016026:Fibroblast Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0016030:Fibroblast [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2911660:Growth [Activity]
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "21"

Phrase: "[+1.8-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "and +"

Phrase: "1.5-fold,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]
   734   C0450316:1/5 [Quantitative Concept]

Phrase: "respectively"

Phrase: "(53"

Phrase: ")"

Phrase: "]."
Processing 00000000.tx.149: Moreover, several factors involved in adipocyte differentiation were upregulated by MPR, including MAP kinase phosphatase-1 [MKP-1, +2.2-fold (64)] as well as transcription factors CCAAT box enhancer-binding protein (C/EBP)- and C/EBP- [+1.9- and +1.6-fold, respectively (22)]. 

Phrase: "Moreover,"

Phrase: "several factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "involved in adipocyte differentiation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1159884:adipocyte differentiation [Cell Function]
   770   C0007589:Differentiation [Cell Function]
   770   C0206131:Adipocyte [Cell]
   770   C1314939:Involved [Functional Concept]
   770   C1511938:Differentiation [Clinical Attribute]
   770   C2945687:Differentiation [Functional Concept]

Phrase: "were"

Phrase: "upregulated by MPR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0443288:Restriction [Functional Concept]
   748   C2347083:Maternal [Family Group]
   748   C3161035:Model [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "MAP kinase phosphatase-1"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0096069:Map Kinase Phosphatase 1 [Amino Acid, Peptide, or Protein,Enzyme]
           MAP Phosphatase-1
  1000   C0287531:MAP Kinase Phosphatase-1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1333257:MAP KINASE PHOSPHATASE 1 [Gene or Genome]
   923   C0170168:MAP Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   902   C1424473:MAP-1 [Gene or Genome]
   861   C0752312:Map Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0024779:Map [Manufactured Object]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1149880:phosphatase [Molecular Function]
   812   C1706473:Map [Conceptual Entity]

Phrase: "[MKP-1,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0096069:Map Kinase Phosphatase 1 [Amino Acid, Peptide, or Protein,Enzyme]
           MAP Phosphatase-1
  1000   C0287531:MAP Kinase Phosphatase-1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1333257:MAP KINASE PHOSPHATASE 1 [Gene or Genome]
   923   C0170168:MAP Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   902   C1424473:MAP-1 [Gene or Genome]
   861   C0752312:Map Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0024779:Map [Manufactured Object]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1149880:phosphatase [Molecular Function]
   812   C1706473:Map [Conceptual Entity]

Phrase: "+2.2-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "(64"

Phrase: ")"

Phrase: "]"

Phrase: "as well as"

Phrase: "transcription factors CCAAT box enhancer-binding protein (C/EBP)-"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   879   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   867   C1149367:transcription factor binding [Genetic Function]
   845   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C2752241:enhancer binding [Genetic Function]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0243122:binding [Functional Concept]
   795   C1145667:Binding [Activity]
   795   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "C/EBP-"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   933   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C2752241:enhancer binding [Genetic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]

Phrase: "[+1.9-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "and +"

Phrase: "1.6-fold,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "respectively"

Phrase: "(22"

Phrase: ")"

Phrase: "]."
Processing 00000000.tx.150: MPR alters expression of genes associated with ECM remodeling. 

Phrase: "MPR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "expression of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   841   C0017262:Gene Expression [Genetic Function]
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "associated with ECM remodeling."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0015350:Extracellular Matrix [Tissue]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0521119:Extracellular [Cell Component]
   760   C1704640:Matrix [Spatial Concept]
   760   C1706515:Matrix [Body Substance]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.151: MPR increased the expression of matrix metalloproteinase (MMP)-24 (+1.7-fold), which functions to activate MMP-2 (62), an enzyme known to play an important role in adipose tissue ECM remodeling. 

Phrase: "MPR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the expression of matrix metalloproteinase (MMP)-24"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(+1.7-fold"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]
   734   C3541329:1-7 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "functions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "MMP-2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0172537:Matrix Metalloproteinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334522:MATRIX METALLOPROTEINASE 2 [Gene or Genome]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "(62"

Phrase: ")"

Phrase: ","

Phrase: "an enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role in adipose tissue ECM remodeling."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.152: The expression of the ECM proteoglycans tetranectin [+8.7-fold (76)] and fibromodulin [+1.8-fold (32)], which are involved in cell-cell adhesion and participate in the assembly of the ECM, was upregulated by MPR. 

Phrase: "The expression of the ECM proteoglycans tetranectin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "[+8.7-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "(76"

Phrase: ")"

Phrase: "]"

Phrase: "and"

Phrase: "fibromodulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0060375:fibromodulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1414648:FIBROMODULIN [Gene or Genome]

Phrase: "[+1.8-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "(32"

Phrase: ")"

Phrase: "],"

Phrase: "which"

Phrase: "are"

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "in cell-cell adhesion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1154382:cell-cell adhesion [Cell Function]
   875   C0007577:Cell Adhesion [Cell Function]
   812   C0001511:Adhesion [Pathologic Function]
   812   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "participate in the assembly of the ECM,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   793   C3156843:extracellular matrix assembly [Cell Function]
   770   C0015350:Extracellular Matrix [Tissue]
   744   C0521119:Extracellular [Cell Component]
   744   C1704640:Matrix [Spatial Concept]
   744   C1706515:Matrix [Body Substance]
   744   C1706853:Assembly [Activity]
   744   C1879748:Assembly [Manufactured Object]

Phrase: "was"

Phrase: "upregulated by MPR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0443288:Restriction [Functional Concept]
   748   C2347083:Maternal [Family Group]
   748   C3161035:Model [Intellectual Product]
Processing 00000000.tx.153: There was also a marked downregulation of genes encoding ECM components, including osteopontin (5.2-fold), fibrillin (4.0-fold), glycoprotein nmb (3.6-fold), cadherin-22 (2.7-fold), and type-1 collagen (1.8-fold) (59). 

Phrase: "There"

Phrase: "was"

Phrase: "also"

Phrase: "a marked downregulation of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0920533:Gene Down-Regulation [Genetic Function]
   760   C0013081:Down-Regulation [Cell Function,Molecular Function]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "ECM components,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0449432:Components [Manufactured Object]
   793 E C1705248:Component [Conceptual Entity]
   734   C0015350:Extracellular Matrix [Tissue]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "osteopontin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0069676:osteopontin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420369:OSTEOPONTIN [Gene or Genome]

Phrase: "(5.2-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "fibrillin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0060321:fibrillin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1325326:fibrillin [Molecular Function]
  1000   C1414542:FIBRILLIN [Gene or Genome]

Phrase: "(4.0-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "glycoprotein nmb"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1415205:GLYCOPROTEIN NMB [Gene or Genome]
           NMB
   861   C0068601:NMB [Amino Acid, Peptide, or Protein]
   861   C1417740:NMB [Gene or Genome]

Phrase: "(3.6-fold"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]
   734   C0442759:3 6 [Finding]

Phrase: ")"

Phrase: ","

Phrase: "cadherin-22"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1421905:CADHERIN 22 [Gene or Genome]
   861   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1413274:cadherin [Gene or Genome]

Phrase: "(2.7-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "type-1 collagen"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0041455:Type 1 Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0441729:Type 1 [Classification]
   827   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   827   C0332307:Type [Qualitative Concept]
   827   C1167364:collagen [Cell Component]
   827   C1547052:*Type [Quantitative Concept]
   755 E C0439689:Collagenous [Qualitative Concept]

Phrase: "(1.8-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: "(59"

Phrase: ")."
Processing 00000000.tx.154: In addition, expression of cystatin N [8.6-fold (1)], which functions as an endogenous inhibitor of the lysosomal cysteine proteinases, was profoundly downregulated. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "expression of cystatin N [8.6-fold"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "],"

Phrase: "which"

Phrase: "functions as an endogenous inhibitor of the lysosomal cysteine proteinases,"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   760   C2717970:Cysteine Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   741   C0033607:proteinase inhibitor [Biologically Active Substance,Pharmacologic Substance]
   741   C1961133:Proteinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   741   C2673177:proteinase inhibitor [Molecular Function]
   739   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0030940:Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0030946:proteinases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   739   C0031843:function [Physiologic Function]
   739   C0205227:Endogenous [Functional Concept]
   739   C0521450:Lysosomal [Body Location or Region]
   739   C0542341:Function [Functional Concept]
   739   C0700205:FUNCTION [Classification]
   739   C1705273:Function [Intellectual Product]
   739   C1999216:Inhibitor [Qualitative Concept]
   706 E C1622131:proteinase [Molecular Function]
   706 E C1947941:Proteinase [Enzyme]

Phrase: "was"

Phrase: "profoundly"

Phrase: "downregulated."
Processing 00000000.tx.155: Interestingly, expression of genes encoding a range of proteins associated with cytoskeletal structure of cells was upregulated by MPR. 

Phrase: "Interestingly,"

Phrase: "expression of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   841   C0017262:Gene Expression [Genetic Function]
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "a range of proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1514721:Range [Quantitative Concept]
   770   C2348147:Range [Quantitative Concept]
   770   C3542016:Range [Intellectual Product]

Phrase: "associated with cytoskeletal structure of cells"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   783   C0243092:cells structure [Cell Component]
   767 E C0007634:Cell structure [Cell]
           Cells
   767   C0699040:cell associated [Cell Component]
   767 E C0935919:cell structure [Qualitative Concept]
   753   C0010853:Cytoskeletal [Cell Component]
   753   C0678594:Structure [Spatial Concept]
   753   C3282337:Cells [Cell]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1706221:Associate [Professional or Occupational Group]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "upregulated by MPR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0443288:Restriction [Functional Concept]
   748   C2347083:Maternal [Family Group]
   748   C3161035:Model [Intellectual Product]
Processing 00000000.tx.156: These included actin (+7.6-fold), myosin light chain-1 (+2.1-fold), myosin light chain-2 (+1.7-fold), tropomyosin (+1.8-fold), integrin (+1.9-fold), and the integrin-complexing protein Tspan-2 (+1.5-fold). 

Phrase: "These included actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   789 E C0439681:Actinic [Qualitative Concept]

Phrase: "(+7.6-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "myosin light chain-1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0027108:Myosin Light Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0023693:Light [Natural Phenomenon or Process]
   812   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0337112:Chain [Manufactured Object]
   812   C1306462:Light [Functional Concept]
   812   C1524075:Chain [Idea or Concept]
   812   C1881376:Light [Qualitative Concept]

Phrase: "(+2.1-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "myosin light chain-2"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0663694:myosin light chain 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0027108:Myosin Light Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0023693:Light [Natural Phenomenon or Process]
   812   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0337112:Chain [Manufactured Object]
   812   C1306462:Light [Functional Concept]
   812   C1524075:Chain [Idea or Concept]
   812   C1881376:Light [Qualitative Concept]

Phrase: "(+1.7-fold"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]
   734   C3541329:1-7 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "tropomyosin (+1.8-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332462:Fold [Spatial Concept]
   812   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "integrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "(+1.9-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the integrin-complexing protein Tspan-2"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   840   C1540082:TSPAN-2 [Gene or Genome]
   823   C1167227:integrin complex [Cell Component]
   823   C1180347:complex protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0021701:Integrin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1540098:TSPAN [Gene or Genome]
   771   C0439855:Complex [Qualitative Concept]
   771   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(+1.5-fold"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]
   734   C0450316:1/5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.157: Moreover, MPR increased the expression of several neuron-related structural proteins, including myelin protein zero (+4.5-fold), proteolipid protein (+2.1-fold), and limbic system-associated membrane protein (+1.9-fold). 

Phrase: "Moreover,"

Phrase: "MPR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the expression of several neuron-related structural proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   750   C1171362:expression protein [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "myelin protein zero"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0071316:Myelin Protein Zero [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417248:MYELIN PROTEIN ZERO [Gene or Genome]
   827   C0919414:Zero [Quantitative Concept]
   734   C0026972:Myelin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(+4.5-fold"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]
   734   C0450367:4 5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "proteolipid protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033693:proteolipid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]

Phrase: "(+2.1-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "limbic system-associated membrane protein"
Meta Candidates (Total=17; Excluded=4; Pruned=0; Remaining=13)
  1000   C0380918:limbic system-associated membrane protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1416924:LIMBIC SYSTEM-ASSOCIATED MEMBRANE PROTEIN [Gene or Genome]
   840   C0023715:Limbic System [Body System]
   840   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1283887:Limbic system [Body System]
   804   C0025255:Membrane [Tissue]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0332281:Associated [Qualitative Concept]
   804   C0449913:System [Functional Concept]
   804   C0596901:Membrane [Cell Component]
   804   C1553451:System [Manufactured Object]
   804   C1704459:System [Medical Device]
   804   C1706182:Membrane [Manufactured Object]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]
   733 E C0205287:Membranous [Qualitative Concept]
   733 E C0205373:Systemic [Functional Concept]

Phrase: "(+1.9-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: ")."
Processing 00000000.tx.158: Therefore, these complex alterations in the expression of many ECM proteins and enzymes were indicative of increased ECM remodeling activities in the adipose tissue of MPR animals. 

Phrase: "Therefore,"

Phrase: "these complex alterations in the expression of many ECM proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   772   C0545012:Extracellular Matrix Alterations [Cell or Molecular Dysfunction]
   754   C0544991:Extracellular Alterations [Cell or Molecular Dysfunction]
   704   C1515926:Alteration [Idea or Concept]

Phrase: "and"

Phrase: "enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014442:Enzymes [Enzyme,Organic Chemical]
  1000   C0014445:enzymes [Functional Concept]

Phrase: "were"

Phrase: "indicative of increased ECM remodeling activities"

Phrase: "in the adipose tissue"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001527:Adipose tissue [Tissue]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
   789   C0028754:Adiposity [Disease or Syndrome]
   789   C1563743:adiposity [Organism Attribute]

Phrase: "of MPR animals."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   813   C0440447:protein animal [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0003062:Animals [Animal]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0332285:Of [Spatial Concept]
   795   C0443288:Restriction [Functional Concept]
   795   C2347083:Maternal [Family Group]
   795   C3161035:Model [Intellectual Product]
   740 E C0026591:Mother [Family Group]
   712 E C1826438:MATER [Gene or Genome]
Processing 00000000.tx.159: MPR enhances expression of angiogenic factors. 

Phrase: "MPR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "expression of angiogenic factors."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.160: Accumulating evidence suggests that adipose tissue growth/expansion is dependent on angiogenesis. 

Phrase: "Accumulating evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that adipose tissue growth/expansion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   875   C0040290:Tissue Expansion [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "dependent on angiogenesis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0851827:Dependent [Qualitative Concept]
   790   C1701901:Dependent [Qualitative Concept]
   790   C3244310:dependent [Functional Concept]
Processing 00000000.tx.161: The expression of several proangiogenic factors was upregulated by MPR. 

Phrase: "The expression of several proangiogenic factors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "upregulated by MPR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0443288:Restriction [Functional Concept]
   748   C2347083:Maternal [Family Group]
   748   C3161035:Model [Intellectual Product]
Processing 00000000.tx.162: These factors included leptin [+1.9-fold (7)], CTGF [+1.8-fold (8)], cysteine-rich protein-61 [CYR61, +1.8-fold (8)], and dermatopontin [+1.6-fold (51)]. 

Phrase: "These factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "leptin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0299583:Leptin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1416825:LEPTIN [Gene or Genome]

Phrase: "[+1.9-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "(7"

Phrase: ")"

Phrase: "],"

Phrase: "CTGF"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
  1000   C0110610:connective tissue growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413791:CONNECTIVE TISSUE GROWTH FACTOR [Gene or Genome]
   875   C0040048:Tissue Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C1333522:TISSUE FACTOR [Gene or Genome]
   861   C0009780:Connective Tissue [Tissue]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1621966:Tissue Growth [Organ or Tissue Function]
           Growth
   812   C0018270:'growth' NOS [Organism Function]
   812   C0040300:Tissue [Tissue]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1547928:Tissue [Intellectual Product]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "[+1.8-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "(8"

Phrase: ")"

Phrase: "],"

Phrase: "cysteine-rich protein-61"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C2350413:Cysteine-Rich Protein 61 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0599731:cysteine rich protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1413766:CYSTEINE-RICH PROTEIN [Gene or Genome]
   923   C1420342:cysteine-rich protein [Gene or Genome]
   812   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0699759:Rich [Qualitative Concept]

Phrase: "[CYR61,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0699759:Rich [Qualitative Concept]

Phrase: "+1.8-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "(8"

Phrase: ")"

Phrase: "],"

Phrase: "and"

Phrase: "dermatopontin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414143:DERMATOPONTIN [Gene or Genome]

Phrase: "[+1.6-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "(51"

Phrase: ")"

Phrase: "]."
Processing 00000000.tx.163: In addition, MPR increased the expression of chymase-1 (+2.0-fold), a proangiogenic enzyme involved in the conversion of ANG I to ANG II (15). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "MPR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the expression of chymase-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(+2.0-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "a proangiogenic enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "involved in the conversion of ANG I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021966:I- [Inorganic Chemical]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0439836:Conversion [Functional Concept]
   748   C1314939:Involved [Functional Concept]

Phrase: "to ANG II"

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.164: The angiogenic effects of ANG II in adipose tissue were likely further enhanced in MPR animals, since the expression of leucyl-specific aminopeptidase (1.8-fold), an extracellular enzyme that inactivates ANG II (73), was decreased. 

Phrase: "The angiogenic effects of ANG II"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "in adipose tissue"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001527:Adipose tissue [Tissue]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
   789   C0028754:Adiposity [Disease or Syndrome]
   789   C1563743:adiposity [Organism Attribute]

Phrase: "were"

Phrase: "likely further"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]
   861   C1517331:Further [Spatial Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "enhanced in MPR animals,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   750   C0440447:Animal protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   750   C0599779:Animal Model [Animal]
   744   C0003062:Animals [Animal]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0443288:Restriction [Functional Concept]
   744   C2347083:Maternal [Family Group]
   744   C2349975:Enhanced [Activity]
   744   C3161035:Model [Intellectual Product]

Phrase: "since"

Phrase: "the expression of leucyl-specific aminopeptidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(1.8-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "an extracellular enzyme"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   861   C0521119:Extracellular [Cell Component]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "that"

Phrase: "inactivates"

Phrase: "ANG II"

Phrase: "(73"

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "decreased."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.165: In contrast, MPR caused downregulation of the two antiangiogenic factors, F-spondin [2.6-fold (69)] and properdin [2.6-fold (42]). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "MPR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "downregulation of the two antiangiogenic factors,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0013081:Down-Regulation [Cell Function,Molecular Function]

Phrase: "F-spondin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1420366:f-spondin [Gene or Genome]
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "[2.6-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "(69"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: ")"

Phrase: "]"

Phrase: "and"

Phrase: "properdin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033452:Properdin [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1418482:PROPERDIN [Gene or Genome]

Phrase: "[2.6-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "(42"

Phrase: "]"

Phrase: ")."
Processing 00000000.tx.166: Thus MPR altered the pattern of adipose tissue gene expression in favor of angiogenesis. 

Phrase: "Thus MPR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]

Phrase: "altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "the pattern of adipose tissue gene expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449774:Pattern [Spatial Concept]

Phrase: "in favor of angiogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0302600:Angiogenesis [Organ or Tissue Function]
  1000   C1519670:angiogenesis [Neoplastic Process]
Processing 00000000.tx.167: MPR decreases expression of genes associated with cell-cycle regulation. 

Phrase: "MPR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "expression of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   841   C0017262:Gene Expression [Genetic Function]
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "associated with cell-cycle regulation."
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   862   C1155872:Cell Cycle Regulation [Cell Function]
   806   C0007586:Cell Cycle [Cell Function]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C1155839:Cell Cycle [Cell Function]
   797   C0699040:cell associated [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1269647:Cell [Cell]
   760   C1327622:Regulation [Biologic Function]
   760   C1511572:Cycle [Temporal Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.168: Bcl-2-related protein-A1 is involved in regulating cell-cycle progression, and its expression (2.8-fold) was repressed by MPR. 

Phrase: "Bcl-2-related protein-A1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   722   C0597712:BCL-2 Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "involved in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1314939:Involved [Functional Concept]

Phrase: "regulating"

Phrase: "cell-cycle progression,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1516334:Cell Cycle Progression [Cell Function]
   827   C0242656:progression [Pathologic Function]
   827   C0449258:Progression [Functional Concept]
   734   C0007586:Cell Cycle [Cell Function]
   734   C1155839:Cell Cycle [Cell Function]

Phrase: "and"

Phrase: "its expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(2.8-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: "was"

Phrase: "repressed by MPR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0443288:Restriction [Functional Concept]
   748   C2347083:Maternal [Family Group]
   748   C3161035:Model [Intellectual Product]
Processing 00000000.tx.169: In addition, several other genes involved in regulating the cell cycle include mitogen-inducible gene 2 (2.7-fold), cyclin-dependent kinase (2.3-fold) and cell division cycle 25B (1.5-fold) were also downregulated by MPR. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "several"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439064:Several [Quantitative Concept]
  1000   C0443302:Several [Quantitative Concept]

Phrase: "other genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "involved in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1314939:Involved [Functional Concept]

Phrase: "regulating"

Phrase: "the cell cycle"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007586:Cell Cycle [Cell Function]
  1000   C1155839:Cell Cycle [Cell Function]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1511572:Cycle [Temporal Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "mitogen-inducible gene 2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1423716:MITOGEN-INDUCIBLE GENE 2 [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0205263:Inducible [Functional Concept]
   812   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(2.7-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "cyclin-dependent kinase"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0243045:Cyclin-Dependent Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0851827:Dependent [Qualitative Concept]
   827   C1150565:cyclin [Molecular Function]
   827   C1701901:Dependent [Qualitative Concept]
   827   C3244310:dependent [Functional Concept]

Phrase: "(2.3-fold"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]
   734   C1519042:2-3 [Research Activity]

Phrase: ")"

Phrase: "and"

Phrase: "cell division cycle 25B"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1413258:CELL DIVISION CYCLE 25B [Gene or Genome]
   756   C0007586:Cell Division Cycle [Cell Function]
           Cell Cycle
   708   C1155839:Cell Cycle [Cell Function]

Phrase: "(1.5-fold"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]
   734   C0450316:1/5 [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "also"

Phrase: "downregulated by MPR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0443288:Restriction [Functional Concept]
   748   C2347083:Maternal [Family Group]
   748   C3161035:Model [Intellectual Product]
Processing 00000000.tx.170: MPR suppresses expression of genes involved in inflammation. 

Phrase: "MPR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "expression of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   841   C0017262:Gene Expression [Genetic Function]
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "involved in inflammation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0021368:Inflammation [Pathologic Function]
   790   C1314939:Involved [Functional Concept]
Processing 00000000.tx.171: The most notable class of genes downregulated by MPR was that associated with inflammation (Tables 3 and 5). 

Phrase: "The most notable class of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0456387:Class [Intellectual Product]
   753   C1705943:Class [Classification]

Phrase: "downregulated by MPR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0443288:Restriction [Functional Concept]
   748   C2347083:Maternal [Family Group]
   748   C3161035:Model [Intellectual Product]

Phrase: "was"

Phrase: "that"

Phrase: "associated with inflammation"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0021368:Inflammation [Pathologic Function]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(Tables 3"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0039224:tables [Manufactured Object]
   861   C1706074:Tables [Intellectual Product]
   827 E C1706073:Table [Medical Device]

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.172: The expression of several immunoglobulin and antigen genes was decreased (Table 5). 

Phrase: "The expression of several immunoglobulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "antigen genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1706821:Antigen Gene [Gene or Genome]
   861   C0017337:Genes [Gene or Genome]

Phrase: "was"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "(Table 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.173: Glycosylation-dependent cell adhesion molecule 1 (Glycam-1) is an endothelial cell glycoprotein that functions as an adhesive ligand for the lymphocyte adhesion molecule, L-selectin. 

Phrase: "Glycosylation-dependent cell adhesion molecule 1 (Glycam-1)"
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
  1000   C0169362:glycosylation-dependent cell adhesion molecule 1 [Amino Acid, Peptide, or Protein]
   901   C1416373:cell adhesion molecule 1 [Gene or Genome]
   861   C0007578:Cell adhesion molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Adhesion Molecule
   827   C0007577:Cell Adhesion [Cell Function]
   799   C0001511:Adhesion [Pathologic Function]
   799   C0007634:Cell [Cell]
   799   C0017982:glycosylation [Natural Phenomenon or Process]
   799   C0175633:Adhesion [Natural Phenomenon or Process]
   799   C0376322:Glycosylation [Molecular Function]
   799   C0567416:Molecule [Substance]
   799   C0851827:Dependent [Qualitative Concept]
   799   C1269647:Cell [Cell]
   799   C1701901:Dependent [Qualitative Concept]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]
   799   C3244310:dependent [Functional Concept]
   727 E C1521991:Molecular [Qualitative Concept]

Phrase: "is"

Phrase: "an endothelial cell glycoprotein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017968:Glycoprotein [Amino Acid, Peptide, or Protein,Carbohydrate]
   734   C0225336:Endothelial cell [Cell]

Phrase: "that functions as an adhesive ligand"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0542341:Functions [Functional Concept]
   719 E C0031843:function [Physiologic Function]
   719 E C0700205:FUNCTION [Classification]
   719 E C1705273:Function [Intellectual Product]

Phrase: "for the lymphocyte adhesion molecule,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0007578:Adhesion Molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0001511:Adhesion [Pathologic Function]
   827   C0024264:Lymphocyte [Cell]
   827   C0175633:Adhesion [Natural Phenomenon or Process]
   827   C0567416:Molecule [Substance]
   755 E C1521991:Molecular [Qualitative Concept]

Phrase: "L-selectin."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0125090:L-Selectin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
  1000   C1335808:L-SELECTIN [Gene or Genome]
   861   C0282651:Selectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1325391:selectin [Molecular Function]
Processing 00000000.tx.174: Glycam-1 (6.5-fold) expression was downregulated dramatically by MPR. 

Phrase: "Glycam-1"
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
  1000   C0169362:glycosylation-dependent cell adhesion molecule 1 [Amino Acid, Peptide, or Protein]
   901   C1416373:cell adhesion molecule 1 [Gene or Genome]
   861   C0007578:Cell adhesion molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Adhesion Molecule
   827   C0007577:Cell Adhesion [Cell Function]
   799   C0001511:Adhesion [Pathologic Function]
   799   C0007634:Cell [Cell]
   799   C0017982:glycosylation [Natural Phenomenon or Process]
   799   C0175633:Adhesion [Natural Phenomenon or Process]
   799   C0376322:Glycosylation [Molecular Function]
   799   C0567416:Molecule [Substance]
   799   C0851827:Dependent [Qualitative Concept]
   799   C1269647:Cell [Cell]
   799   C1701901:Dependent [Qualitative Concept]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]
   799   C3244310:dependent [Functional Concept]
   727 E C1521991:Molecular [Qualitative Concept]

Phrase: "(6.5-fold"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]
   734   C0442749:6/5 [Finding]

Phrase: ")"

Phrase: "expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "downregulated"

Phrase: "dramatically by MPR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0443288:Restriction [Functional Concept]
   748   C2347083:Maternal [Family Group]
   748   C3161035:Model [Intellectual Product]
Processing 00000000.tx.175: Expression of 12-lipoxygenase, one of the key enzymes involved in arachidonic acid metabolism, was decreased more than fourfold (Table 5). 

Phrase: "Expression of 12-lipoxygenase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "one of the key enzymes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "involved in arachidonic acid metabolism,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   862   C1158360:arachidonic acid metabolism [Molecular Function]
   862   C1879725:Arachidonic Acid Metabolism [Molecular Function]
   806   C0003695:Arachidonic Acid [Eicosanoid]
   806   C2316832:Arachidonic Acid [Laboratory Procedure]
   797   C0596480:arachidonic metabolism [Molecular Function]
   760   C0001128:Acid [Chemical]
   760   C0025519:Metabolism [Organism Function]
   760   C0025520:metabolism [Functional Concept]
   760   C0202406:Acid [Laboratory Procedure]
   760   C1314939:Involved [Functional Concept]

Phrase: "was"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "more than fourfold"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205172:More [Functional Concept]

Phrase: "(Table 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.176: Expression of two inflammatory proteins, S100 calcium-binding protein-A8 (2.7-fold) and S100 calcium-binding protein-A9 (2.2-fold), which form functional heterodimers, was reduced by MPR. 

Phrase: "Expression of two inflammatory proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1171362:expression protein [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "S100 calcium-binding protein-A8"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0054504:S100 Calcium Binding Protein A8 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1366582:S100 CALCIUM-BINDING PROTEIN A8 [Gene or Genome]
   804   C0933644:A8 [Body Part, Organ, or Organ Component]
   771   C0027758:S100 Calcium Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           S-100 Protein
   717   C0006732:Calcium-binding protein [Amino Acid, Peptide, or Protein,Receptor]
   717   C1822659:calcium binding protein [Gene or Genome]

Phrase: "(2.7-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: "and"

Phrase: "S100 calcium-binding protein-A9"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0054505:S100 Calcium Binding Protein A9 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1335798:S100 CALCIUM-BINDING PROTEIN A9 [Gene or Genome]
   804   C0933647:A9 [Body Part, Organ, or Organ Component]
   771   C0027758:S100 Calcium Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           S-100 Protein
   717   C0006732:Calcium-binding protein [Amino Acid, Peptide, or Protein,Receptor]
   717   C1822659:calcium binding protein [Gene or Genome]

Phrase: "(2.2-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "functional heterodimers,"

Phrase: "was"

Phrase: "reduced by MPR."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0392756:Reduced [Qualitative Concept]
   748   C0443288:Restriction [Functional Concept]
   748   C2347083:Maternal [Family Group]
   748   C3161035:Model [Intellectual Product]
Processing 00000000.tx.177: The expression of sialophorin (3.3-fold), a member of a ligand receptor complex involved in T cell activation, was also downregulated. 

Phrase: "The expression of sialophorin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(3.3-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "a member of a ligand receptor complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0680022:member [Population Group]
   748   C2698041:Member [Professional or Occupational Group]

Phrase: "involved in T cell activation,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C1155065:T-Cell Activation [Cell Function]
   806   C0039194:T-cell [Cell]
   806   C1326120:cell activation [Cell Function]
   760   C0007634:Cell [Cell]
   760   C1269647:Cell [Cell]
   760   C1314939:Involved [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1879547:Activation [Activity]
   760   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "also"

Phrase: "downregulated."
Processing 00000000.tx.178: Moreover, MPR downregulated the expression of complement component 3A (1.8-fold) and 8 (1.5-fold), which are members of the complement immunity pathway. 

Phrase: "Moreover,"

Phrase: "MPR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]

Phrase: "downregulated"

Phrase: "the expression of complement component 3A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(1.8-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: "and"

Phrase: "8"

Phrase: "(1.5-fold"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]
   734   C0450316:1/5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "are"

Phrase: "members of the complement immunity pathway."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0680022:members [Population Group]
   719 E C2698041:Member [Professional or Occupational Group]
Processing 00000000.tx.179: Only three inflammation-related genes were upregulated by MPR, and they were NF-B inhibitor- (IB, +2.1-fold), FK506-binding protein-2 (+1.9-fold), and CD1D (+1.8-fold). 

Phrase: "Only three inflammation-related genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017337:Genes [Gene or Genome]

Phrase: "were"

Phrase: "upregulated by MPR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0443288:Restriction [Functional Concept]
   748   C2347083:Maternal [Family Group]
   748   C3161035:Model [Intellectual Product]

Phrase: "and"

Phrase: "they"

Phrase: "were"

Phrase: "NF-B inhibitor-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(IB,"

Phrase: "+2.1-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "FK506-binding protein-2"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1414624:FK506-BINDING PROTEIN 2 [Gene or Genome]
   923   C0082584:FK506 Binding Protein [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1148603:FK506 binding [Molecular Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243122:binding [Functional Concept]
   812   C0729218:FK506 [Organic Chemical,Pharmacologic Substance]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "(+1.9-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "CD1D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413210:CD1D [Gene or Genome]

Phrase: "(+1.8-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: ")."
Processing 00000000.tx.180: Two of the three upregulated genes, IB and FK506-binding protein-2, are negative regulators of inflammatory processes. 

Phrase: "Two of the three upregulated genes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205448:Two [Quantitative Concept]

Phrase: "IB"

Phrase: "and"

Phrase: "FK506-binding protein-2,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1414624:FK506-BINDING PROTEIN 2 [Gene or Genome]
   923   C0082584:FK506 Binding Protein [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1148603:FK506 binding [Molecular Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243122:binding [Functional Concept]
   812   C0729218:FK506 [Organic Chemical,Pharmacologic Substance]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "are"

Phrase: "negative regulators of inflammatory processes."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0182953:regulators [Medical Device]
   760   C0205160:Negative [Qualitative Concept]
   760   C1513916:Negative [Finding]
   760   C2825415:Negative [Conceptual Entity]
   760   C2825491:Negative [Qualitative Concept]
   726 E C1704734:Regulator [Medical Device]
   726 E C1704735:Regulator [Conceptual Entity]
Processing 00000000.tx.181: Thus MPR altered the expression of genes associated with inflammation in a manner compatible with a suppressed inflammatory state. 

Phrase: "Thus MPR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]

Phrase: "altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "the expression of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0017262:Gene Expression [Genetic Function]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "associated with inflammation"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0021368:Inflammation [Pathologic Function]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in a manner"

Phrase: "compatible with a suppressed inflammatory state."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332290:compatible [Idea or Concept]
   753   C1524057:Compatible [Qualitative Concept]
Processing 00000000.tx.182: Confirmation of microarray data by qRT-PCR. 

Phrase: "Confirmation of microarray data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0521091:Confirmation of [Qualitative Concept]
           confirmation
   770   C0750484:Confirmation [Idea or Concept]

Phrase: "by qRT-PCR."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   901   C0599161:RT-PCR [Molecular Biology Research Technique]
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0392762:Quantitative [Quantitative Concept]
   827   C0677874:pCR [Finding]
Processing 00000000.tx.183: To validate the DNA microarray data, we determined the expression of several candidate genes that exhibited increased or decreased expression by microarray by use of qRT-PCR. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "validate"

Phrase: "the DNA microarray data,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]
   734   C0600596:DNA Microarray [Research Device]
   734   C1522053:DNA Microarray [Molecular Biology Research Technique]

Phrase: "we"

Phrase: "determined"

Phrase: "the expression of several candidate genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0017262:Gene Expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "increased"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]

Phrase: "or"

Phrase: "decreased expression by microarray"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "by use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "of qRT-PCR."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   901   C0599161:RT-PCR [Molecular Biology Research Technique]
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0392762:Quantitative [Quantitative Concept]
   827   C0677874:pCR [Finding]
Processing 00000000.tx.184: In addition, the expression of two genes that displayed no change in expression by microarray was also examined. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the expression of two genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0017262:Gene Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "no change in expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0442739:No change [Finding]
   833   C1548568:No change [Intellectual Product]
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]

Phrase: "by microarray"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709016:Microarray [Manufactured Object]

Phrase: "was"

Phrase: "also"

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.185: qRT-PCR confirmed that the data from the gene chips were robust and that in many cases the magnitude of fold changes was underestimated on the microarrays (Fig. 3). 

Phrase: "qRT-PCR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   901   C0599161:RT-PCR [Molecular Biology Research Technique]
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0392762:Quantitative [Quantitative Concept]
   827   C0677874:pCR [Finding]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the data from the gene chips"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1511726:Data [Idea or Concept]
   753   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "robust"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986815:Robust [Qualitative Concept]

Phrase: "and"

Phrase: "that in many cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "the magnitude of fold changes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449286:magnitude [Quantitative Concept]
   760   C1704240:Magnitude [Quantitative Concept]

Phrase: "was"

Phrase: "underestimated on the microarrays"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1709016:Microarray [Manufactured Object]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.186: View larger version (33K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(33K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.187: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.188: Levels of mRNA of selected representative genes (as indicated in AI) quantified by quantitative RT-PCR. 

Phrase: "Levels of mRNA of selected representative genes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "("

Phrase: "as"

Phrase: "indicated in AI)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0003353:AI [Geographic Area]
   790   C0003504:ai [Disease or Syndrome]
   790   C1444656:Indicated [Finding]

Phrase: "quantified by quantitative RT-PCR."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   806   C0599161:RT-PCR [Molecular Biology Research Technique]
   760   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0392762:Quantitative [Quantitative Concept]
   760   C0677874:pCR [Finding]
   726   C1709793:Quantify [Quantitative Concept]
Processing 00000000.tx.189: See text for definitions. 

Phrase: "See"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "text for definitions."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1527021:Text [Intellectual Product]
   790   C1554111:Text [Idea or Concept]
   790   C1705606:Text [Intellectual Product]
   790   C3541382:Text [Intellectual Product]
Processing 00000000.tx.190: Data are expressed as means  SE; 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as means  SE"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1704970:Means [Conceptual Entity]
   737 E C0444504:Mean [Quantitative Concept]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.191: n = 6 rats. 

Phrase: "n = 6 rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
Processing 00000000.tx.192: *P < 0.05 and **P < 0.01 compared with controls (male offspring of rat dams on control diet). 

Phrase: "*P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "and **"

Phrase: "P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared with controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "(male offspring of rat dams"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680063:Offspring [Family Group]

Phrase: "on control diet"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0012155:Diet [Food]
   861   C1442959:Diet [Organism Function]
   861   C1519433:DIET [Therapeutic or Preventive Procedure]
   861   C2983588:DIET [Food]
   789 E C2699635:DIETARY [Functional Concept]

Phrase: ")."
Processing 00000000.tx.193: For comparison, fold changes as determined by DNA microarray are shown in brackets.   

Phrase: "For comparison,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "fold changes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   983   C1880833:Fold Change [Quantitative Concept]
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "as"

Phrase: "determined by DNA microarray"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0600596:DNA Microarray [Research Device]
   833   C1522053:DNA Microarray [Molecular Biology Research Technique]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1709016:Microarray [Manufactured Object]

Phrase: "are"

Phrase: "shown in brackets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0179407:brackets [Medical Device]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.194: DISCUSSION TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION GRANTS REFERENCES  Accumulating evidence suggests that poor early growth is associated with an increased risk of developing insulin resistance, type 2 diabetes, and hypertension in later life (25, 29). 

Phrase: "DISCUSSION TOP ABSTRACT MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION GRANTS REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C1514811:Reference [Idea or Concept]
   771   C1706462:Reference [Conceptual Entity]

Phrase: "Accumulating"

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that poor early growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C1837385:Poor growth [Finding]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2911660:Growth [Activity]

Phrase: "is"

Phrase: "associated with an increased risk of developing insulin resistance,"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   764   C0021655:Insulin Resistance [Pathologic Function]
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   764   C2700570:INSULIN RESISTANCE [Gene or Genome]
   762   C0020459:increased insulin [Disease or Syndrome]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0035647:Risk [Qualitative Concept]
   742   C0205217:Increased [Quantitative Concept]
   742   C0237834:Resistance [Mental Process]
   742   C0442805:Increased [Functional Concept]
   742   C1514892:Resistance [Physiologic Function]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1706221:Associate [Professional or Occupational Group]

Phrase: "type 2 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "hypertension in later life"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020538:Hypertension [Disease or Syndrome]
   770   C1963138:Hypertension [Finding]

Phrase: "(25,"

Phrase: "29"

Phrase: ")."
Processing 00000000.tx.195: Although it is generally accepted that obesity is required for the full expression of this thrifty phenotype (56), very few studies have focused on the long-term impact of poor early growth on the susceptibility to obesity in adult life. 

Phrase: "Although"

Phrase: "it"

Phrase: "is"

Phrase: "generally"

Phrase: "accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: "that obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "is"

Phrase: "required for the full expression of this thrifty phenotype"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0031437:Phenotype [Organism Attribute]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   742   C0443225:Full [Qualitative Concept]
   742   C1285572:Phenotype [Laboratory Procedure]
   742   C1514873:Required [Functional Concept]

Phrase: "(56"

Phrase: ")"

Phrase: ","

Phrase: "very few studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "focused on the long-term impact of poor early growth"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   760   C0443252:Long-term [Temporal Concept]
   757   C1837385:Poor growth [Finding]
   741   C0423044:Poor focus [Finding]
   739   C0018270:'growth' NOS [Organism Function]
   739   C0032854:Poor [Group Attribute]
   739   C0205166:Long [Qualitative Concept]
   739   C0205234:Focused [Spatial Concept]
   739   C0220844:growth [Physiologic Function]
   739   C0542537:Poor [Qualitative Concept]
   739   C1279919:Early [Temporal Concept]
   739   C1285542:focused [Functional Concept]
   739   C1515273:Term [Temporal Concept]
   739   C1621966:Growth [Organ or Tissue Function]
   739   C1705313:Term [Idea or Concept]
   739   C1706317:Long [Qualitative Concept]
   739   C1825598:IMPACT [Gene or Genome]
   739   C2700379:Poor [Qualitative Concept]
   739   C2826302:TERM [Intellectual Product]
   739   C2911660:Growth [Activity]

Phrase: "on the susceptibility"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0012655:Susceptibility [Clinical Attribute]
  1000   C0220898:Susceptibility [Organism Attribute]
  1000   C1264642:Susceptibility [Functional Concept]
  1000   C1547045:*Susceptibility [Quantitative Concept]
   928 E C0231204:Susceptible [Functional Concept]
   928 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "to obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "in adult life."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0376558:Life [Idea or Concept]
   777 E C0595998:lives [Finding]
Processing 00000000.tx.196: Ozanne et al. 

Phrase: "Ozanne et al."
Processing 00000000.tx.197: (57) recently reported the long-term effects of poor early nutrition on weight gain and the development of obesity in response to a highly palatable cafeteria-style diet. 

Phrase: "(57"

Phrase: ")"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "the long-term effects of poor early nutrition"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   800   C0023983:Long-Term Effects [Phenomenon or Process]
   770   C0443252:Long-term [Temporal Concept]
   744   C0205166:Long [Qualitative Concept]
   744   C1280500:effects [Qualitative Concept]
   744   C1515273:Term [Temporal Concept]
   744   C1705313:Term [Idea or Concept]
   744   C1706317:Long [Qualitative Concept]
   744   C2826302:TERM [Intellectual Product]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "on weight gain"
Meta Candidates (Total=15; Excluded=8; Pruned=0; Remaining=7)
  1000   C0043094:Weight Gain [Finding]
  1000   C2911647:Weight gain [Finding]
   958 E C0231246:weight gaining [Sign or Symptom]
   861   C0005910:weight [Organism Attribute]
   861   C0043100:Weight [Quantitative Concept]
   861   C1305866:weight [Diagnostic Procedure]
   861   C1517378:Gain [Quantitative Concept]
   861   C1705104:Weight [Idea or Concept]
   805 E C0205217:Increased [Quantitative Concept]
   805 E C0439661:Acquired [Temporal Concept]
   805 E C0442805:Increase [Functional Concept]
   805 E C0442808:Increasing [Functional Concept]
   805 E C1301820:Obtain [Functional Concept]
   805 E C1706701:Acquire [Activity]
   805 E C3245488:acquired [Intellectual Product]

Phrase: "and"

Phrase: "the development of obesity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to a highly palatable cafeteria-style diet."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   804   C0012155:Diet [Food]
   804   C1442959:Diet [Organism Function]
   804   C1519433:DIET [Therapeutic or Preventive Procedure]
   804   C2983588:DIET [Food]
   733 E C2699635:DIETARY [Functional Concept]
Processing 00000000.tx.198: They showed that MPR mice at defined time windows not only had long-term (programmed) effects on weight gain but also altered the response to an obesity-inducing cafeteria-style diet and, hence, the susceptibility to obesity in later life. 

Phrase: "They"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that MPR mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C2986594:Mouse Model [Experimental Model of Disease]
   748   C3161035:Model [Intellectual Product]

Phrase: "at defined time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "windows"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "had"

Phrase: "long-term"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0443252:Long-term [Temporal Concept]
   861   C0205166:Long [Qualitative Concept]
   861   C1515273:Term [Temporal Concept]
   861   C1705313:Term [Idea or Concept]
   861   C1706317:Long [Qualitative Concept]
   861   C2826302:TERM [Intellectual Product]

Phrase: "(programmed"

Phrase: ")"

Phrase: "effects on weight gain"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   791   C0595938:effects increased [Pathologic Function]
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "but"

Phrase: "also"

Phrase: "altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "the response to an obesity-inducing cafeteria-style diet"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0871261:Response [Organism Attribute]
   742   C1704632:Response [Finding]
   742   C1706817:Response [Intellectual Product]
   742   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: ","

Phrase: "hence,"

Phrase: "the susceptibility to obesity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0012655:Susceptibility [Clinical Attribute]
   770   C0220898:Susceptibility [Organism Attribute]
   770   C1264642:Susceptibility [Functional Concept]
   770   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "in later life."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0376558:Life [Idea or Concept]
   777 E C0595998:lives [Finding]
Processing 00000000.tx.199: Mice who were growth restricted in utero but underwent rapid postnatal catch-up growth were heavier than control offspring throughout the study. 

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "who"

Phrase: "were"

Phrase: "growth restricted in utero"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708480:In Utero [Age Group]
   812   C0042149:Utero- [Body Part, Organ, or Organ Component]

Phrase: "but"

Phrase: "underwent"

Phrase: "rapid postnatal catch-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0231617:Catch [Sign or Symptom]

Phrase: "up growth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018270:'growth' NOS [Organism Function]
  1000   C0220844:growth [Physiologic Function]
  1000   C1621966:Growth [Organ or Tissue Function]
  1000   C2911660:Growth [Activity]

Phrase: "were"

Phrase: "heavier than control offspring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0439539:Heavy [Qualitative Concept]

Phrase: "throughout the study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]
Processing 00000000.tx.200: These animals also gained more weight than the control offspring in response to the obesity-inducing diet. 

Phrase: "These animals also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "gained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
   966   C1517378:Gain [Quantitative Concept]
   928 E C0205217:Increased [Quantitative Concept]
   928 E C0439661:Acquired [Temporal Concept]
   928 E C0442805:Increase [Functional Concept]
   928 E C0442808:Increasing [Functional Concept]
   928 E C1301820:Obtain [Functional Concept]
   928 E C1706701:Acquire [Activity]
   928 E C3245488:acquired [Intellectual Product]

Phrase: "more weight than the control offspring"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0920298:Weight control [Therapeutic or Preventive Procedure]
   753   C0005910:weight [Organism Attribute]
   753   C0043100:Weight [Quantitative Concept]
   753   C1305866:weight [Diagnostic Procedure]
   753   C1705104:Weight [Idea or Concept]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to the obesity-inducing diet."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0012155:Diet [Food]
   827   C1442959:Diet [Organism Function]
   827   C1519433:DIET [Therapeutic or Preventive Procedure]
   827   C2983588:DIET [Food]
   755 E C2699635:DIETARY [Functional Concept]
Processing 00000000.tx.201: In marked contrast, mice that were growth restricted during lactation remained permanently smaller than controls. 

Phrase: "In marked contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1979874:Contrast [Qualitative Concept]

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "that"

Phrase: "were"

Phrase: "growth restricted during lactation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0018270:'growth' NOS [Organism Function]
   770   C0220844:growth [Physiologic Function]
   770   C0443288:Restricted [Functional Concept]
   770   C1621966:Growth [Organ or Tissue Function]
   770   C2911660:Growth [Activity]

Phrase: "remained"

Phrase: "permanently smaller than controls."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0547044:Smaller [Qualitative Concept]
   770   C0700321:Smaller [Quantitative Concept]
Processing 00000000.tx.202: Moreover, when these mice were weaned onto the obesity-inducing diet, they showed no additional weight gain compared with their littermates on a control diet. 

Phrase: "Moreover,"

Phrase: "when"

Phrase: "these mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "weaned onto the obesity-inducing diet,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0012155:Diet [Food]
   753   C0028754:Obesity [Disease or Syndrome]
   753   C0043084:weaned [Organism Function]
   753   C0205263:Inducing [Functional Concept]
   753   C1442959:Diet [Organism Function]
   753   C1519433:DIET [Therapeutic or Preventive Procedure]
   753   C1963185:Obesity [Finding]
   753   C2983588:DIET [Food]

Phrase: "they"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no additional weight gain"
Meta Candidates (Total=15; Excluded=8; Pruned=0; Remaining=7)
   901   C0043094:Weight Gain [Finding]
   901   C2911647:Weight gain [Finding]
   859 E C0231246:weight gaining [Sign or Symptom]
   827   C0005910:weight [Organism Attribute]
   827   C0043100:Weight [Quantitative Concept]
   827   C1305866:weight [Diagnostic Procedure]
   827   C1517378:Gain [Quantitative Concept]
   827   C1705104:Weight [Idea or Concept]
   771 E C0205217:Increased [Quantitative Concept]
   771 E C0439661:Acquired [Temporal Concept]
   771 E C0442805:Increase [Functional Concept]
   771 E C0442808:Increasing [Functional Concept]
   771 E C1301820:Obtain [Functional Concept]
   771 E C1706701:Acquire [Activity]
   771 E C3245488:acquired [Intellectual Product]

Phrase: "compared with their littermates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Compared [Activity]

Phrase: "on a control diet."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0012155:Diet [Food]
   861   C1442959:Diet [Organism Function]
   861   C1519433:DIET [Therapeutic or Preventive Procedure]
   861   C2983588:DIET [Food]
   789 E C2699635:DIETARY [Functional Concept]
Processing 00000000.tx.203: These findings suggest that nutritional influences, both pre- and postnatal, can exert long-term (programmed) effects on body weight homoeostasis in later life. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that nutritional influences,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   777   C0021399:influential [Idea or Concept]

Phrase: "both pre-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332152:Pre [Temporal Concept]
  1000   C0740175:Pre [Qualitative Concept]
  1000   C2257086:PRE [Genetic Function]

Phrase: "and"

Phrase: "postnatal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443281:Postnatal [Temporal Concept]

Phrase: "can"

Phrase: "exert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "long-term"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0443252:Long-term [Temporal Concept]
   861   C0205166:Long [Qualitative Concept]
   861   C1515273:Term [Temporal Concept]
   861   C1705313:Term [Idea or Concept]
   861   C1706317:Long [Qualitative Concept]
   861   C2826302:TERM [Intellectual Product]

Phrase: "(programmed"

Phrase: ")"

Phrase: "effects on body weight homoeostasis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "in later life."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0376558:Life [Idea or Concept]
   777 E C0595998:lives [Finding]
Processing 00000000.tx.204: However, the molecular mechanisms that underlie this programming effect of poor early nutrition are unknown. 

Phrase: "However,"

Phrase: "the molecular mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "underlie"

Phrase: "this programming effect of poor early nutrition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "are"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.205: In the present study, we used a similar rat model of MPR in which dams were fed a low-protein diet throughout pregnancy and lactation (33, 58). 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a similar rat model of MPR"

Phrase: "in which dams"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2239937:DAMS [Gene or Genome]

Phrase: "were"

Phrase: "fed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0342895:FED [Disease or Syndrome]
   966 E C0204695:Feed [Health Care Activity]
   966 E C2987508:Feed [Activity]

Phrase: "a low-protein diet throughout pregnancy"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   833   C0242972:Low-Protein Diet [Therapeutic or Preventive Procedure]
           low protein
   790   C0452269:Protein diet [Therapeutic or Preventive Procedure]
   790   C0748025:low protein [Finding]
   783   C0032974:pregnancy protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   753   C0012155:Diet [Food]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205251:low [Qualitative Concept]
   753   C1299352:Low [Qualitative Concept]
   753   C1442959:Diet [Organism Function]
   753   C1519433:DIET [Therapeutic or Preventive Procedure]
   753   C1550472:low [Idea or Concept]
   753   C2983588:DIET [Food]
   748 E C0012177:Dietary Protein [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "lactation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006147:Lactation [Organism Function]
  1000   C0022925:Lactation [Organ or Tissue Function]

Phrase: "(33,"

Phrase: "58"

Phrase: ")."
Processing 00000000.tx.206: We chose to study specifically visceral adiposity/obesity because it is the best predictor of the metabolic syndrome (45), which is known to occur in this rat model (55). 

Phrase: "We"

Phrase: "chose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Choose [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "specifically visceral adiposity/obesity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C2936179:Obesity, Visceral [Sign or Symptom]
   812   C0028754:Obesity [Disease or Syndrome]
   812   C1963185:Obesity [Finding]

Phrase: "because"

Phrase: "it"

Phrase: "is"

Phrase: "the best predictor of the metabolic syndrome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2698872:Predictor [Idea or Concept]

Phrase: "(45"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "occur in this rat model"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
   760   C3161035:Model [Intellectual Product]

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.207: We demonstrate that MPR predisposes the male offspring to visceral adiposity but not overweight in early adult life. 

Phrase: "We"

Phrase: "demonstrate"

Phrase: "that MPR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]

Phrase: "predisposes"

Phrase: "the male offspring to visceral adiposity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0680063:Offspring [Family Group]

Phrase: "but"

Phrase: "not overweight in early adult life."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0497406:OVER WEIGHT [Sign or Symptom]
Processing 00000000.tx.208: Moreover, we show that MPR dramatically alters the transcriptional profile of VAT. 

Phrase: "Moreover,"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that MPR dramatically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3161035:Model [Intellectual Product]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the transcriptional profile of VAT."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1979963:Profile [Laboratory Procedure]
   748   C2003903:Profile [Functional Concept]
Processing 00000000.tx.209: The cellular development associated with adipose tissue expansion involves adipocyte hypertrophy (increase in cell size) and/or adipocyte hyperplasia (increase in cell number) (26). 

Phrase: "The cellular development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "associated with adipose tissue expansion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0001527:Adipose tissue [Tissue]
   806   C0040290:Tissue Expansion [Therapeutic or Preventive Procedure]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0040300:Tissue [Tissue]
   760   C1547928:Tissue [Intellectual Product]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "involves"

Phrase: "adipocyte hypertrophy"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0020564:Hypertrophy [Pathologic Function]
   789 E C0333959:Hypertrophic [Functional Concept]

Phrase: "(increase in cell size"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1268652:Increase in size [Finding]
           increase size
   861   C0162658:Cell Size [Organism Attribute,Quantitative Concept]
   812   C0456389:size [Spatial Concept]

Phrase: ")"

Phrase: "and/or"

Phrase: "adipocyte hyperplasia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020507:Hyperplasia [Pathologic Function]

Phrase: "(increase in cell number"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007584:Cell Number [Laboratory Procedure]
   812   C0237753:*Number [Quantitative Concept]
   812   C0449788:Number [Quantitative Concept]

Phrase: ")"

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.210: Hypertrophy is the result of excess triglyceride accumulation in preexisting adipocytes due to a positive energy balance (energy intake in excess of energy expenditure). 

Phrase: "Hypertrophy"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0020564:Hypertrophy [Pathologic Function]
   928 E C0333959:Hypertrophic [Functional Concept]

Phrase: "is"

Phrase: "the result of excess triglyceride accumulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]

Phrase: "in preexisting adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206131:Adipocytes [Cell]

Phrase: "due to a positive energy balance"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0597987:Energy Balance [Organism Function]
   827   C0014653:Balance [Organism Function]
   827   C0205415:Balance [Functional Concept]
   827   C0424589:Energy [Finding]
   827   C0542479:Energy [Natural Phenomenon or Process]
   827   C0560184:Balance [Finding]
   827   C1442080:Energy [Quantitative Concept]

Phrase: "(energy intake in excess of energy expenditure"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0006777:Energy Intake [Quantitative Concept]
   778   C0600082:% energy intake [Quantitative Concept]
   774   C0014272:Energy Expenditure [Physiologic Function]
   748   C0424589:Energy [Finding]
   748   C0542479:Energy [Natural Phenomenon or Process]
   748   C1442080:Energy [Quantitative Concept]
   748   C1512806:Intake [Functional Concept]

Phrase: ")."
Processing 00000000.tx.211: Hyperplasia, also known as adipogenesis, results from the recruitment of new preadipocytes from progenitor cells in adipose tissue. 

Phrase: "Hyperplasia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020507:Hyperplasia [Pathologic Function]

Phrase: "also"

Phrase: "known as adipogenesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205309:Known [Qualitative Concept]
   790   C0596843:Adipogenesis [Molecular Function]

Phrase: "results from the recruitment of new preadipocytes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0205314:New [Temporal Concept]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C2825142:Result [Finding]
   748   C2949735:Recruitment [Activity]

Phrase: "from progenitor cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0038250:Progenitor Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "in adipose tissue."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001527:Adipose tissue [Tissue]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
   789   C0028754:Adiposity [Disease or Syndrome]
   789   C1563743:adiposity [Organism Attribute]
Processing 00000000.tx.212: In addition, it involves the proliferation of preadipocytes and their differentiation into lipid filled mature adipocytes. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "it"

Phrase: "involves"

Phrase: "the proliferation of preadipocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0334094:Proliferation [Pathologic Function]
   770   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "their differentiation into lipid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0007589:Differentiation [Cell Function]
   770   C1511938:Differentiation [Clinical Attribute]
   770   C2945687:Differentiation [Functional Concept]

Phrase: "filled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708059:Filled [Activity]

Phrase: "mature adipocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206131:Adipocytes [Cell]
Processing 00000000.tx.213: Two processes contribute to lipid accumulation in adipocytes, increased lipogenesis and reduced lipolysis. 

Phrase: "Two processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "contribute to lipid accumulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0333574:Lipid accumulation [Finding]
   770   C0023779:Lipid [Lipid]
   770   C1880177:Contribute [Activity]

Phrase: "in adipocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206131:Adipocytes [Cell]

Phrase: "increased lipogenesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1372378:Increased Lipogenesis [Molecular Function]
   861   C0596843:lipogenesis [Molecular Function]
   861   C1563744:Lipogenesis [Organism Function]

Phrase: "and"

Phrase: "reduced lipolysis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023796:Lipolysis [Organism Function]
Processing 00000000.tx.214: The increased expression of genes encoding a number of lipogenic enzymes (e.g., FAS, G3PDH, ACC, and SCD) in the MPR adipose tissue suggested that enhanced lipogenesis was one of the factors contributing to visceral adiposity in this rat model. 

Phrase: "The increased expression of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0017262:Gene Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "a number of lipogenic enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "FAS,"

Phrase: "G3PDH,"

Phrase: "ACC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0175754:ACC [Congenital Abnormality,Disease or Syndrome]
  1000   C0282160:ACC [Congenital Abnormality]
  1000   C3541413:ACC [Gene or Genome]

Phrase: "and"

Phrase: "SCD) in the MPR adipose tissue"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that enhanced lipogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0596843:lipogenesis [Molecular Function]
   861   C1563744:Lipogenesis [Organism Function]

Phrase: "was"

Phrase: "one of the factors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "contributing to visceral adiposity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0028754:Adiposity [Disease or Syndrome]
   770   C0442045:Visceral [Spatial Concept]
   770   C1563743:adiposity [Organism Attribute]
   770   C1880177:Contributing [Activity]

Phrase: "in this rat model."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]
Processing 00000000.tx.215: Furthermore, an enhanced ability to take up FAA from circulation resulting from increased expression of VLDL receptor and its functionally related protein, as well as an increased capacity for cholesterol synthesis as a result of increased expression of genes coding for enzymes involved in the biosynthesis of cholesterol, also likely contributed to the excess adipose tissue expansion in MPR rats. 

Phrase: "Furthermore,"

Phrase: "an enhanced ability to take up FAA from circulation"

Phrase: "resulting from increased expression of VLDL receptor"
Meta Candidates (Total=25; Excluded=3; Pruned=0; Remaining=22)
   833   C1421455:VERY LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   806   C0023825:Very low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   806   C0034821:Low Density Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   806   C1366529:LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   782   C0023823:Low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   760   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C0442811:Very low [Finding]
   757   C0029053:Increased density [Finding]
   757   C0597360:receptor expression [Genetic Function]
   757   C0599283:receptor density [Genetic Function]
   757   C1291138:Increased lipoprotein [Finding]
   739   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0178587:density [Quantitative Concept]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]
   739   C0205217:Increased [Quantitative Concept]
   739   C0205251:low [Qualitative Concept]
   739   C0442805:Increased [Functional Concept]
   739   C0442824:Very [Qualitative Concept]
   739   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   739   C0678226:resulting [Functional Concept]
   739   C1299352:Low [Qualitative Concept]
   739   C1550472:low [Idea or Concept]
   706 E C1274040:Result [Functional Concept]
   706 E C1546471:Result [Idea or Concept]
   706 E C2825142:Result [Finding]

Phrase: "and"

Phrase: "its functionally related protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "as well as"

Phrase: "an increased capacity for cholesterol synthesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1516240:Capacity [Quantitative Concept]

Phrase: "as a result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "of increased expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "coding for enzymes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0009219:Coding [Occupational Activity]
   790   C0014442:Enzymes [Enzyme,Organic Chemical]
   790   C0014445:enzymes [Functional Concept]
   756 E C0805701:Code [Intellectual Product]

Phrase: "involved in the biosynthesis of cholesterol,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0599474:biosynthesis cholesterol [Molecular Function]
   753   C0005572:biosynthesis [Functional Concept]
   753   C0008377:Cholesterol [Biologically Active Substance,Steroid]
   753   C0220781:Biosynthesis [Biologic Function]
   753   C1314939:Involved [Functional Concept]

Phrase: "also likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "contributed to the excess adipose tissue expansion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0001527:Adipose tissue [Tissue]
   778   C0040290:Tissue Expansion [Therapeutic or Preventive Procedure]
   748   C0040300:Tissue [Tissue]
   748   C1547928:Tissue [Intellectual Product]
   748   C1979886:Excess [Qualitative Concept]
   714   C1880177:Contribute [Activity]

Phrase: "in MPR rats."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0034693:rats [Mammal]
   795   C0034721:Rats [Mammal]
   795   C0150312:In [Quantitative Concept]
   795   C0332285:In [Spatial Concept]
   795   C0443288:Restriction [Functional Concept]
   795   C2347083:Maternal [Family Group]
   795   C3161035:Model [Intellectual Product]
   740 E C0026591:Mother [Family Group]
   712 E C1826438:MATER [Gene or Genome]
Processing 00000000.tx.216: In addition, increases in the expression of genes encoding several growth factors known to be involved in regulating cell proliferation and differentiation suggested that an enhanced adipogenesis program was likely a contributing factor in the MPR-induced programming of visceral adiposity. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "increases in the expression of genes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0017262:Gene Expression [Genetic Function]
   753   C0017337:Genes [Gene or Genome]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0442805:Increase [Functional Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "several growth factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2911660:Growth [Activity]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "involved in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1314939:Involved [Functional Concept]

Phrase: "regulating"

Phrase: "cell proliferation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0596290:Cell Proliferation [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0334094:Proliferation [Pathologic Function]
   861   C1269647:Cell [Cell]
   861   C1514485:Proliferation [Functional Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "an enhanced adipogenesis program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1709697:Program [Conceptual Entity]
   827   C2728259:Program [Pharmacologic Substance]
   827   C3484370:Program [Functional Concept]

Phrase: "was"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "a contributing factor in the MPR-induced programming"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   751   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   751   C0960756:factor A [Organic Chemical]
   736   C1521761:Factor [Functional Concept]
   736   C2827422:Factor [Conceptual Entity]

Phrase: "of visceral adiposity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0028754:Adiposity [Disease or Syndrome]
   861   C1563743:adiposity [Organism Attribute]
Processing 00000000.tx.217: The observed upregulation of MKP-1, a recently identified factor essential for in vitro adipocyte differentiation (64), as well as increased expression of the key transcription factors C/EBP- and C/EBP- involved in promoting adipocyte differentiation, are consistent with this notion. 

Phrase: "The observed upregulation of MKP-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0041904:Up-Regulation [Cell Function,Molecular Function]
   744   C0162493:Up-Regulation [Genetic Function]

Phrase: "a recently identified factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "essential for in vitro adipocyte differentiation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205224:Essential [Qualitative Concept]

Phrase: "(64"

Phrase: ")"

Phrase: ","

Phrase: "as well as"

Phrase: "increased expression of the key transcription factors C/EBP-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   751   C1171362:expression protein [Genetic Function]
   736   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "C/EBP-"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   933   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C2752241:enhancer binding [Genetic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]

Phrase: "involved in promoting adipocyte differentiation,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C1159884:adipocyte differentiation [Cell Function]
   760   C0007589:Differentiation [Cell Function]
   760   C0033414:Promoting [Activity]
   760   C0206131:Adipocyte [Cell]
   760   C1314939:Involved [Functional Concept]
   760   C1511938:Differentiation [Clinical Attribute]
   760   C2945687:Differentiation [Functional Concept]

Phrase: "are"

Phrase: "consistent with this notion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.218: It was shown previously that a large number of cell cycle-related genes were repressed during in vitro adipogenesis (68). 

Phrase: "It"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "previously"

Phrase: "that"

Phrase: "a large number of cell cycle-related genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0007584:Cell Number [Laboratory Procedure]
   744   C0237753:*Number [Quantitative Concept]
   744   C0449788:Number [Quantitative Concept]

Phrase: "were"

Phrase: "repressed during in vitro adipogenesis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0021135:In Vitro [Intellectual Product]
   806   C1533691:in vitro [Qualitative Concept]
           vitro
   806   C2827718:In Vitro [Functional Concept]
   760   C0596843:Adipogenesis [Molecular Function]

Phrase: "(68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.219: It is interesting to note that an equally extensive list of genes associated with cell cycle regulation was downregulated in adipose tissue of MPR rats, adding further support to the notion that adipogenesis was enhanced in this rat model. 

Phrase: "It"

Phrase: "is"

Phrase: "interesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "an equally extensive list of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0745732:List [Conceptual Entity]
   753   C3272378:LIST [Intellectual Product]

Phrase: "associated with cell cycle regulation"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   862   C1155872:Cell Cycle Regulation [Cell Function]
   806   C0007586:Cell Cycle [Cell Function]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C1155839:Cell Cycle [Cell Function]
   797   C0699040:cell associated [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1269647:Cell [Cell]
   760   C1327622:Regulation [Biologic Function]
   760   C1511572:Cycle [Temporal Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "was"

Phrase: "downregulated in adipose tissue of MPR rats,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   756   C0001527:Adipose tissue [Tissue]
   754   C1519523:Tissue Model [Experimental Model of Disease]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0034693:rats [Mammal]
   738   C0034721:Rats [Mammal]
   738   C0040300:Tissue [Tissue]
   738   C0443288:Restriction [Functional Concept]
   738   C1547928:Tissue [Intellectual Product]
   738   C2347083:Maternal [Family Group]
   738   C3161035:Model [Intellectual Product]
   737   C1335665:Rat Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "adding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1883712:Add [Functional Concept]

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "support to the notion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0183683:Support [Medical Device]
   770   C1521721:Support [Conceptual Entity]

Phrase: "that adipogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596843:Adipogenesis [Molecular Function]

Phrase: "was"

Phrase: "enhanced in this rat model."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C2349975:Enhanced [Activity]
   760   C3161035:Model [Intellectual Product]
Processing 00000000.tx.220: Moreover, there were no apparent differences in the size of adipocytes between control and MPR rats. 

Phrase: "Moreover,"

Phrase: "there"

Phrase: "were"

Phrase: "no apparent differences in the size of adipocytes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   782   C1268722:Difference in size [Finding]
           differences size
   711   C1705241:*Difference [Quantitative Concept]
   711   C1705242:Difference [Qualitative Concept]

Phrase: "between control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "MPR rats."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]
Processing 00000000.tx.221: Collectively, these findings suggested that the MPR-induced visceral adiposity was primarily a result of adipocyte hyperplasia. 

Phrase: "Collectively,"

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the MPR-induced visceral adiposity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C3161035:Model [Intellectual Product]

Phrase: "was"

Phrase: "primarily"

Phrase: "a result of adipocyte hyperplasia."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]
Processing 00000000.tx.222: Adipocyte differentiation in vitro involves remodeling of the ECM (22). 

Phrase: "Adipocyte differentiation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1159884:adipocyte differentiation [Cell Function]
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "involves"

Phrase: "remodeling of the ECM"

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.223: ECM remodeling is a complex and dynamic process that involves alterations in the expression and activity of ECM remodeling enzymes and the subsequent modification to ECM components. 

Phrase: "ECM remodeling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0015350:Extracellular Matrix [Tissue]

Phrase: "is"

Phrase: "a complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "dynamic process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "that"

Phrase: "involves"

Phrase: "alterations in the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1515926:Alteration [Idea or Concept]

Phrase: "and"

Phrase: "activity of ECM remodeling enzymes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0243102:enzyme activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "the subsequent modification to ECM components."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392747:Modification [Functional Concept]
   748   C1554963:modification [Qualitative Concept]
Processing 00000000.tx.224: MMP-2 is known to be upregulated in obesity and plays a critical role in adipose tissue ECM remodeling (11, 38). 

Phrase: "MMP-2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0172537:Matrix Metalloproteinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1334522:MATRIX METALLOPROTEINASE 2 [Gene or Genome]
   901   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704640:Matrix [Spatial Concept]
   827   C1706515:Matrix [Body Substance]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "upregulated in obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0028754:Obesity [Disease or Syndrome]
   790   C1963185:Obesity [Finding]

Phrase: "and"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a critical role in adipose tissue ECM remodeling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "(11,"

Phrase: "38"

Phrase: ")."
Processing 00000000.tx.225: Expression of MMP-24, an enzyme involved in the activation of MMP-2 (62), was increased in MPR rats. 

Phrase: "Expression of MMP-24,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "an enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "involved in the activation of MMP-2"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   800   C0172537:Matrix Metalloproteinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   800   C1334522:MATRIX METALLOPROTEINASE 2 [Gene or Genome]
   770   C0623362:Matrix Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1314939:Involved [Functional Concept]
   744   C1704640:Matrix [Spatial Concept]
   744   C1706515:Matrix [Body Substance]
   744   C1879547:Activation [Activity]

Phrase: "(62"

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "increased in MPR rats."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   750   C1335665:Rat Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0034693:rats [Mammal]
   744   C0034721:Rats [Mammal]
   744   C0205217:Increased [Quantitative Concept]
   744   C0442805:Increased [Functional Concept]
   744   C0443288:Restriction [Functional Concept]
   744   C2347083:Maternal [Family Group]
   744   C3161035:Model [Intellectual Product]
Processing 00000000.tx.226: Furthermore, MPR upregulated the expression of tetranectin, a plasminogen-binding protein that has been suggested to play an important role in tissue remodeling due to its ability to stimulate plasminogen activation and its expression in developing tissues such as the bone and muscle (31). 

Phrase: "Furthermore,"

Phrase: "MPR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]

Phrase: "upregulated"

Phrase: "the expression of tetranectin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "a plasminogen-binding protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C2364020:Plasminogen-Binding Protein [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "that"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role in tissue remodeling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "due to its ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "stimulate"

Phrase: "plasminogen activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1622667:plasminogen activation [Molecular Function]
   861   C0032140:Plasminogen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1367553:PLASMINOGEN [Gene or Genome]
   861   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "its expression in developing tissues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "such as the bone"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
  1000   C0391978:Bone [Tissue]
  1000   C1266908:Bone [Body Part, Organ, or Organ Component]
  1000   C1266909:Bone [Body System]
   928 E C0443157:Bony [Functional Concept]

Phrase: "and"

Phrase: "muscle"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026845:Muscle [Tissue]
   928 E C0442025:Muscular [Spatial Concept]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.227: In addition, expression of genes encoding a large number of cellular structural proteins and pancreatic proteases was also upregulated in MPR rats. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "expression of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   841   C0017262:Gene Expression [Genetic Function]
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "a large number of cellular structural proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "pancreatic proteases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Proteases [Enzyme]

Phrase: "was"

Phrase: "also"

Phrase: "upregulated in MPR rats."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   750   C1335665:Rat Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0034693:rats [Mammal]
   744   C0034721:Rats [Mammal]
   744   C0443288:Restriction [Functional Concept]
   744   C2347083:Maternal [Family Group]
   744   C3161035:Model [Intellectual Product]
Processing 00000000.tx.228: Therefore, active adipose tissue remodeling was likely a major factor contributing to the development of visceral adiposity in this rat model. 

Phrase: "Therefore,"

Phrase: "active adipose tissue remodeling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1820201:tissue remodeling [Biologic Function]

Phrase: "was"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "a major factor contributing to the development of visceral adiposity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1880177:Contributing [Activity]

Phrase: "in this rat model."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]
Processing 00000000.tx.229: In addition to promoting adipocyte differentiation, ECM remodeling is also involved in angiogenesis (10). 

Phrase: "In addition to promoting adipocyte differentiation,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C1159884:adipocyte differentiation [Cell Function]
   827   C0007589:Differentiation [Cell Function]
   827   C1511938:Differentiation [Clinical Attribute]
   827   C2945687:Differentiation [Functional Concept]
   755 E C0205615:Differentiated [Qualitative Concept]

Phrase: "ECM remodeling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0015350:Extracellular Matrix [Tissue]

Phrase: "is"

Phrase: "also"

Phrase: "involved in angiogenesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0302600:Angiogenesis [Organ or Tissue Function]
   790   C1314939:Involved [Functional Concept]
   790   C1519670:angiogenesis [Neoplastic Process]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.230: Recent evidence suggests that adipose tissue expansion is angiogenesis dependent (63). 

Phrase: "Recent evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that adipose tissue expansion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0040290:Tissue Expansion [Therapeutic or Preventive Procedure]
   734   C0001527:Adipose tissue [Tissue]

Phrase: "is"

Phrase: "angiogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0302600:Angiogenesis [Organ or Tissue Function]
  1000   C1519670:angiogenesis [Neoplastic Process]

Phrase: "dependent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0851827:Dependent [Qualitative Concept]
  1000   C1701901:Dependent [Qualitative Concept]
  1000   C3244310:dependent [Functional Concept]

Phrase: "(63"

Phrase: ")."
Processing 00000000.tx.231: It is believed that the angiogenic switch is tightly controlled by a balance between pro- and antiangiogenic factors (17). 

Phrase: "It"

Phrase: "is"

Phrase: "believed"

Phrase: "that"

Phrase: "the angiogenic switch"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1510885:Angiogenic Switch [Neoplastic Process]
   861   C1707719:Switch [Manufactured Object]

Phrase: "is"

Phrase: "tightly"

Phrase: "controlled by a balance"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   833   C0332298:Controlled by [Functional Concept]
   770   C0014653:Balance [Organism Function]
   770   C0205415:Balance [Functional Concept]
   770   C0560184:Balance [Finding]
   770   C2587213:Controlled [Functional Concept]
   737 E C0243148:control [Qualitative Concept]
   737 E C1550141:Control [Substance]
   737 E C1882979:Control [Conceptual Entity]
   737 E C3274648:Control [Qualitative Concept]

Phrase: "between pro-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2987124:PRO [Intellectual Product]

Phrase: "and"

Phrase: "antiangiogenic factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0596087:antiangiogenic [Biologically Active Substance,Pharmacologic Substance]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.232: Thus angiogenesis occurs in a tissue when levels of proangiogenic factors are increased while those of antiangiogenic factors are reduced (18). 

Phrase: "Thus angiogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0302600:Angiogenesis [Organ or Tissue Function]
   861   C1519670:angiogenesis [Neoplastic Process]

Phrase: "occurs in a tissue"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0040300:Tissue [Tissue]
   770   C1547928:Tissue [Intellectual Product]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]

Phrase: "when"

Phrase: "levels of proangiogenic factors"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "while"

Phrase: "those of antiangiogenic factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0596087:antiangiogenic [Biologically Active Substance,Pharmacologic Substance]
   737   C1521761:Factor [Functional Concept]
   737   C2827422:Factor [Conceptual Entity]

Phrase: "are"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.233: In the present study, we observed coordinated upregulation of angiogenic factors (leptin, TGF-, CTGF, CYR61, dermatopontin, and chymase-1) and downregulation of antiangiogenic factors (leucyl-specific aminopeptidase, F-spondin and properdin) in MPR rats. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "coordinated upregulation of angiogenic factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0041904:Up-Regulation [Cell Function,Molecular Function]
   760   C0162493:Up-Regulation [Genetic Function]

Phrase: "(leptin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0299583:Leptin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1416825:LEPTIN [Gene or Genome]

Phrase: "TGF-,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "CTGF,"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
  1000   C0110610:connective tissue growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413791:CONNECTIVE TISSUE GROWTH FACTOR [Gene or Genome]
   875   C0040048:Tissue Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C1333522:TISSUE FACTOR [Gene or Genome]
   861   C0009780:Connective Tissue [Tissue]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1621966:Tissue Growth [Organ or Tissue Function]
           Growth
   812   C0018270:'growth' NOS [Organism Function]
   812   C0040300:Tissue [Tissue]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1547928:Tissue [Intellectual Product]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "CYR61,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0699759:Rich [Qualitative Concept]

Phrase: "dermatopontin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414143:DERMATOPONTIN [Gene or Genome]

Phrase: "and"

Phrase: "chymase-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0055673:Chymase-1 [Amino Acid, Peptide, or Protein,Enzyme]
           Chymase
  1000   C1413516:CHYMASE 1 [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "downregulation of antiangiogenic factors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0013081:Down-Regulation [Cell Function,Molecular Function]

Phrase: "(leucyl-specific aminopeptidase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0023402:Leucyl Aminopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0002570:Aminopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "F-spondin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1420366:f-spondin [Gene or Genome]
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "properdin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033452:Properdin [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1418482:PROPERDIN [Gene or Genome]

Phrase: ")"

Phrase: "in MPR rats."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0034693:rats [Mammal]
   795   C0034721:Rats [Mammal]
   795   C0150312:In [Quantitative Concept]
   795   C0332285:In [Spatial Concept]
   795   C0443288:Restriction [Functional Concept]
   795   C2347083:Maternal [Family Group]
   795   C3161035:Model [Intellectual Product]
   740 E C0026591:Mother [Family Group]
   712 E C1826438:MATER [Gene or Genome]
Processing 00000000.tx.234: This suggested that angiogenesis likely played a key role in the pathogenesis of visceral adiposity in this rat model. 

Phrase: "This"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that angiogenesis likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0302600:Angiogenesis [Organ or Tissue Function]
   861   C1519670:angiogenesis [Neoplastic Process]

Phrase: "played"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0600138:played [Finding]
   966 E C0032214:Play [Daily or Recreational Activity]

Phrase: "a key role in the pathogenesis of visceral adiposity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "in this rat model."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]
Processing 00000000.tx.235: It is noteworthy that the majority of these factors whose expression was altered by MPR have not been described previously in adipose tissue, thus attesting to the utility of this functional genomics approach in identifying new players involved in adiposity/obesity. 

Phrase: "It"

Phrase: "is"

Phrase: "noteworthy"

Phrase: "that"

Phrase: "the majority of these factors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680220:majority [Social Behavior]

Phrase: "whose expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "altered by MPR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0392747:Altered [Functional Concept]
   748   C0443288:Restriction [Functional Concept]
   748   C2347083:Maternal [Family Group]
   748   C3161035:Model [Intellectual Product]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously in adipose tissue,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0001527:Adipose tissue [Tissue]
   770   C0040300:Tissue [Tissue]
   770   C1547928:Tissue [Intellectual Product]

Phrase: "thus"

Phrase: "attesting to the utility of this functional genomics"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0872316:functional genomics [Biomedical Occupation or Discipline]
   744   C0205245:Functional [Functional Concept]
   744   C0542341:Functional [Functional Concept]
   744   C0582205:utility [Organization]
   744   C0887950:Genomics [Biomedical Occupation or Discipline]
   744   C2700217:Functional [Conceptual Entity]

Phrase: "approach in identifying new players"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205314:New [Temporal Concept]
   760   C0449445:Approach [Spatial Concept]

Phrase: "involved in adiposity/obesity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0028754:Adiposity [Disease or Syndrome]
           Obesity
   770   C1314939:Involved [Functional Concept]
   770   C1563743:adiposity [Organism Attribute]
   770   C1963185:Obesity [Finding]
Processing 00000000.tx.236: In several rodent models of obesity, adipose tissue gene expression profiling has revealed a global upregulation of genes associated with inflammation (46, 47, 67). 

Phrase: "In several rodent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035804:Rodent [Mammal]

Phrase: "models of obesity,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0028754:Obesity [Disease or Syndrome]
   790   C1963185:Obesity [Finding]
   790   C3161035:Model [Intellectual Product]

Phrase: "adipose tissue gene expression profiling"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   884   C0752248:Gene Expression Profiling [Laboratory Procedure,Molecular Biology Research Technique]
   884   C1449575:Gene Expression Profiling [Laboratory Procedure]
   867 E C1956267:Profile, Gene Expression [Quantitative Concept]
   840   C1513400:Expression Profiling [Molecular Biology Research Technique]
   771   C1979963:Profile [Laboratory Procedure]
   771   C2003903:Profile [Functional Concept]

Phrase: "has"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a global upregulation of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0041904:Up-Regulation [Cell Function,Molecular Function]
   760   C0162493:Up-Regulation [Genetic Function]

Phrase: "associated with inflammation"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0021368:Inflammation [Pathologic Function]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(46,"

Phrase: "47,"

Phrase: "67"

Phrase: ")."
Processing 00000000.tx.237: Adipocytes are capable of expressing inflammatory genes (34). 

Phrase: "Adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206131:Adipocytes [Cell]

Phrase: "are"

Phrase: "capable of expressing inflammatory genes"

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.238: In addition, inflammatory cells such as macrophages have been demonstrated to be present in higher numbers in adipose tissue in obesity (75, 77). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "inflammatory cells such as macrophages"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C0440752:inflammatory cells [Cell]
   760   C0007634:Cells [Cell]
   760   C0333348:Inflammatory [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "have"

Phrase: "been"

Phrase: "demonstrated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "present in higher numbers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "in adipose tissue"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001527:Adipose tissue [Tissue]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
   789   C0028754:Adiposity [Disease or Syndrome]
   789   C1563743:adiposity [Organism Attribute]

Phrase: "in obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "(75,"

Phrase: "77"

Phrase: ")."
Processing 00000000.tx.239: It was surprising that a large number of genes involved in inflammatory processes were downregulated in this rat model. 

Phrase: "It"

Phrase: "was"

Phrase: "surprising"

Phrase: "that"

Phrase: "a large number of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "involved in inflammatory processes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0333348:Inflammatory [Functional Concept]
   770   C1314939:Involved [Functional Concept]
   737   C1184743:Process [Body Part, Organ, or Organ Component]
   737   C1522240:Process [Phenomenon or Process]

Phrase: "were"

Phrase: "downregulated in this rat model."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C3161035:Model [Intellectual Product]
Processing 00000000.tx.240: Although the precise reasons for this disparity are not apparent at the present time, it is tempting to speculate that the suppressed inflammatory state in the MPR adipose tissue may represent an earlier event occurring during the development of adiposity/obesity, because it is believed that the increased inflammatory response is likely a result of obesity (77). 

Phrase: "Although"

Phrase: "the precise reasons for this disparity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392360:reasons [Idea or Concept]

Phrase: "are"

Phrase: "not apparent at the present time,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0750489:apparent [Idea or Concept]

Phrase: "it"

Phrase: "is"

Phrase: "tempting"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "speculate"

Phrase: "that"

Phrase: "the suppressed inflammatory state in the MPR adipose tissue"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C0443288:State of restriction [Functional Concept]
   735   C0333348:Inflammatory [Functional Concept]
   735   C1301808:State [Geographic Area]
   735   C1442792:State [Functional Concept]
   735   C3148680:State [Geographic Area]

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "an earlier event"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441471:Event [Event]

Phrase: "occurring during the development of adiposity/obesity,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0028754:Adiposity [Disease or Syndrome]
           Obesity
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C1527148:Development [Functional Concept]
   748   C1563743:adiposity [Organism Attribute]
   748   C1963185:Obesity [Finding]
   714   C1709305:Occur [Activity]
   714   C2745955:OCCUR [Temporal Concept]

Phrase: "because"

Phrase: "it"

Phrase: "is"

Phrase: "believed"

Phrase: "that"

Phrase: "the increased inflammatory response"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1155266:Inflammatory Response [Pathologic Function]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "a result of obesity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "(77"

Phrase: ")."
Processing 00000000.tx.241: Consequently, it has been suggested that this enhanced inflammatory response may link obesity to its associated metabolic diseases (36). 

Phrase: "Consequently,"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this enhanced inflammatory response"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1155266:Inflammatory Response [Pathologic Function]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "may"

Phrase: "link"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "obesity to its associated metabolic diseases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0028754:Obesity [Disease or Syndrome]
   753   C1963185:Obesity [Finding]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.242: However, the pathophysiological significance of a suppressed inflammation state within the adipose tissue remains to be determined. 

Phrase: "However,"

Phrase: "the pathophysiological significance of a suppressed inflammation state"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0237881:Significance [Quantitative Concept]
   744   C0750502:Significance [Idea or Concept]

Phrase: "within the adipose tissue"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001527:Adipose tissue [Tissue]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
   789   C0028754:Adiposity [Disease or Syndrome]
   789   C1563743:adiposity [Organism Attribute]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "determined."
Processing 00000000.tx.243: Interestingly, several of the changes in the transcriptional profile of VAT as a result of MPR are similar to those observed in white adipose tissue following long-term caloric restriction (27). 

Phrase: "Interestingly,"

Phrase: "several of the changes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439064:Several [Quantitative Concept]
   770   C0443302:Several [Quantitative Concept]

Phrase: "in the transcriptional profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1979963:Profile [Laboratory Procedure]
   861   C2003903:Profile [Functional Concept]

Phrase: "of VAT"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1563740:Visceral Adipose Tissue [Tissue]
   901   C0001527:Adipose tissue [Tissue]
   827   C0040300:Tissue [Tissue]
   827   C0442045:Visceral [Spatial Concept]
   827   C1547928:Tissue [Intellectual Product]
   755   C0028754:Adiposity [Disease or Syndrome]
   755   C1563743:adiposity [Organism Attribute]

Phrase: "as a result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "of MPR"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0332285:Of [Spatial Concept]
   799   C0443288:Restriction [Functional Concept]
   799   C2347083:Maternal [Family Group]
   799   C3161035:Model [Intellectual Product]
   743 E C0026591:Mother [Family Group]
   716 E C1826438:MATER [Gene or Genome]

Phrase: "are"

Phrase: "similar to those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "observed in white adipose tissue"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C1704223:White Adipose Tissue [Tissue]
   806   C0001527:Adipose tissue [Tissue]
   760   C0007457:White [Population Group]
   760   C0040300:Tissue [Tissue]
   760   C0043157:White [Population Group]
   760   C0220938:White [Qualitative Concept]
   760   C1441672:Observed [Functional Concept]
   760   C1547928:Tissue [Intellectual Product]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "long-term caloric restriction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1135809:Caloric Restriction [Therapeutic or Preventive Procedure]
   812   C0443288:Restriction [Functional Concept]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.244: These include enhanced expression of genes involved in regulating lipogenesis and adipocyte differentiation as well as a global downregulation of genes associated with inflammatory processes. 

Phrase: "These"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "enhanced expression of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0017262:Gene Expression [Genetic Function]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "involved in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1314939:Involved [Functional Concept]

Phrase: "regulating"

Phrase: "lipogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0596843:lipogenesis [Molecular Function]
  1000   C1563744:Lipogenesis [Organism Function]

Phrase: "and"

Phrase: "adipocyte differentiation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1159884:adipocyte differentiation [Cell Function]
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "as well as"

Phrase: "a global downregulation of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0920533:Gene Down-Regulation [Genetic Function]
   760   C0013081:Down-Regulation [Cell Function,Molecular Function]

Phrase: "associated with inflammatory processes."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0333348:Inflammatory [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737   C1184743:Process [Body Part, Organ, or Organ Component]
   737   C1522240:Process [Phenomenon or Process]
   737 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.245: This similarity between the two distinct models suggests that MPR and caloric restriction alter adipose tissue gene activity in a similar way, thus underscoring the significance of our present findings utilizing this rat model in understanding the long-term effects of poor early nutrition on susceptibility to visceral adiposity/obesity in later life. 

Phrase: "This similarity between the two distinct models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2348205:Similarity [Qualitative Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that MPR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]

Phrase: "and"

Phrase: "caloric restriction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1135809:Caloric Restriction [Therapeutic or Preventive Procedure]
   861   C0443288:Restriction [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "adipose tissue gene activity in a similar way,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "thus"

Phrase: "underscoring"

Phrase: "the significance of our present findings"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237881:Significance [Quantitative Concept]
   753   C0750502:Significance [Idea or Concept]

Phrase: "utilizing"

Phrase: "this rat model in understanding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]

Phrase: "the long-term effects of poor early nutrition"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   800   C0023983:Long-Term Effects [Phenomenon or Process]
   770   C0443252:Long-term [Temporal Concept]
   744   C0205166:Long [Qualitative Concept]
   744   C1280500:effects [Qualitative Concept]
   744   C1515273:Term [Temporal Concept]
   744   C1705313:Term [Idea or Concept]
   744   C1706317:Long [Qualitative Concept]
   744   C2826302:TERM [Intellectual Product]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "on susceptibility"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0012655:Susceptibility [Clinical Attribute]
  1000   C0220898:Susceptibility [Organism Attribute]
  1000   C1264642:Susceptibility [Functional Concept]
  1000   C1547045:*Susceptibility [Quantitative Concept]
   928 E C0231204:Susceptible [Functional Concept]
   928 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "to visceral adiposity/obesity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C2936179:Obesity, Visceral [Sign or Symptom]
   827   C0028754:Obesity [Disease or Syndrome]
   827   C1963185:Obesity [Finding]

Phrase: "in later life."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0376558:Life [Idea or Concept]
   777 E C0595998:lives [Finding]
Processing 00000000.tx.246: It is noteworthy that the present study, like many others in the literature (20, 37, 46, 47, 67), used RNA samples derived from adipose tissue for gene expression profile analysis. 

Phrase: "It"

Phrase: "is"

Phrase: "noteworthy"

Phrase: "that"

Phrase: "the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "like many others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "in the literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023866:Literature [Intellectual Product]
  1000   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "(20,"

Phrase: "37,"

Phrase: "46,"

Phrase: "47,"

Phrase: "67"

Phrase: ")"

Phrase: ","

Phrase: "used RNA samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]

Phrase: "derived from adipose tissue"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0001527:Adipose tissue [Tissue]
   770   C0040300:Tissue [Tissue]
   770   C1441547:Derived [Qualitative Concept]
   770   C1547928:Tissue [Intellectual Product]
   770   C3245521:derived [Idea or Concept]

Phrase: "for gene expression profile analysis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C1880945:Gene Expression Analysis [Molecular Biology Research Technique]
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]
   756   C1449575:gene expression profile [Laboratory Procedure]
   756   C1956267:Profile, Gene Expression [Quantitative Concept]
Processing 00000000.tx.247: This kind of study design is distinct (in the objectives and, hence, the interpretations of the results) from those in which RNA extracts prepared from a pure population of adipocytes was utilized (68). 

Phrase: "This kind of study design"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332307:Kind [Qualitative Concept]

Phrase: "is"

Phrase: "distinct"

Phrase: "("

Phrase: "in the objectives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0018017:objectives [Intellectual Product]
   966 E C1571702:Objective [Qualitative Concept]

Phrase: "and"

Phrase: ","

Phrase: "hence,"

Phrase: "the interpretations of the results"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0459471:interpretations [Intellectual Product]
   726 E C3173575:Interpretation [Clinical Attribute]

Phrase: ")"

Phrase: "from those in which RNA extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2828366:Extract [Substance]

Phrase: "prepared from a pure population of adipocytes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0032659:Population [Quantitative Concept]
   748   C0206131:Adipocytes [Cell]
   748   C1257890:Population [Population Group]
   748   C2247561:PurE [Molecular Function]
   714   C1521827:Prepare [Functional Concept]

Phrase: "was"

Phrase: "utilized"

Phrase: "(68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.248: Consequently, many of the alterations in adipose tissue gene expression that we observed in this study could be explained by a change in the ratio of adipocytes to other cell types between control and MPR rats. 

Phrase: "Consequently,"

Phrase: "many of the alterations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439064:Many [Quantitative Concept]
   770   C0747726:many [Conceptual Entity]
   737   C1515926:Alteration [Idea or Concept]

Phrase: "in adipose tissue gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0017262:Gene Expression [Genetic Function]
   812   C0017337:Gene [Gene or Genome]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "we"

Phrase: "observed in this study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0557651:Study [Manufactured Object]
   770   C1441672:Observed [Functional Concept]
   770   C2603343:Study [Research Activity]

Phrase: "could"

Phrase: "be"

Phrase: "explained by a change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]

Phrase: "in the ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456603:Ratio [Quantitative Concept]
  1000   C1547037:Ratio [Intellectual Product]

Phrase: "of adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206131:Adipocytes [Cell]

Phrase: "to other cell types"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0449475:Cell types [Intellectual Product]
   966 E C0007634:Cell Type [Cell]
           Cell
   861   C0332307:Types [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1547052:*Type [Quantitative Concept]

Phrase: "between control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "MPR rats."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]
Processing 00000000.tx.249: Obviously, the validity of this contention requires future scrutiny. 

Phrase: "Obviously,"

Phrase: "the validity of this contention"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2349101:Validity [Quantitative Concept]

Phrase: "requires"

Phrase: "future scrutiny."
Processing 00000000.tx.250: In conclusion, we demonstrate that maternal protein restriction during pregnancy and lactation programs the susceptibility to visceral adiposity in the adult rat offspring, and that the coordinated upregulation of molecular pathways involved in adipogenesis and angiogenesis likely plays a key role in this process (Fig. 4). 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "we"

Phrase: "demonstrate"

Phrase: "that maternal protein restriction during pregnancy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0443288:Restriction [Functional Concept]

Phrase: "and"

Phrase: "lactation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006147:Lactation [Organism Function]
  1000   C0022925:Lactation [Organ or Tissue Function]

Phrase: "programs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0376691:Programs [Intellectual Product]
  1000   C1709697:Program [Conceptual Entity]
  1000   C2728259:Program [Pharmacologic Substance]
  1000   C3484370:Program [Functional Concept]

Phrase: "the susceptibility to visceral adiposity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0012655:Susceptibility [Clinical Attribute]
   760   C0220898:Susceptibility [Organism Attribute]
   760   C1264642:Susceptibility [Functional Concept]
   760   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "in the adult rat offspring,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0683572:Offspring, Adult [Family Group]
   827   C0680063:Offspring [Family Group]

Phrase: "and"

Phrase: "that"

Phrase: "the coordinated upregulation of molecular pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0041904:Up-Regulation [Cell Function,Molecular Function]
   753   C0162493:Up-Regulation [Genetic Function]

Phrase: "involved in adipogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0596843:Adipogenesis [Molecular Function]
   790   C1314939:Involved [Functional Concept]

Phrase: "and"

Phrase: "angiogenesis likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0302600:Angiogenesis [Organ or Tissue Function]
   861   C1519670:angiogenesis [Neoplastic Process]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a key role in this process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.251: View larger version (21K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(21K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.252: 4. 

Phrase: "4."
Processing 00000000.tx.253: Schematic overview depicting key differentially expressed genes and postulated molecular pathways that may be involved in the pathogenesis of visceral adiposity in this rat model. 

Phrase: "Schematic overview depicting key differentially expressed genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0017337:Genes [Gene or Genome]

Phrase: "and"

Phrase: "postulated molecular pathways"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C1704259:molecular pathway [Molecular Function]
           Pathways
   827   C1705987:Pathways [Conceptual Entity]

Phrase: "that"

Phrase: "may"

Phrase: "be"

Phrase: "involved in the pathogenesis of visceral adiposity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0028754:Adiposity [Disease or Syndrome]
   748   C0442045:Visceral [Spatial Concept]
   748   C0543483:pathogenesis [Functional Concept]
   748   C0699748:Pathogenesis [Pathologic Function]
   748   C1314939:Involved [Functional Concept]
   748   C1563743:adiposity [Organism Attribute]

Phrase: "in this rat model."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]
Processing 00000000.tx.254: For full explanation and definitions, see RESULTS and DISCUSSION.   

Phrase: "For full explanation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0681841:Explanation [Intellectual Product]

Phrase: "and"

Phrase: "definitions,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1550452:definition [Idea or Concept]
   966   C1704788:Definition [Conceptual Entity]
   966   C3539107:Definition [Intellectual Product]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "and"

Phrase: "DISCUSSION."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]
Processing 00000000.tx.255: GRANTS TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION GRANTS REFERENCES  This work was supported by grants from the Canadian Institutes of Health Research.  

Phrase: "GRANTS TOP ABSTRACT MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION GRANTS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0018173:Grants [Quantitative Concept]
   779 E C1548284:Grant [Idea or Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by grants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from the Canadian Institutes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0021622:Institutes [Organization]
   827 E C1272753:Institute [Idea or Concept]

Phrase: "of Health Research."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
Processing 00000000.tx.256: ACKNOWLEDGMENTS  We thank Brenda Strutt for performing fat tissue histology.  

Phrase: "ACKNOWLEDGMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Brenda Strutt for performing fat tissue histology."
Processing 00000000.tx.257: FOOTNOTES  Address for reprint requests and other correspondence: K. 

Phrase: "FOOTNOTES  Address for reprint requests"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0376649:Address [Intellectual Product]
   760   C1442065:Address [Spatial Concept]

Phrase: "and"

Phrase: "other correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: ":"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.258: Yang, Children's Health Research Institute, Rm. 

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "Children's Health Research Institute,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   861   C0008078:Children's Health [Health Care Activity]
   861   C0035172:Research Institute [Organization]
   812   C0018684:Health [Idea or Concept]
   812   C0021622:institute [Organization]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: "Rm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2951520:RM [Body Location or Region]
Processing 00000000.tx.259: A5-132, Victoria Research Laboratories- Westminster Campus, 800 Commissioners Road East, London, ON, Canada N6A 4G5 (E-mail: kyang{at}uwo.ca ) The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "A5-132,"

Phrase: "Victoria Research Laboratories- Westminster Campus,"

Phrase: "800 Commissioners Road East,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1707877:East [Spatial Concept]

Phrase: "London,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023973:London [Geographic Area]

Phrase: "ON,"

Phrase: "Canada N6A 4G5"

Phrase: "(E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "kyang{at}uwo.ca )"

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.260: The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.261: Section 1734 solely to indicate this fact.  

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.262: REFERENCES TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION GRANTS REFERENCES  Abrahamson M, Alvarez-Fernandez M, and Nathanson CM. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION GRANTS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0018173:Grants [Quantitative Concept]
   779 E C1548284:Grant [Idea or Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Abrahamson M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Alvarez-Fernandez M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Nathanson CM."
Processing 00000000.tx.263: Cystatins. 

Phrase: "Cystatins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010646:Cystatins [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.264: Biochem Soc Symp: 179199, 2003. 

Phrase: "Biochem Soc Symp"

Phrase: ":"

Phrase: "179199,"

Phrase: "2003."
Processing 00000000.tx.265: Ailhaud G, Teboul M, and Massiera F. 

Phrase: "Ailhaud G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Teboul M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Massiera F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.266: Angogen, adipocyte differentiation and fat mass enlargement. 

Phrase: "Angogen,"

Phrase: "adipocyte differentiation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1159884:adipocyte differentiation [Cell Function]
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "fat mass enlargement."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0020564:Enlargement, NOS [Pathologic Function]
   827   C1293134:Enlargement [Therapeutic or Preventive Procedure]
   827   C2711450:Enlargement [Anatomical Abnormality]
Processing 00000000.tx.267: Curr Opin Clin Nutr Metab Care 5: 385389, 2002.[CrossRef][ISI][Medline] Bahamonde ME and Lyons KM. 

Phrase: "Curr Opin Clin Nutr Metab Care 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C1315013:CLIN [Intellectual Product]
   795   C1947933:Care [Activity]

Phrase: ":"

Phrase: "385389,"

Phrase: "2002."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bahamonde"

Phrase: "ME"

Phrase: "and"

Phrase: "Lyons KM."
Processing 00000000.tx.268: BMP3: to be or not to be a BMP. 

Phrase: "BMP3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0069675:BMP3 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332425:BMP3 [Gene or Genome]

Phrase: ":"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "or"

Phrase: "not to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "a BMP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0053932:BMP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0279266:BMP [Therapeutic or Preventive Procedure]
Processing 00000000.tx.269: J Bone Joint Surg Am 83-A, Suppl 1: S56S62, 2001. 

Phrase: "J Bone Joint Surg"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3541227:Surg [Temporal Concept]

Phrase: "Am"

Phrase: "83-"

Phrase: "A,"

Phrase: "Suppl 1"

Phrase: ":"

Phrase: "S56S62,"

Phrase: "2001."
Processing 00000000.tx.270: Barker DJ. 

Phrase: "Barker DJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]
Processing 00000000.tx.271: Fetal origins of coronary heart disease. 

Phrase: "Fetal origins of coronary heart disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0079946:origins [Classification]
   753   C0439659:Origins [Temporal Concept]
   748   C0019247:Genetic disease [Disease or Syndrome]
   719 E C1550512:origin [Intellectual Product]
   706 E C2316203:Genetic diseases [Finding]
   706 E C2924406:Genetic diseases [Laboratory Procedure]
Processing 00000000.tx.272: BMJ 311: 171174, 1995.[Free FullText] Bell GI, Quinto C, Quiroga M, Valenzuela P, Craik CS, and Rutter WJ. 

Phrase: "BMJ 311"

Phrase: ":"

Phrase: "171174,"

Phrase: "1995."

Phrase: "[Free FullText"

Phrase: "] Bell GI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: "Quinto C,"

Phrase: "Quiroga M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Valenzuela P,"

Phrase: "Craik CS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540510:cs [Quantitative Concept]

Phrase: "and"

Phrase: "Rutter WJ."
Processing 00000000.tx.273: Isolation and sequence of a rat chymotrypsin B gene. 

Phrase: "Isolation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0204727:Isolation [Therapeutic or Preventive Procedure]
  1000   C0205409:Isolation [Functional Concept]
  1000   C0220862:isolation [Laboratory Procedure]
   928 E C1548221:Isolated [Idea or Concept]

Phrase: "and"

Phrase: "sequence of a rat chymotrypsin B gene."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.274: J Biol Chem 259: 1426514270, 1984.[Abstract/Free FullText] Biardi L and Krisans SK. 

Phrase: "J Biol Chem 259"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1426514270,"

Phrase: "1984."

Phrase: "[Abstract/Free FullText"

Phrase: "] Biardi L"

Phrase: "and"

Phrase: "Krisans SK."
Processing 00000000.tx.275: Compartmentalization of cholesterol biosynthesis. 

Phrase: "Compartmentalization of cholesterol biosynthesis."
Processing 00000000.tx.276: Conversion of mevalonate to farnesyl diphosphate occurs in the peroxisomes. 

Phrase: "Conversion of mevalonate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439836:Conversion [Functional Concept]

Phrase: "to farnesyl diphosphate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0060069:farnesyl diphosphate [Organophosphorus Compound]
   861   C0034320:diphosphate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "occurs in the peroxisomes."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0752063:Peroxisomes [Cell Component]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]
   737 E C2984308:Peroxisome [Functional Concept]
Processing 00000000.tx.277: J Biol Chem 271: 17841788, 1996.[Abstract/Free FullText] Boucher P, Gotthardt M, Li WP, Anderson RG, and Herz J. 

Phrase: "J Biol Chem 271"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "17841788,"

Phrase: "1996."

Phrase: "[Abstract/Free FullText"

Phrase: "] Boucher P,"

Phrase: "Gotthardt M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Li WP,"

Phrase: "Anderson RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "and"

Phrase: "Herz J."
Processing 00000000.tx.278: LRP: role in vascular wall integrity and protection from atherosclerosis. 

Phrase: "LRP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540560:LRP [Gene or Genome]

Phrase: ":"

Phrase: "role in vascular wall integrity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "protection from atherosclerosis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1545588:Protection [Finding]
Processing 00000000.tx.279: Science 300: 329332, 2003.[Abstract/Free FullText] Bouloumie A, Drexler HC, Lafontan M, and Busse R. 

Phrase: "Science 300"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "329332,"

Phrase: "2003."

Phrase: "[Abstract/Free FullText"

Phrase: "] Bouloumie A,"

Phrase: "Drexler HC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020268:HC [Hormone,Pharmacologic Substance,Steroid]
   861   C1413512:Hc [Gene or Genome]

Phrase: "Lafontan M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Busse R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.280: Leptin, the product of Ob gene, promotes angiogenesis. 

Phrase: "Leptin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0299583:Leptin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1416825:LEPTIN [Gene or Genome]

Phrase: "the product of Ob gene,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   844   C0299583:Ob Gene Product [Amino Acid, Peptide, or Protein,Hormone]
   797   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C1514468:product [Entity]
   760   C1704444:Product [Quantitative Concept]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "angiogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0302600:Angiogenesis [Organ or Tissue Function]
  1000   C1519670:angiogenesis [Neoplastic Process]
Processing 00000000.tx.281: Circ Res 83: 10591066, 1998.[Abstract/Free FullText] Brigstock DR. 

Phrase: "Circ Res 83"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332520:Circ [Quantitative Concept]
   827   C2347379:RES [Finding]
   827   C2347774:circ [Quantitative Concept]

Phrase: ":"

Phrase: "10591066,"

Phrase: "1998."

Phrase: "[Abstract/Free FullText"

Phrase: "] Brigstock DR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]
Processing 00000000.tx.282: Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61). 

Phrase: "Regulation of angiogenesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1160251:regulation of angiogenesis [Organism Function]
   790   C0851285:Regulation [Governmental or Regulatory Activity]
   790   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "endothelial cell function by connective tissue growth factor (CTGF)"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   819   C0016026:Endothelial Cell Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   819   C1333536:ENDOTHELIAL CELL GROWTH FACTOR [Gene or Genome]
   793   C0009781:Connective tissue cell [Cell]
   793   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0007613:Cell Function [Cell Function]
   770   C0225336:Endothelial cell [Cell]
   767   C0007595:Cell Growth [Cell Function]
   767   C0014257:Endothelial tissue [Tissue]
           Endothelial
   744   C0007634:Cell [Cell]
   744   C0031843:function [Physiologic Function]
   744   C0542341:Function [Functional Concept]
   744   C0700205:FUNCTION [Classification]
   744   C1269647:Cell [Cell]
   744   C1704653:Cell [Medical Device]
   744   C1705273:Function [Intellectual Product]
   744   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "cysteine-rich 61 (CYR61)."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0699759:Rich [Qualitative Concept]
Processing 00000000.tx.283: Angiogenesis 5: 153165, 2002.[CrossRef][Medline] Byrne CD and Phillips DI. 

Phrase: "Angiogenesis 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0302600:Angiogenesis [Organ or Tissue Function]
   861   C1519670:angiogenesis [Neoplastic Process]

Phrase: ":"

Phrase: "153165,"

Phrase: "2002."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Byrne CD"

Phrase: "and"

Phrase: "Phillips DI."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3538902:DI [Gene or Genome]
   861   C3541881:DI [Idea or Concept]
Processing 00000000.tx.284: Fetal origins of adult disease: epidemiology and mechanisms. 

Phrase: "Fetal origins of adult disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   762   C0019247:Genetic disease [Disease or Syndrome]
   760   C0079946:origins [Classification]
   760   C0439659:Origins [Temporal Concept]
   726 E C1550512:origin [Intellectual Product]
   720 E C2316203:Genetic diseases [Finding]
   720 E C2924406:Genetic diseases [Laboratory Procedure]

Phrase: ":"

Phrase: "epidemiology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014507:Epidemiology [Biomedical Occupation or Discipline]
  1000   C0014508:epidemiology [Functional Concept]
  1000   C0699910:epidemiology [Health Care Activity]

Phrase: "and"

Phrase: "mechanisms."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.285: J Clin Pathol 53: 822828, 2000.[Abstract/Free FullText] Chang C and Werb Z. 

Phrase: "J Clin Pathol 53"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "822828,"

Phrase: "2000."

Phrase: "[Abstract/Free FullText"

Phrase: "] Chang C"

Phrase: "and"

Phrase: "Werb Z."
Processing 00000000.tx.286: The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. 

Phrase: "The"

Phrase: "many faces of metalloproteases"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0015450:Faces [Body Location or Region]
   737 E C1281591:Face [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "cell growth,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0007595:Cell Growth [Cell Function]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]

Phrase: "invasion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1269955:Invasion [Finding]
  1000   C2699153:Invasion [Pathologic Function]

Phrase: "angiogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0302600:Angiogenesis [Organ or Tissue Function]
  1000   C1519670:angiogenesis [Neoplastic Process]

Phrase: "and"

Phrase: "metastasis."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0027627:Metastasis [Neoplastic Process]
  1000   C2939420:metastasis [Neoplastic Process]
   928 E C0036525:Metastatic [Functional Concept]
   928 E C1522484:metastatic [Quantitative Concept]
Processing 00000000.tx.287: Trends Cell Biol 11: S3743, 2001.[CrossRef][ISI][Medline] Chavey C, Mari B, Monthouel MN, Bonnafous S, ANGlard P, Van Obberghen E, and Tartare-Deckert S. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Cell Biol 11"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "S3743,"

Phrase: "2001."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Chavey C,"

Phrase: "Mari B,"

Phrase: "Monthouel MN,"

Phrase: "Bonnafous S,"

Phrase: "ANGlard P,"

Phrase: "Van Obberghen E,"

Phrase: "and"

Phrase: "Tartare-Deckert S."
Processing 00000000.tx.288: Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation. 

Phrase: "Matrix metalloproteinases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]

Phrase: "are"

Phrase: "differentially"

Phrase: "expressed in adipose tissue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0001527:Adipose tissue [Tissue]
   770   C0040300:Tissue [Tissue]
   770   C1547928:Tissue [Intellectual Product]

Phrase: "during obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "and"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "adipocyte differentiation."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1159884:adipocyte differentiation [Cell Function]
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.289: J Biol Chem 278: 1188811896, xxxx. 

Phrase: "J Biol Chem 278"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1188811896,"

Phrase: "xxxx."
Processing 00000000.tx.290: Chiappe De Cingolani GE and Caldiz CI. 

Phrase: "Chiappe De Cingolani GE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3538705:GE [Gene or Genome]

Phrase: "and"

Phrase: "Caldiz CI."
Processing 00000000.tx.291: Insulin resistance and GLUT-4 glucose transporter in adipocytes from hypertensive rats. 

Phrase: "Insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "GLUT-4 glucose transporter in adipocytes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   820   C1420175:GLUCOSE TRANSPORTER 4 [Gene or Genome]
   790   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "from hypertensive rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
Processing 00000000.tx.292: Metabolism 53: 382387, 2004.[CrossRef][ISI][Medline] Clauser E, Gardell SJ, Craik CS, MacDonald RJ, and Rutter WJ. 

Phrase: "Metabolism 53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: ":"

Phrase: "382387,"

Phrase: "2004."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Clauser E,"

Phrase: "Gardell SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Craik CS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540510:cs [Quantitative Concept]

Phrase: "MacDonald RJ,"

Phrase: "and"

Phrase: "Rutter WJ."
Processing 00000000.tx.293: Structural characterization of the rat carboxypeptidase A1 and B genes. 

Phrase: "Structural characterization of the rat carboxypeptidase A1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "B genes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]
Processing 00000000.tx.294: Comparative analysis of the rat carboxypeptidase gene family. 

Phrase: "Comparative analysis of the rat carboxypeptidase gene family."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0683941:comparative analysis [Research Activity]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]
Processing 00000000.tx.295: J Biol Chem 263: 1783717845, 1988.[Abstract/Free FullText] Compe E, de Sousa G, Francois K, Roche R, Rahmani R, Torresani J, Raymondjean M, and Planells R. 

Phrase: "J Biol Chem 263"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1783717845,"

Phrase: "1988."

Phrase: "[Abstract/Free FullText"

Phrase: "] Compe E,"

Phrase: "de Sousa G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "Francois K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Roche R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Rahmani R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Torresani J,"

Phrase: "Raymondjean M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Planells R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.296: Spot 14 protein interacts and co-operates with chicken ovalbumin upstream promoter-transcription factor 1 in the transcription of the L-type pyruvate kinase gene through a specificity protein 1 (Sp1) binding site. 

Phrase: "Spot 14 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "interacts"

Phrase: "and"

Phrase: "co-operates with chicken ovalbumin upstream promoter-transcription factor 1"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   893   C1417833:CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR 1 [Gene or Genome]
   799   C1421376:upstream transcription factor 1 [Gene or Genome]
   782   C0209278:Transcription Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   782   C1420631:TRANSCRIPTION FACTOR 1 [Gene or Genome]
   777   C0076925:Upstream Transcription Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0008051:Chicken [Bird]
   739   C0029923:Ovalbumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0040649:Transcription [Genetic Function]
   739   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0522505:Upstream [Spatial Concept]
   739   C0677521:Chicken [Food]
   739   C1365945:CHICKEN [Food]
   739   C1521761:Factor [Functional Concept]
   739   C2827422:Factor [Conceptual Entity]
   739   C3242339:operate [Functional Concept]

Phrase: "in the transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcription [Genetic Function]

Phrase: "of the L-type pyruvate kinase gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0017337:Gene [Gene or Genome]
   771   C0034349:L-Type Pyruvate Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "through a specificity protein 1 (Sp1) binding site."
Meta Candidates (Total=18; Excluded=2; Pruned=0; Remaining=16)
   884   C1335858:SPECIFICITY PROTEIN 1 [Gene or Genome]
   862   C0449604:Specific site [Spatial Concept]
   853   C0033618:Protein Binding [Molecular Function]
   840   C0005456:Binding Site [Receptor]
   840   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0682969:Binding Site [Amino Acid Sequence]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0037791:Specificity [Quantitative Concept]
   804   C0205145:Site [Spatial Concept]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1511884:Specificity [Quantitative Concept]
   804   C1515974:Site [Body Location or Region]
   804   C2825164:Site [Spatial Concept]
   733 E C0205369:Specific [Qualitative Concept]
   733 E C1552740:specific [Intellectual Product]
Processing 00000000.tx.297: Biochem J 358: 175183, 2001.[CrossRef][ISI][Medline] Dell'Italia LJ and Husain A. 

Phrase: "Biochem J 358"

Phrase: ":"

Phrase: "175183,"

Phrase: "2001."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Dell'Italia LJ"

Phrase: "and"

Phrase: "Husain A."
Processing 00000000.tx.298: Dissecting the role of chymase in ANG II formation and heart and blood vessel diseases. 

Phrase: "Dissecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205239:Dissecting [Functional Concept]

Phrase: "the role of chymase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in ANG II formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "heart"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018787:Heart [Body Part, Organ, or Organ Component]
  1000   C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "blood vessel diseases."
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   983   C0042373:blood vessel disease [Disease or Syndrome]
   958 E C0018939:Blood Diseases [Disease or Syndrome]
   941 E C1533163:Blood disease [Disease or Syndrome]
   827   C0012634:Diseases [Disease or Syndrome]
   755 E C1836721:MALS [Finding]
   755 E C3538764:MALS [Gene or Genome]
   755 E C3540595:MAL [Gene or Genome]
   734   C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   734   C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   734   C1511228:VESSEL, BLOOD [Tissue]
Processing 00000000.tx.299: Curr Opin Cardiol 17: 374379, 2002.[CrossRef][ISI][Medline] Figarella C, De Caro A, Leupold D, and Poley JR. 

Phrase: "Curr Opin Cardiol 17"

Phrase: ":"

Phrase: "374379,"

Phrase: "2002."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Figarella C,"

Phrase: "De Caro A,"

Phrase: "Leupold D,"

Phrase: "and"

Phrase: "Poley JR."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.300: Congenital pancreatic lipase deficiency. 

Phrase: "Congenital pancreatic lipase deficiency."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0268240:Congenital pancreatic lipase deficiency [Disease or Syndrome]
   923   C3280527:PANCREATIC LIPASE DEFICIENCY [Disease or Syndrome]
   902   C0333006:Congenital deficiency [Congenital Abnormality]
   861   C1291447:lipase deficiency [Disease or Syndrome]
   812   C0011155:Deficiency [Functional Concept]
   812   C0162429:Deficiency [Disease or Syndrome]
   812   C1623416:deficiency [Qualitative Concept]
   741 E C1636779:% deficient [Quantitative Concept]
Processing 00000000.tx.301: J Pediatr 96: 412416, 1980.[ISI][Medline] Folkman J. 

Phrase: "J Pediatr 96"

Phrase: ":"

Phrase: "412416,"

Phrase: "1980."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Folkman J."
Processing 00000000.tx.302: Angiogenesis in cancer, vascular, rheumatoid and other disease. 

Phrase: "Angiogenesis in cancer,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C1536999:cancer angiogenesis [Neoplastic Process]
   790   C0302600:Angiogenesis [Organ or Tissue Function]
   790   C1519670:angiogenesis [Neoplastic Process]

Phrase: "vascular,"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005847:vascular [Body Part, Organ, or Organ Component]
  1000   C1558950:VASCULAR [Finding]
  1000   C1801960:Vascular [Qualitative Concept]
   944 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   944 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C0005767:Blood [Tissue]
   900 E C0005768:blood [Body Substance]
   900 E C0229664:Blood [Body Substance]
   900 E C0392895:Bloods [Population Group]
   884 E C0333275:Bloody [Qualitative Concept]

Phrase: "rheumatoid"

Phrase: "and"

Phrase: "other disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.303: Nat Med 1: 2731, 1995.[CrossRef][ISI][Medline] Folkman J. 

Phrase: "Nat Med 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C1426489:NAT-1 [Gene or Genome]

Phrase: ":"

Phrase: "2731,"

Phrase: "1995."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Folkman J."
Processing 00000000.tx.304: Fundamental concepts of the angiogenic process. 

Phrase: "Fundamental concepts of the angiogenic process."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0178566:concepts [Idea or Concept]
Processing 00000000.tx.305: Curr Mol Med 3: 643651, 2003.[CrossRef][ISI][Medline] Froguel P and Boutin P. 

Phrase: "Curr Mol Med 3"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "643651,"

Phrase: "2003."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Froguel P"

Phrase: "and"

Phrase: "Boutin P."
Processing 00000000.tx.306: Genetics of pathways regulating body weight in the development of obesity in humans. 

Phrase: "Genetics of pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017398:Genetics [Biomedical Occupation or Discipline]
   790   C0017399:genetics [Biologic Function]

Phrase: "regulating"

Phrase: "body weight in the development of obesity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0005910:Body Weight [Organism Attribute]
           weight
   778   C1305866:body weight [Diagnostic Procedure]
           weight
   748   C0043100:Weight [Quantitative Concept]
   748   C0242821:body [Human]
   748   C0460148:Body [Anatomical Structure]
   748   C1268086:Body [Anatomical Structure]
   748   C1705104:Weight [Idea or Concept]

Phrase: "in humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]
Processing 00000000.tx.307: Exp Biol Med (Maywood) 226: 991996, 2001.[Abstract/Free FullText] Gomez-Ambrosi J, Catalan V, Diez-Caballero A, Martinez-Cruz LA, Gil MJ, Garcia-Foncillas J, Cienfuegos JA, Salvador J, Mato JM, and Fruhbeck G. 

Phrase: "Exp Biol Med (Maywood"

Phrase: ")"

Phrase: "226"

Phrase: ":"

Phrase: "991996,"

Phrase: "2001."

Phrase: "[Abstract/Free FullText"

Phrase: "] Gomez-Ambrosi J,"

Phrase: "Catalan V,"

Phrase: "Diez-Caballero A,"

Phrase: "Martinez-Cruz LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023031:La [Element, Ion, or Isotope]

Phrase: "Gil MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Garcia-Foncillas J,"

Phrase: "Cienfuegos JA,"

Phrase: "Salvador J,"

Phrase: "Mato JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "and"

Phrase: "Fruhbeck G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.308: Gene expression profile of omental adipose tissue in human obesity. 

Phrase: "Gene expression profile of omental adipose tissue"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   814   C1449575:gene expression profile [Laboratory Procedure]
   814   C1956267:Profile, Gene Expression [Quantitative Concept]
   748   C1979963:Profile [Laboratory Procedure]
   748   C2003903:Profile [Functional Concept]

Phrase: "in human obesity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0028754:Obesity [Disease or Syndrome]
   861   C1963185:Obesity [Finding]
Processing 00000000.tx.309: FASEB J 18: 215217, 2004.[Abstract/Free FullText] Goudriaan JR, Tacken PJ, Dahlmans VE, Gijbels MJ, van Dijk KW, Havekes LM, and Jong MC. 

Phrase: "FASEB J 18"

Phrase: ":"

Phrase: "215217,"

Phrase: "2004."

Phrase: "[Abstract/Free FullText"

Phrase: "] Goudriaan JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Tacken PJ,"

Phrase: "Dahlmans VE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042469:VE [Geographic Area]

Phrase: "Gijbels MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "van Dijk KW,"

Phrase: "Havekes LM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1261082:LM [Body Part, Organ, or Organ Component]
   861   C1551056:lm [Quantitative Concept]
   861   C2981682:LM [Quantitative Concept]

Phrase: "and"

Phrase: "Jong MC."
Processing 00000000.tx.310: Protection from obesity in mice lacking the VLDL receptor. 

Phrase: "Protection from obesity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1545588:Protection [Finding]

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "the VLDL receptor."
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
  1000   C1421455:VERY LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   937   C0023825:Very low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   937   C0034821:Low Density Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   937   C1366529:LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   884   C0023823:Low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   840   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   840   C0442811:Very low [Finding]
   804   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0178587:density [Quantitative Concept]
   804   C0205251:low [Qualitative Concept]
   804   C0442824:Very [Qualitative Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1299352:Low [Qualitative Concept]
   804   C1550472:low [Idea or Concept]
   733 E C0439794:Dense [Qualitative Concept]
Processing 00000000.tx.311: Arterioscler Thromb Vasc Biol 21: 14881493, 2001.[Abstract/Free FullText] Gregoire FM, Smas CM, and Sul HS. 

Phrase: "Arterioscler Thromb Vasc Biol 21"

Phrase: ":"

Phrase: "14881493,"

Phrase: "2001."

Phrase: "[Abstract/Free FullText"

Phrase: "] Gregoire FM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540627:FM [Gene or Genome]

Phrase: "Smas CM,"

Phrase: "and"

Phrase: "Sul HS."
Processing 00000000.tx.312: Understanding adipocyte differentiation. 

Phrase: "Understanding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understanding [Mental Process]

Phrase: "adipocyte differentiation."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1159884:adipocyte differentiation [Cell Function]
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.313: Physiol Rev 78: 783809, 1998.[Abstract/Free FullText] Haemmerle G, Zimmermann R, Hayn M, Theussl C, Waeg G, Wagner E, Sattler W, Magin TM, Wagner EF, and Zechner R. 

Phrase: "Physiol Rev 78"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "783809,"

Phrase: "1998."

Phrase: "[Abstract/Free FullText"

Phrase: "] Haemmerle G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Zimmermann R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Hayn M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Theussl C,"

Phrase: "Waeg G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Wagner E,"

Phrase: "Sattler W,"

Phrase: "Magin TM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
   861   C3540468:TM [Gene or Genome]

Phrase: "Wagner EF,"

Phrase: "and"

Phrase: "Zechner R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.314: Hormone-sensitive lipase deficiency in mice causes diglyceride accumulation in adipose tissue, muscle, and testis. 

Phrase: "Hormone-sensitive lipase deficiency in mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1291447:lipase deficiency [Disease or Syndrome]
   783   C0599750:deficiency hormone [Disease or Syndrome]
   753   C0011155:Deficiency [Functional Concept]
   753   C0162429:Deficiency [Disease or Syndrome]
   753   C1623416:deficiency [Qualitative Concept]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "diglyceride accumulation in adipose tissue,"

Phrase: "muscle,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026845:Muscle [Tissue]
   928 E C0442025:Muscular [Spatial Concept]

Phrase: "and"

Phrase: "testis."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0039597:Testis [Body Part, Organ, or Organ Component]
  1000   C1278981:Testis [Body Part, Organ, or Organ Component]
   916 E C0021358:Testes [Body Part, Organ, or Organ Component]
   907 E C0205070:Testicular [Spatial Concept]
   888 E C1284096:Testicle [Body Part, Organ, or Organ Component]
Processing 00000000.tx.315: J Biol Chem 277: 48064815, 2002.[Abstract/Free FullText] Hales CN and Barker DJ. 

Phrase: "J Biol Chem 277"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "48064815,"

Phrase: "2002."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hales CN"

Phrase: "and"

Phrase: "Barker DJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]
Processing 00000000.tx.316: Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. 

Phrase: "Type 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441730:Type 2 [Classification]
   861   C0332307:Type [Qualitative Concept]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "(non-insulin-dependent) diabetes mellitus"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
  1000   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
           Non-Insulin Dependent Diabetes
  1000   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
   937   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   840   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0851827:Dependent [Qualitative Concept]
   804   C1518422:Non [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1701901:Dependent [Qualitative Concept]
   804   C3244310:dependent [Functional Concept]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ":"

Phrase: "the thrifty phenotype hypothesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512571:Hypothesis [Idea or Concept]
Processing 00000000.tx.317: Diabetologia 35: 595601, 1992.[CrossRef][ISI][Medline] Hales CN and Ozanne SE. 

Phrase: "Diabetologia 35"

Phrase: ":"

Phrase: "595601,"

Phrase: "1992."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hales CN"

Phrase: "and"

Phrase: "Ozanne SE."
Processing 00000000.tx.318: For debate: fetal and early postnatal growth restriction lead to diabetes, the metabolic syndrome and renal failure. 

Phrase: "For debate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0870392:debate [Activity]

Phrase: ":"

Phrase: "fetal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015965:Fetal [Embryonic Structure]
  1000   C0521457:Fetal [Functional Concept]

Phrase: "and"

Phrase: "early postnatal growth restriction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0443288:Restriction [Functional Concept]

Phrase: "lead to diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1522538:Lead [Functional Concept]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "the metabolic syndrome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0524620:Metabolic syndrome [Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   861   C0311400:Metabolic [Functional Concept]
   861   C1524026:Metabolic [Cell Function]
   861   C2707259:Metabolic [Clinical Attribute]

Phrase: "and"

Phrase: "renal failure."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035078:Renal Failure [Disease or Syndrome]
  1000   C1963154:Renal failure [Finding]
   861   C0022646:Renal [Body Part, Organ, or Organ Component]
   861   C0231174:Failure [Functional Concept]
   861   C0680095:failure [Individual Behavior]
Processing 00000000.tx.319: Diabetologia 46: 10131019, 2003.[CrossRef][ISI][Medline] Hausman DB, DiGirolamo M, Bartness TJ, Hausman GJ, and Martin RJ. 

Phrase: "Diabetologia 46"

Phrase: ":"

Phrase: "10131019,"

Phrase: "2003."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hausman DB,"

Phrase: "DiGirolamo M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bartness TJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039247:TJ [Geographic Area]

Phrase: "Hausman GJ,"

Phrase: "and"

Phrase: "Martin RJ."
Processing 00000000.tx.320: The biology of white adipocyte proliferation. 

Phrase: "The biology of white adipocyte proliferation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0005532:Biology [Biomedical Occupation or Discipline]
Processing 00000000.tx.321: Obes Rev 2: 239254, 2001.[CrossRef][Medline] Higami Y, Pugh TD, Page GP, Allison DB, Prolla TA, and Weindruch R. 

Phrase: "Obes Rev 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "239254,"

Phrase: "2001."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Higami Y,"

Phrase: "Pugh TD,"

Phrase: "Page GP,"

Phrase: "Allison DB,"

Phrase: "Prolla TA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]

Phrase: "and"

Phrase: "Weindruch R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.322: Adipose tissue energy metabolism: altered gene expression profile of mice subjected to long-term caloric restriction. 

Phrase: "Adipose tissue energy metabolism"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0014272:Energy Metabolism [Physiologic Function]
   812   C0025519:Metabolism [Organism Function]
   812   C0025520:metabolism [Functional Concept]
   812   C0424589:Energy [Finding]
   812   C0542479:Energy [Natural Phenomenon or Process]
   812   C1442080:Energy [Quantitative Concept]

Phrase: ":"

Phrase: "altered gene expression profile of mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1449575:gene expression profile [Laboratory Procedure]
   833   C1956267:Profile, Gene Expression [Quantitative Concept]
   753   C1979963:Profile [Laboratory Procedure]
   753   C2003903:Profile [Functional Concept]

Phrase: "subjected to long-term caloric restriction."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C0443252:Long-term [Temporal Concept]
   790   C1135809:Caloric Restriction [Therapeutic or Preventive Procedure]
   753   C0205166:Long [Qualitative Concept]
   753   C0443288:Restriction [Functional Concept]
   753   C1515273:Term [Temporal Concept]
   753   C1705313:Term [Idea or Concept]
   753   C1706317:Long [Qualitative Concept]
   753   C2826302:TERM [Intellectual Product]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]
Processing 00000000.tx.323: FASEB J 18: 415417, 2004.[Abstract/Free FullText] Hofbauer KG. 

Phrase: "FASEB J 18"

Phrase: ":"

Phrase: "415417,"

Phrase: "2004."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hofbauer KG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022718:KG [Geographic Area]
   861   C0439209:kg [Quantitative Concept]
Processing 00000000.tx.324: Molecular pathways to obesity. 

Phrase: "Molecular pathways to obesity."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   816   C1704259:molecular pathway [Molecular Function]
           Pathways
   770   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.325: Int J Obes Relat Metab Disord 26: S18S27, 2002. 

Phrase: "Int J Obes Relat Metab Disord 26"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0063789:INT [Organic Chemical]
   795   C3272375:INT [Intellectual Product]

Phrase: ":"

Phrase: "S18S27,"

Phrase: "2002."
Processing 00000000.tx.326: Holemans K, Aerts L, and Van Assche FA. 

Phrase: "Holemans K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Aerts L,"

Phrase: "and"

Phrase: "Van Assche FA."
Processing 00000000.tx.327: Fetal growth restriction and consequences for the offspring in animal models. 

Phrase: "Fetal growth restriction"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0015934:Fetal growth restriction [Pathologic Function]
   901   C0743925:Fetal Growth [Physiologic Function]
   827   C0015965:Fetal [Embryonic Structure]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C0443288:Restriction [Functional Concept]
   827   C0521457:Fetal [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "consequences for the offspring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0686907:consequences [Functional Concept]

Phrase: "in animal models."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599779:Models, Animal [Animal]
   861   C0003062:Animal [Animal]
   861   C3161035:Models [Intellectual Product]
Processing 00000000.tx.328: J Soc Gynecol Investig 10: 392399, 2003.[CrossRef][ISI][Medline] Horton JD, Goldstein JL, and Brown MS. 

Phrase: "J Soc Gynecol Investig 10"

Phrase: ":"

Phrase: "392399,"

Phrase: "2003."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Horton JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Goldstein JL,"

Phrase: "and"

Phrase: "Brown MS."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]
Processing 00000000.tx.329: SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. 

Phrase: "SREBPs"

Phrase: ":"

Phrase: "activators of the complete program of cholesterol"

Phrase: "and"

Phrase: "fatty acid synthesis in the liver."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0596562:fatty acid synthesis [Molecular Function]
   753   C0220781:synthesis [Biologic Function]
   753   C1883254:Synthesis [Activity]
Processing 00000000.tx.330: J Clin Invest 109: 11251131, 2002.[Free FullText] Iba K, Durkin ME, Johnsen L, Hunziker E, Damgaard-Pedersen K, Zhang H, Engvall E, Albrechtsen R, and Wewer UM. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "109"

Phrase: ":"

Phrase: "11251131,"

Phrase: "2002."

Phrase: "[Free FullText"

Phrase: "] Iba K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Durkin"

Phrase: "ME,"

Phrase: "Johnsen L,"

Phrase: "Hunziker E,"

Phrase: "Damgaard-Pedersen K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: "Zhang H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Engvall E,"

Phrase: "Albrechtsen R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Wewer UM."
Processing 00000000.tx.331: Mice with a targeted deletion of the tetranectin gene exhibit a spinal deformity. 

Phrase: "Mice with a targeted deletion of the tetranectin gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C1417166:MICE gene [Gene or Genome]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "a spinal deformity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0575157:Spinal deformity [Anatomical Abnormality]
   861   C0000768:Deformity [Congenital Abnormality]
   861   C0221430:Deformity, NOS [Acquired Abnormality]
   861   C0302142:Deformity [Anatomical Abnormality]
Processing 00000000.tx.332: Mol Cell Biol 21: 78177825, 2001.[Abstract/Free FullText] Jepsen KJ, Wu F, Peragallo JH, Paul J, Roberts L, Ezura Y, Oldberg A, Birk DE, and Chakravarti S. 

Phrase: "Mol Cell Biol 21"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0007634:Cell [Cell]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1269647:Cell [Cell]
   812   C1456781:mole [Neoplastic Process]
   812   C1704653:Cell [Medical Device]
   812   C1824986:mol [Gene or Genome]
   812   C1948049:Cell [Spatial Concept]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "78177825,"

Phrase: "2001."

Phrase: "[Abstract/Free FullText"

Phrase: "] Jepsen KJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439255:kJ [Quantitative Concept]

Phrase: "Wu F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Peragallo JH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]

Phrase: "Paul J,"

Phrase: "Roberts L,"

Phrase: "Ezura Y,"

Phrase: "Oldberg A,"

Phrase: "Birk DE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "and"

Phrase: "Chakravarti S."
Processing 00000000.tx.333: A syndrome of joint laxity and impaired tendon integrity in lumican- and fibromodulin-deficient mice. 

Phrase: "A syndrome of joint laxity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0039082:Syndrome [Disease or Syndrome]

Phrase: "and"

Phrase: "impaired tendon integrity in lumican-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205266:integrity [Qualitative Concept]
   760   C0872403:integrity [Individual Behavior]
   760   C1947912:Integrity [Qualitative Concept]

Phrase: "and"

Phrase: "fibromodulin-deficient mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.334: J Biol Chem 277: 3553235540, 2002.[Abstract/Free FullText] Joanette EA, Reusens B, Arany E, Thyssen S, Remacle RC, and Hill DJ. 

Phrase: "J Biol Chem 277"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "3553235540,"

Phrase: "2002."

Phrase: "[Abstract/Free FullText"

Phrase: "] Joanette EA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014963:EA [Organic Chemical,Pharmacologic Substance]
   861   C1457900:EA [Quantitative Concept]

Phrase: "Reusens B,"

Phrase: "Arany E,"

Phrase: "Thyssen S,"

Phrase: "Remacle RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: "and"

Phrase: "Hill DJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]
Processing 00000000.tx.335: Low-protein diet during early life causes a reduction in the frequency of cells immunopositive for nestin and CD34 in both pancreatic ducts and islets in the rat. 

Phrase: "Low-protein diet during early life"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   833   C0242972:Low-Protein Diet [Therapeutic or Preventive Procedure]
           low protein
   790   C0452269:Protein diet [Therapeutic or Preventive Procedure]
   790   C0748025:low protein [Finding]
   753   C0012155:Diet [Food]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205251:low [Qualitative Concept]
   753   C1299352:Low [Qualitative Concept]
   753   C1442959:Diet [Organism Function]
   753   C1519433:DIET [Therapeutic or Preventive Procedure]
   753   C1550472:low [Idea or Concept]
   753   C2983588:DIET [Food]
   748 E C0012177:Dietary Protein [Amino Acid, Peptide, or Protein]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a reduction in the frequency of cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "immunopositive for nestin"

Phrase: "and"

Phrase: "CD34 in both pancreatic ducts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3538723:CD34 [Laboratory Procedure]

Phrase: "and"

Phrase: "islets in the rat."
Processing 00000000.tx.336: Endocrinology 145: 30043013, 2004.[Abstract/Free FullText] Kershaw EE and Flier JS. 

Phrase: "Endocrinology 145"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "30043013,"

Phrase: "2004."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kershaw EE"

Phrase: "and"

Phrase: "Flier JS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]
Processing 00000000.tx.337: Adipose tissue as an endocrine organ. 

Phrase: "Adipose tissue as an endocrine organ."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0001527:Adipose tissue [Tissue]
   783   C0229524:Endocrine tissue [Tissue]
   753   C0040300:Tissue [Tissue]
   753   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.338: J Clin Endocrinol Metab 89: 25482556, 2004.[Abstract/Free FullText] Krysiak R, Okopien B, Belowski D, Madej A, and Herman ZS. 

Phrase: "J Clin Endocrinol Metab 89"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "25482556,"

Phrase: "2004."

Phrase: "[Abstract/Free FullText"

Phrase: "] Krysiak R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Okopien B,"

Phrase: "Belowski D,"

Phrase: "Madej A,"

Phrase: "and"

Phrase: "Herman ZS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043459:ZS [Congenital Abnormality,Disease or Syndrome]
Processing 00000000.tx.339: Recent insights into body weight control: from physiology to pathology. 

Phrase: "Recent insights into body weight control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0233820:insights [Mental Process]

Phrase: ":"

Phrase: "from physiology"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031842:Physiology [Biomedical Occupation or Discipline]
  1000   C0031843:physiology [Physiologic Function]
   928 E C0205463:Physiologic [Functional Concept]

Phrase: "to pathology."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030664:Pathology [Biomedical Occupation or Discipline]
  1000   C0205469:pathology [Functional Concept]
  1000   C0677042:pathology [Pathologic Function]
   928 E C1521733:Pathologic [Functional Concept]
Processing 00000000.tx.340: J Pept Sci 7: 571578, 2001.[CrossRef][ISI][Medline] Lehrke M and Lazar MA. 

Phrase: "J Pept Sci 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0080384:PEPT [Organic Chemical,Pharmacologic Substance]
   812   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "571578,"

Phrase: "2001."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lehrke M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Lazar MA."
Processing 00000000.tx.341: Inflamed about obesity. 

Phrase: "Inflamed about obesity."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0028754:Obesity [Disease or Syndrome]
   790   C0333348:Inflamed [Functional Concept]
   790   C1963185:Obesity [Finding]
Processing 00000000.tx.342: Nat Med 10: 126127, 2004.[CrossRef][ISI][Medline] Li J, Yu X, Pan W, and Unger RH. 

Phrase: "Nat Med 10"

Phrase: ":"

Phrase: "126127,"

Phrase: "2004."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Li J,"

Phrase: "Yu X,"

Phrase: "Pan W,"

Phrase: "and"

Phrase: "Unger RH."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035493:Rh [Element, Ion, or Isotope]
   861   C2699077:Rh- [Classification]
   861   C2699078:Rh+ [Classification]
Processing 00000000.tx.343: Gene expression profile of rat adipose tissue at the onset of high-fat-diet obesity. 

Phrase: "Gene expression profile of rat adipose tissue"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   814   C1449575:gene expression profile [Laboratory Procedure]
   814   C1956267:Profile, Gene Expression [Quantitative Concept]
   748   C1979963:Profile [Laboratory Procedure]
   748   C2003903:Profile [Functional Concept]

Phrase: "at the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "of high-fat-diet obesity."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0028754:Obesity [Disease or Syndrome]
   812   C1963185:Obesity [Finding]
   756   C0521974:Diet, High-Fat [Therapeutic or Preventive Procedure]
Processing 00000000.tx.344: Am J Physiol Endocrinol Metab 282: E1334E1341, 2002.[Abstract/Free FullText] Lijnen HR, Maquoi E, Holvoet P, Mertens A, Lupu F, Morange P, Alessi MC, and Juhan-Vague I. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 282"

Phrase: ":"

Phrase: "E1334E1341,"

Phrase: "2002."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lijnen HR,"

Phrase: "Maquoi E,"

Phrase: "Holvoet P,"

Phrase: "Mertens A,"

Phrase: "Lupu F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Morange P,"

Phrase: "Alessi MC,"

Phrase: "and"

Phrase: "Juhan-Vague I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.345: Adipose tissue expression of gelatinases in mouse models of obesity. 

Phrase: "Adipose tissue expression of gelatinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "models of obesity."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0028754:Obesity [Disease or Syndrome]
   790   C1963185:Obesity [Finding]
   790   C3161035:Model [Intellectual Product]
Processing 00000000.tx.346: Thromb Haemost 85: 11111116, 2001.[ISI][Medline] Liu Q, Yan H, Dawes NJ, Mottino GA, Frank JS, and Zhu H. 

Phrase: "Thromb Haemost 85"

Phrase: ":"

Phrase: "11111116,"

Phrase: "2001."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Liu Q,"

Phrase: "Yan H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Dawes NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Mottino GA,"

Phrase: "Frank JS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "Zhu H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.347: Insulin-like growth factor II induces DNA synthesis in fetal ventricular myocytes in vitro. 

Phrase: "Insulin-like growth factor II"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "DNA synthesis in fetal ventricular myocytes"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0598312:DNA Synthesis [Genetic Function]
   790   C1328870:DNA synthesis [Laboratory Procedure]
   790   C1817262:DNA synthesis [Genetic Function]
   753   C0220781:synthesis [Biologic Function]
   753   C1883254:Synthesis [Activity]
   748 E C0598279:synthetic DNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.348: Circ Res 79: 716726, 1996.[Abstract/Free FullText] Loftus TM, Jaworsky DE, Frehywot GL, Townsend CA, Ronnett GV, Lane MD, and Kuhajda FP. 

Phrase: "Circ Res 79"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332520:Circ [Quantitative Concept]
   827   C2347379:RES [Finding]
   827   C2347774:circ [Quantitative Concept]

Phrase: ":"

Phrase: "716726,"

Phrase: "1996."

Phrase: "[Abstract/Free FullText"

Phrase: "] Loftus TM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
   861   C3540468:TM [Gene or Genome]

Phrase: "Jaworsky DE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "Frehywot GL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0018229:GL [Geographic Area]
   861   C1423073:GL [Gene or Genome]
   861   C1427674:GL [Gene or Genome]

Phrase: "Townsend CA,"

Phrase: "Ronnett GV,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0376406:gv [Virus]

Phrase: "Lane MD,"

Phrase: "and"

Phrase: "Kuhajda FP."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1419068:FP [Gene or Genome]
   861   C1419906:FP [Gene or Genome]
   861   C3541238:Fp [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3541412:FP [Gene or Genome]
Processing 00000000.tx.349: Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. 

Phrase: "Reduced food intake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0013470:Food Intake [Organism Function]
   827   C1512806:Intake [Functional Concept]

Phrase: "and"

Phrase: "body weight in mice"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0005910:Body Weight [Organism Attribute]
           weight
   833   C1305866:body weight [Diagnostic Procedure]
           weight
   770   C0043100:Weight [Quantitative Concept]
   770   C0242821:body [Human]
   770   C0460148:Body [Anatomical Structure]
   770   C1268086:Body [Anatomical Structure]
   770   C1705104:Weight [Idea or Concept]

Phrase: "treated with fatty acid synthase inhibitors."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   833   C0015683:Fatty-acid synthase [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1367441:FATTY ACID SYNTHASE [Gene or Genome]
   790   C0015684:Fatty acid [Lipid]
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0001128:Acid [Chemical]
   753   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0243077:inhibitors [Chemical Viewed Functionally]
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]
   719 E C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.350: Science 288: 23792381, 2000.[Abstract/Free FullText] Matthews SG. 

Phrase: "Science 288"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "23792381,"

Phrase: "2000."

Phrase: "[Abstract/Free FullText"

Phrase: "] Matthews SG."
Processing 00000000.tx.351: Early programming of the hypothalamo-pituitary-adrenal axis. 

Phrase: "Early programming of the hypothalamo-pituitary-adrenal axis."
Processing 00000000.tx.352: Trends Endocrinol Metab 13: 373380, 2002.[CrossRef][ISI][Medline] Maves KK and Weiler JM. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Endocrinol Metab 13"

Phrase: ":"

Phrase: "373380,"

Phrase: "2002."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Maves KK"

Phrase: "and"

Phrase: "Weiler JM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]
Processing 00000000.tx.353: Properdin: approaching four decades of research. 

Phrase: "Properdin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033452:Properdin [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1418482:PROPERDIN [Gene or Genome]

Phrase: ":"

Phrase: "approaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:approaching [Spatial Concept]

Phrase: "four decades of research."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C2981279:Decade [Quantitative Concept]
Processing 00000000.tx.354: Immunol Res 12: 233243, 1993.[ISI][Medline] Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, and Marks JS. 

Phrase: "Immunol Res 12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "233243,"

Phrase: "1993."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mokdad AH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1836672:AH [Disease or Syndrome]

Phrase: "Ford ES,"

Phrase: "Bowman BA,"

Phrase: "Dietz WH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2349143:Wh [Quantitative Concept]

Phrase: "Vinicor F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Bales"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2826220:BALE [Quantitative Concept]

Phrase: "VS"

Phrase: ","

Phrase: "and"

Phrase: "Marks JS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]
Processing 00000000.tx.355: Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. 

Phrase: "Prevalence of obesity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0033105:Prevalence [Quantitative Concept]
   790   C0220900:prevalence [Quantitative Concept]

Phrase: "diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "obesity-related health risk factors,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   881   C0299583:Obesity Factor [Amino Acid, Peptide, or Protein,Hormone]
   840   C0035648:risk factors [Quantitative Concept]
   840   C1553898:risk factors [Idea or Concept]
   804   C0035647:Risk [Qualitative Concept]
   771   C1521761:Factor [Functional Concept]
   771   C2827422:Factor [Conceptual Entity]

Phrase: "2001."
Processing 00000000.tx.356: JAMA 289: 7679, 2003.[Abstract/Free FullText] Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins JB, and O'Rahilly S. 

Phrase: "JAMA 289"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1422839:JAMA [Gene or Genome]

Phrase: ":"

Phrase: "7679,"

Phrase: "2003."

Phrase: "[Abstract/Free FullText"

Phrase: "] Montague CT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540513:CT [Gene or Genome]

Phrase: "Farooqi"

Phrase: "IS"

Phrase: ","

Phrase: "Whitehead JP,"

Phrase: "Soos MA,"

Phrase: "Rau H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Wareham NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Sewter CP,"

Phrase: "Digby JE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0454673:JE [Geographic Area]
   861   C1550752:JE [Temporal Concept]

Phrase: "Mohammed SN,"

Phrase: "Hurst JA,"

Phrase: "Cheetham CH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0558269:Ch. [Professional or Occupational Group]
   861   C1552984:[Ch] [Quantitative Concept]

Phrase: "Earley AR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986463:AR+ [Finding]

Phrase: "Barnett AH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1836672:AH [Disease or Syndrome]

Phrase: "Prins JB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]

Phrase: "and"

Phrase: "O'Rahilly S."
Processing 00000000.tx.357: Congenital leptin deficiency is associated with severe early-onset obesity in humans. 

Phrase: "Congenital leptin deficiency"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   913   C0333006:Congenital deficiency [Congenital Abnormality]
   901   C3554224:LEPTIN DEFICIENCY [Disease or Syndrome]
   827   C0011155:Deficiency [Functional Concept]
   827   C0162429:Deficiency [Disease or Syndrome]
   827   C1623416:deficiency [Qualitative Concept]
   755 E C1636779:% deficient [Quantitative Concept]

Phrase: "is"

Phrase: "associated with severe early-onset obesity"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   833   C1833056:Obesity, early-onset [Finding]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C1833334:Early-onset [Finding]
   783   C0028756:Obesity, Severe [Disease or Syndrome]
   753   C0028754:Obesity [Disease or Syndrome]
   753   C0205082:Severe [Qualitative Concept]
   753   C0332162:Onset [Qualitative Concept]
   753   C1279919:Early [Temporal Concept]
   753   C1963185:Obesity [Finding]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]
Processing 00000000.tx.358: Nature 387: 903908, 1997.[CrossRef][ISI][Medline] Montague CT and O'Rahilly S. 

Phrase: "Nature 387"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "903908,"

Phrase: "1997."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Montague CT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540513:CT [Gene or Genome]

Phrase: "and"

Phrase: "O'Rahilly S."
Processing 00000000.tx.359: The perils of portliness: causes and consequences of visceral adiposity. 

Phrase: "The perils of portliness"

Phrase: ":"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015127:causes [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "and"

Phrase: "consequences of visceral adiposity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   816   C0686907:Consequence of [Functional Concept]
           consequences
Processing 00000000.tx.360: Diabetes 49: 883888, 2000.[Abstract] Moraes RC, Blondet A, Birkenkamp-Demtroeder K, Tirard J, Orntoft TF, Gertler A, Durand P, Naville D, and Begeot M. 

Phrase: "Diabetes 49"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "883888,"

Phrase: "2000."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Moraes RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: "Blondet A,"

Phrase: "Birkenkamp-Demtroeder K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: "Tirard J,"

Phrase: "Orntoft TF,"

Phrase: "Gertler A,"

Phrase: "Durand P,"

Phrase: "Naville D,"

Phrase: "and"

Phrase: "Begeot M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.361: Study of the alteration of gene expression in adipose tissue of diet-induced obese mice by microarray and reverse transcription-polymerase chain reaction analyses. 

Phrase: "Study of the alteration of gene expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0557651:Study [Manufactured Object]
   748   C2603343:Study [Research Activity]

Phrase: "in adipose tissue"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001527:Adipose tissue [Tissue]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
   789   C0028754:Adiposity [Disease or Syndrome]
   789   C1563743:adiposity [Organism Attribute]

Phrase: "of diet-induced obese mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0025933:Mice, Obese [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "by microarray"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709016:Microarray [Manufactured Object]

Phrase: "and"

Phrase: "reverse transcription-polymerase chain reaction analyses."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   947   C0814037:reverse transcription polymerase chain reaction [Genetic Function]
   867   C0200931:Polymerase chain reaction analysis [Laboratory Procedure]
   861   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0035380:Reverse Transcription [Genetic Function]
   799   C0040649:Transcription [Genetic Function]
   799   C0337112:Chain [Manufactured Object]
   799   C0443286:Reaction [Functional Concept]
   799   C1114821:Reaction [Clinical Attribute]
   799   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C1524075:Chain [Idea or Concept]
   799   C1555029:Reverse [Idea or Concept]
   766   C0002778:Analysis [Laboratory Procedure]
   766   C0936012:Analysis [Research Activity]
   766   C1524024:analysis [Functional Concept]
Processing 00000000.tx.362: Endocrinology 144: 47734782, 2003.[Abstract/Free FullText] Nadler ST, Stoehr JP, Schueler KL, Tanimoto G, Yandell BS, and Attie AD. 

Phrase: "Endocrinology 144"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "47734782,"

Phrase: "2003."

Phrase: "[Abstract/Free FullText"

Phrase: "] Nadler ST,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "Stoehr JP,"

Phrase: "Schueler KL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1366480:KL [Gene or Genome]
   861   C1416656:KL [Gene or Genome]

Phrase: "Tanimoto G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Yandell BS,"

Phrase: "and"

Phrase: "Attie AD."
Processing 00000000.tx.363: The expression of adipogenic genes is decreased in obesity and diabetes mellitus. 

Phrase: "The expression of adipogenic genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0017262:Gene Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "decreased in obesity"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0028754:Obesity [Disease or Syndrome]
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   790   C1963185:Obesity [Finding]
   756 E C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "diabetes mellitus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]
Processing 00000000.tx.364: Proc Natl Acad Sci USA 97: 1137111376, 2000.[Abstract/Free FullText] Nakanishi T, Yamaai T, Asano M, Nawachi K, Suzuki M, Sugimoto T, and Takigawa M. 

Phrase: "Proc Natl Acad Sci USA 97"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C0439073:97 [Intellectual Product]
   799   C0439082:>97 [Quantitative Concept]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "1137111376,"

Phrase: "2000."

Phrase: "[Abstract/Free FullText"

Phrase: "] Nakanishi T,"

Phrase: "Yamaai T,"

Phrase: "Asano M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Nawachi K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Suzuki M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Sugimoto T,"

Phrase: "and"

Phrase: "Takigawa M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.365: Overexpression of connective tissue growth factor/hypertrophic chondrocyte-specific gene product 24 decreases bone density in adult mice and induces dwarfism. 

Phrase: "Overexpression of connective tissue growth factor/hypertrophic chondrocyte-specific gene product 24"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1512282:Growth Factor Overexpression [Laboratory or Test Result]
   736   C1514559:Overexpression [Genetic Function]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "bone density in adult mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0005938:Bone Density [Clinical Attribute]
   806   C0177804:bone density [Diagnostic Procedure]
   781   C1511240:Mouse Bone [Tissue]
   760   C0178587:density [Quantitative Concept]
   760   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   760   C0391978:Bone [Tissue]
   760   C1266908:Bone [Body Part, Organ, or Organ Component]
   760   C1266909:Bone [Body System]

Phrase: "and"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "dwarfism."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013336:Dwarfism [Congenital Abnormality,Disease or Syndrome]
Processing 00000000.tx.366: Biochem Biophys Res Commun 281: 678681, 2001.[CrossRef][ISI][Medline] Nishi S, Nishino H, and Ishibashi T. 

Phrase: "Biochem Biophys Res Commun 281"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "678681,"

Phrase: "2001."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nishi S,"

Phrase: "Nishino H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Ishibashi T."
Processing 00000000.tx.367: cDNA cloning of the mammalian sterol C5-desaturase and the expression in yeast mutant. 

Phrase: "cDNA cloning of the mammalian sterol C5-desaturase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0009015:Cloning [Research Activity]

Phrase: "and"

Phrase: "the expression in yeast mutant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.368: Biochim Biophys Acta 1490: 106108, 2000.[ISI][Medline] Ntambi JM, Miyazaki M, Stoehr JP, Lan H, Kendziorski CM, Yandell BS, Song Y, Cohen P, Friedman JM, and Attie AD. 

Phrase: "Biochim Biophys Acta 1490"

Phrase: ":"

Phrase: "106108,"

Phrase: "2000."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ntambi JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Miyazaki M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Stoehr JP,"

Phrase: "Lan H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Kendziorski CM,"

Phrase: "Yandell BS,"

Phrase: "Song Y,"

Phrase: "Cohen P,"

Phrase: "Friedman JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "and"

Phrase: "Attie AD."
Processing 00000000.tx.369: Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. 

Phrase: "Loss of stearoyl-CoA desaturase-1 function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1517945:Loss [Quantitative Concept]

Phrase: "protects"

Phrase: "mice against adiposity."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
Processing 00000000.tx.370: Proc Natl Acad Sci USA 99: 1148211486, 2002.[Abstract/Free FullText] Okamoto O, Fujiwara S, Abe M, and Sato Y. 

Phrase: "Proc Natl Acad Sci USA 99"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "1148211486,"

Phrase: "2002."

Phrase: "[Abstract/Free FullText"

Phrase: "] Okamoto O,"

Phrase: "Fujiwara S,"

Phrase: "Abe M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Sato Y."
Processing 00000000.tx.371: Dermatopontin interacts with transforming growth factor beta and enhances its biological activity. 

Phrase: "Dermatopontin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414143:DERMATOPONTIN [Gene or Genome]

Phrase: "interacts with transforming growth factor beta"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   882   C0040690:Transforming Growth Factor beta [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C0330390:Beta [Plant]
   753   C0439096:Beta [Intellectual Product]
   753   C1510411:Transforming [Pathologic Function]
   753   C1521761:Factor [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2004068:Beta [Qualitative Concept]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "its biological activity."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0005532:Biological [Biomedical Occupation or Discipline]
   861   C0205177:Activity [Functional Concept]
   861   C0205460:biological [Qualitative Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.372: Biochem J 337: 537541, 1999.[CrossRef][ISI][Medline] Oken E and Gillman MW. 

Phrase: "Biochem J 337"

Phrase: ":"

Phrase: "537541,"

Phrase: "1999."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Oken E"

Phrase: "and"

Phrase: "Gillman MW."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024548:MW [Geographic Area]
   861   C0026385:mw [Quantitative Concept]
   861   C0556966:mW [Quantitative Concept]
Processing 00000000.tx.373: Fetal origins of obesity. 

Phrase: "Fetal origins of obesity."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0079946:origins [Classification]
   770   C0439659:Origins [Temporal Concept]
   737 E C1550512:origin [Intellectual Product]
Processing 00000000.tx.374: Obes Res 11: 496506, 2003.[Abstract/Free FullText] Ornitz DM and Itoh N. 

Phrase: "Obes Res 11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "496506,"

Phrase: "2003."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ornitz DM"

Phrase: "and"

Phrase: "Itoh N."
Processing 00000000.tx.375: Fibroblast growth factors. 

Phrase: "Fibroblast growth factors."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0016026:Fibroblast Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0016030:Fibroblast [Cell]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2911660:Growth [Activity]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.376: Genome Biol 2: Reviews 3005, 2001. 

Phrase: "Genome Biol 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017428:Genome [Gene or Genome]
   827   C2338314:Genome [Conceptual Entity]

Phrase: ":"

Phrase: "Reviews"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "3005,"

Phrase: "2001."
Processing 00000000.tx.377: Osmond C and Barker DJ. 

Phrase: "Osmond C"

Phrase: "and"

Phrase: "Barker DJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]
Processing 00000000.tx.378: Fetal, infant, and childhood growth are predictors of coronary heart disease, diabetes, and hypertension in adult men and women. 

Phrase: "Fetal, infant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021270:Infant [Age Group]

Phrase: "and"

Phrase: "childhood growth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]

Phrase: "are"

Phrase: "predictors of coronary heart disease,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C2698872:Predictor [Idea or Concept]

Phrase: "diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "hypertension in adult men"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020538:Hypertension [Disease or Syndrome]
   770   C1963138:Hypertension [Finding]

Phrase: "and"

Phrase: "women."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043210:Women [Population Group]
Processing 00000000.tx.379: Environ Health Perspect 108: 545553, 2000.[ISI][Medline] Ozanne SE. 

Phrase: "Environ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1568941:Environ [Organic Chemical]

Phrase: "Health Perspect 108"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0018684:Health [Idea or Concept]
   727 E C0031206:healthiness [Finding]

Phrase: ":"

Phrase: "545553,"

Phrase: "2000."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ozanne SE."
Processing 00000000.tx.380: Metabolic programming in animals. 

Phrase: "Metabolic programming in animals."
Processing 00000000.tx.381: Br Med Bull 60: 143152, 2001.[Abstract/Free FullText] Ozanne SE and Hales CN. 

Phrase: "Br Med Bull 60"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0007452:Bull [Mammal]
   812   C1704648:Br. [Conceptual Entity]

Phrase: ":"

Phrase: "143152,"

Phrase: "2001."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ozanne SE"

Phrase: "and"

Phrase: "Hales CN."
Processing 00000000.tx.382: Early programming of glucose-insulin metabolism. 

Phrase: "Early programming of glucose-insulin metabolism."
Processing 00000000.tx.383: Trends Endocrinol Metab 13: 368373, 2002.[CrossRef][ISI][Medline] Ozanne SE, Lewis R, Jennings BJ, and Hales CN. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Endocrinol Metab 13"

Phrase: ":"

Phrase: "368373,"

Phrase: "2002."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ozanne SE,"

Phrase: "Lewis R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Jennings BJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005005:BJ [Geographic Area]

Phrase: "and"

Phrase: "Hales CN."
Processing 00000000.tx.384: Early programming of weight gain in mice prevents the induction of obesity by a highly palatable diet. 

Phrase: "Early programming of weight gain"

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "the induction of obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "by a highly palatable diet."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0012155:Diet [Food]
   827   C1442959:Diet [Organism Function]
   827   C1519433:DIET [Therapeutic or Preventive Procedure]
   827   C2983588:DIET [Food]
   755 E C2699635:DIETARY [Functional Concept]
Processing 00000000.tx.385: Clin Sci (Lond) 106: 141145, 2004.[Medline] Petrik J, Reusens B, Arany E, Remacle C, Coelho C, Hoet JJ, and Hill DJ. 

Phrase: "Clin Sci (Lond) 106"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1315013:CLIN [Intellectual Product]
   812   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "141145,"

Phrase: "2004."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Petrik J,"

Phrase: "Reusens B,"

Phrase: "Arany E,"

Phrase: "Remacle C,"

Phrase: "Coelho C,"

Phrase: "Hoet JJ,"

Phrase: "and"

Phrase: "Hill DJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]
Processing 00000000.tx.386: A low protein diet alters the balance of islet cell replication and apoptosis in the fetal and neonatal rat and is associated with a reduced pancreatic expression of insulin-like growth factor-II. 

Phrase: "A low protein diet"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0242972:Low-Protein Diet [Therapeutic or Preventive Procedure]
           low protein
   901   C0452269:Protein diet [Therapeutic or Preventive Procedure]
   901   C0748025:low protein [Finding]
   827   C0012155:Diet [Food]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0205251:low [Qualitative Concept]
   827   C1299352:Low [Qualitative Concept]
   827   C1442959:Diet [Organism Function]
   827   C1519433:DIET [Therapeutic or Preventive Procedure]
   827   C1550472:low [Idea or Concept]
   827   C2983588:DIET [Food]
   755 E C2699635:DIETARY [Functional Concept]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the balance of islet cell replication"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0014653:Balance [Organism Function]
   753   C0205415:Balance [Functional Concept]
   753   C0560184:Balance [Finding]

Phrase: "and"

Phrase: "apoptosis in the fetal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0162638:Apoptosis [Cell Function]

Phrase: "and"

Phrase: "neonatal rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]

Phrase: "and"

Phrase: "is"

Phrase: "associated with a reduced pancreatic expression"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0392756:Reduced [Qualitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "of insulin-like growth factor-II."
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021666:Insulin-Like Growth Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334091:INSULIN-LIKE GROWTH FACTOR II [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C0306438:Iletin II [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0033706:Factor II [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0200396:Factor II [Laboratory Procedure]
   840   C1414504:FACTOR II [Gene or Genome]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.387: Endocrinology 140: 48614873, 1999.[Abstract/Free FullText] Pupa SM, Menard S, Forti S, and Tagliabue E. 

Phrase: "Endocrinology 140"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "48614873,"

Phrase: "1999."

Phrase: "[Abstract/Free FullText"

Phrase: "] Pupa SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Menard S,"

Phrase: "Forti S,"

Phrase: "and"

Phrase: "Tagliabue E."
Processing 00000000.tx.388: New insights into the role of extracellular matrix during tumor onset and progression. 

Phrase: "New insights into the role of extracellular matrix"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0233820:insights [Mental Process]

Phrase: "during tumor onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332162:Onset [Qualitative Concept]

Phrase: "and"

Phrase: "progression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242656:progression [Pathologic Function]
  1000   C0449258:Progression [Functional Concept]
Processing 00000000.tx.389: J Cell Physiol 192: 259267, 2002.[CrossRef][ISI][Medline] Purdy LP and Metzger BE. 

Phrase: "J Cell Physiol 192"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "259267,"

Phrase: "2002."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Purdy LP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037943:LP [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C0228341:LP [Body Part, Organ, or Organ Component]
   861   C2239920:LP [Gene or Genome]

Phrase: "and"

Phrase: "Metzger"

Phrase: "BE."
Processing 00000000.tx.390: Influences of the intrauterine metabolic environment on adult disease: what may we infer from size at birth? 

Phrase: "Influences of the intrauterine metabolic environment"

Phrase: "on adult disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0277562:Adult disease [Disease or Syndrome]
   861   C0001675:Adult [Age Group]
   861   C0012634:Disease [Disease or Syndrome]
   861   C1706450:Adult [Human]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "what"

Phrase: "may"

Phrase: "we"

Phrase: "infer from size"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0456389:size [Spatial Concept]
   790   C0679201:Infer [Mental Process]

Phrase: "at birth?"
Meta Candidates (Total=16; Excluded=13; Pruned=0; Remaining=3)
  1000   C0005615:Birth [Organism Function]
  1000   C1550722:birth [Idea or Concept]
  1000   C3245487:birth [Intellectual Product]
   944 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   944 E C0314603:Genetic [Functional Concept]
   944 E C0454729:Natal [Geographic Area]
   916 E C0035150:Reproduction [Organism Function]
   916 E C0079946:origin [Classification]
   916 E C0439659:Origin [Temporal Concept]
   916 E C1550512:origin [Intellectual Product]
   900 E C0559522:Genital [Body System]
   900 E C1546649:Genital [Intellectual Product]
   900 E C1550642:Genital [Body Substance]
   893 E C0205313:Original [Idea or Concept]
   893 E C2347409:Original [Occupational Activity]
   880 E C0598240:originality [Mental Process]
Processing 00000000.tx.391: Diabetologia 39: 11261130, 1996.[CrossRef][ISI][Medline] Rogers I. 

Phrase: "Diabetologia 39"

Phrase: ":"

Phrase: "11261130,"

Phrase: "1996."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Rogers I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.392: The influence of birthweight and intrauterine environment on adiposity and fat distribution in later life. 

Phrase: "The influence of birthweight"

Phrase: "and"

Phrase: "intrauterine environment on adiposity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0014406:Environment [Spatial Concept]

Phrase: "and"

Phrase: "fat distribution in later life."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]
Processing 00000000.tx.393: Int J Obes Relat Metab Disord 27: 755777, 2003.[CrossRef][Medline] Romanic AM, Burns-Kurtis CL, Ao Z, Arleth AJ, and Ohlstein EH. 

Phrase: "Int J Obes Relat Metab Disord 27"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0063789:INT [Organic Chemical]
   795   C3272375:INT [Intellectual Product]

Phrase: ":"

Phrase: "755777,"

Phrase: "2003."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Romanic"

Phrase: "AM"

Phrase: ","

Phrase: "Burns-Kurtis CL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "Ao Z,"

Phrase: "Arleth AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "and"

Phrase: "Ohlstein EH."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520135:EH [Geographic Area]
Processing 00000000.tx.394: Upregulated expression of human membrane type-5 matrix metalloproteinase in kidneys from diabetic patients. 

Phrase: "Upregulated expression of human membrane type-5 matrix metalloproteinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in kidneys"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0022646:Kidneys [Body Part, Organ, or Organ Component]
  1000   C0227665:kidneys [Body Part, Organ, or Organ Component]
   966 E C1278978:Kidney [Body Part, Organ, or Organ Component]
   966 E C1514845:KIDNEY [Tissue]
   900 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "from diabetic patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.395: Am J Physiol Renal Physiol 281: F309F317, 2001.[Abstract/Free FullText] Rupnick MA, Panigrahy D, Zhang CY, Dallabrida SM, Lowell BB, Langer R, and Folkman MJ. 

Phrase: "Am"

Phrase: "J Physiol Renal Physiol 281"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0022646:Renal [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "F309F317,"

Phrase: "2001."

Phrase: "[Abstract/Free FullText"

Phrase: "] Rupnick MA,"

Phrase: "Panigrahy D,"

Phrase: "Zhang CY,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010622:CY [Geographic Area]
   861   C0332298:CY [Functional Concept]

Phrase: "Dallabrida SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Lowell BB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0004739:BB [Geographic Area]
   861   C0332297:BB [Spatial Concept]

Phrase: "Langer R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Folkman MJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]
Processing 00000000.tx.396: Adipose tissue mass can be regulated through the vasculature. 

Phrase: "Adipose tissue mass"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]
   827   C3152252:Mass [Quantitative Concept]
   734   C0001527:Adipose tissue [Tissue]

Phrase: "can"

Phrase: "be"

Phrase: "regulated through the vasculature."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0005839:vasculature [Body Part, Organ, or Organ Component]
   770   C0851285:Regulated [Governmental or Regulatory Activity]
Processing 00000000.tx.397: Proc Natl Acad Sci USA 99: 1073010735, 2002.[Abstract/Free FullText] Sakaue H, Ogawa W, Nakamura T, Mori T, Nakamura K, and Kasuga M. 

Phrase: "Proc Natl Acad Sci USA 99"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "1073010735,"

Phrase: "2002."

Phrase: "[Abstract/Free FullText"

Phrase: "] Sakaue H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Ogawa W,"

Phrase: "Nakamura T,"

Phrase: "Mori T,"

Phrase: "Nakamura K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Kasuga M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.398: Role of MAP kinase phosphatase-1 (MKP-1) in adipocyte differentiation. 

Phrase: "Role of MAP kinase phosphatase-1 (MKP-1)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
   716   C0096069:Map Kinase Phosphatase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   716   C0287531:MAP Kinase Phosphatase-1 [Amino Acid, Peptide, or Protein,Enzyme]
   716   C1333257:MAP KINASE PHOSPHATASE 1 [Gene or Genome]

Phrase: "in adipocyte differentiation."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1159884:adipocyte differentiation [Cell Function]
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.399: J Biol Chem 20: 20, 2004. 

Phrase: "J Biol Chem 20"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "20,"

Phrase: "2004."
Processing 00000000.tx.400: Salway JG. 

Phrase: "Salway JG."
Processing 00000000.tx.401: Metabolism at a Glance. 

Phrase: "Metabolism at a Glance."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0025519:Metabolism [Organism Function]
   770   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.402: Malden, MA: Blackwell, 2004. 

Phrase: "Malden,"

Phrase: "MA"

Phrase: ":"

Phrase: "Blackwell,"

Phrase: "2004."
Processing 00000000.tx.403: Serrero G and Lepak N. 

Phrase: "Serrero G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Lepak N."
Processing 00000000.tx.404: Endocrine and paracrine negative regulators of adipose differentiation. 

Phrase: "Endocrine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014136:Endocrine [Body System]
  1000   C0521425:Endocrine [Functional Concept]

Phrase: "and"

Phrase: "paracrine negative regulators of adipose differentiation."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0182953:regulators [Medical Device]
   753   C0205160:Negative [Qualitative Concept]
   753   C1513916:Negative [Finding]
   753   C2825415:Negative [Conceptual Entity]
   753   C2825491:Negative [Qualitative Concept]
   719 E C1704734:Regulator [Medical Device]
   719 E C1704735:Regulator [Conceptual Entity]
Processing 00000000.tx.405: Int J Obes Relat Metab Disord 20: S58S64, 1996.[Medline] Soukas A, Cohen P, Socci ND, and Friedman JM. 

Phrase: "Int J Obes Relat Metab Disord 20"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0063789:INT [Organic Chemical]
   795   C3272375:INT [Intellectual Product]

Phrase: ":"

Phrase: "S58S64,"

Phrase: "1996."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Soukas A,"

Phrase: "Cohen P,"

Phrase: "Socci ND,"

Phrase: "and"

Phrase: "Friedman JM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]
Processing 00000000.tx.406: Leptin-specific patterns of gene expression in white adipose tissue. 

Phrase: "Leptin-specific patterns of gene expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449774:Patterns [Spatial Concept]

Phrase: "in white adipose tissue."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1704223:White Adipose Tissue [Tissue]
   901   C0001527:Adipose tissue [Tissue]
   827   C0007457:White [Population Group]
   827   C0040300:Tissue [Tissue]
   827   C0043157:White [Population Group]
   827   C0220938:White [Qualitative Concept]
   827   C1547928:Tissue [Intellectual Product]
   755   C0028754:Adiposity [Disease or Syndrome]
   755   C1563743:adiposity [Organism Attribute]
Processing 00000000.tx.407: Genes Dev 14: 963980, 2000.[Abstract/Free FullText] Soukas A, Socci ND, Saatkamp BD, Novelli S, and Friedman JM. 

Phrase: "Genes Dev 14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: ":"

Phrase: "963980,"

Phrase: "2000."

Phrase: "[Abstract/Free FullText"

Phrase: "] Soukas A,"

Phrase: "Socci ND,"

Phrase: "Saatkamp BD,"

Phrase: "Novelli S,"

Phrase: "and"

Phrase: "Friedman JM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]
Processing 00000000.tx.408: Distinct transcriptional profiles of adipogenesis in vivo and in vitro. 

Phrase: "Distinct transcriptional profiles of adipogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1979963:Profile [Laboratory Procedure]
   726   C2003903:Profile [Functional Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.409: J Biol Chem 276: 3416734174, 2001.[Abstract/Free FullText] Terai Y, Abe M, Miyamoto K, Koike M, Yamasaki M, Ueda M, Ueki M, and Sato Y. 

Phrase: "J Biol Chem 276"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "3416734174,"

Phrase: "2001."

Phrase: "[Abstract/Free FullText"

Phrase: "] Terai Y,"

Phrase: "Abe M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Miyamoto K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Koike M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Yamasaki M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ueda M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ueki M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Sato Y."
Processing 00000000.tx.410: Vascular smooth muscle cell growth-promoting factor/F-spondin inhibits angiogenesis via the blockade of integrin alphavbeta3 on vascular endothelial cells. 

Phrase: "Vascular smooth muscle cell growth-promoting factor/F-spondin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   807   C0015435:factor f [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   807   C1420366:f-spondin [Gene or Genome]
   791   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   791   C0439133:(f) [Intellectual Product]
   791   C1553038:[f] [Quantitative Concept]
   700   C0078057:vascular factor [Amino Acid, Peptide, or Protein]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "angiogenesis via the blockade of integrin alphavbeta3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0302600:Angiogenesis [Organ or Tissue Function]
   748   C1519670:angiogenesis [Neoplastic Process]

Phrase: "on vascular endothelial cells."
Meta Candidates (Total=22; Excluded=12; Pruned=0; Remaining=10)
  1000   C1257792:Vascular Endothelial Cells [Cell]
   901   C0225336:Endothelial Cells [Cell]
   865   C0014261:Endothelium, Vascular [Tissue]
   863   C0005773:Blood Cells [Cell]
   855 E C2328697:Hemal cell [Cell]
   837 E C1706972:Blood Vessel Endothelium [Tissue]
   827   C0005847:vascular [Body Part, Organ, or Organ Component]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C1558950:VASCULAR [Finding]
   827   C1801960:Vascular [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   771 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   771 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C0005767:Blood [Tissue]
   727 E C0005768:blood [Body Substance]
   727 E C0229664:Blood [Body Substance]
   727 E C0392895:Bloods [Population Group]
   711 E C0333275:Bloody [Qualitative Concept]
Processing 00000000.tx.411: J Cell Physiol 188: 394402, 2001.[CrossRef][ISI][Medline] Towatari T, Ide M, Ohba K, Chiba Y, Murakami M, Shiota M, Kawachi M, Yamada H, and Kido H. 

Phrase: "J Cell Physiol 188"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "394402,"

Phrase: "2001."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Towatari T,"

Phrase: "Ide M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ohba K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Chiba Y,"

Phrase: "Murakami M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Shiota M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kawachi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Yamada H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Kido H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.412: Identification of ectopic anionic trypsin I in rat lungs potentiating pneumotropic virus infectivity and increased enzyme level after virus infection. 

Phrase: "Identification of ectopic anionic trypsin I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0020792:Identification [Mental Process]
   753   C0205396:Identification [Qualitative Concept]

Phrase: "in rat lungs"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   983   C1882727:Rat Lung [Body Part, Organ, or Organ Component]
   861   C0024109:LUNGS [Body Part, Organ, or Organ Component]
   827 E C0819757:LUNG [Tissue]
   827 E C1278908:Lung [Body Part, Organ, or Organ Component]
   789 E C2707265:Pulmonary [Clinical Attribute]
   789 E C2709248:Pulmonary [Qualitative Concept]
   761 E C0032285:Pneumonia [Disease or Syndrome]

Phrase: "potentiating"

Phrase: "pneumotropic virus infectivity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   845   C0042769:virus infection [Disease or Syndrome]
   827   C0030657:infectivity [Qualitative Concept]
   716 E C0009450:Infection, NOS [Disease or Syndrome]
   704 E C0439663:Infected [Functional Concept]

Phrase: "and"

Phrase: "increased enzyme level after virus infection."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0014440:enzyme level [Laboratory Procedure]
   790   C1287349:Enzyme level [Laboratory or Test Result]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.413: Eur J Biochem 269: 26132621, 2002.[Abstract/Free FullText] Van Beek J, Guan H, Julan L, and Yang K. 

Phrase: "Eur J Biochem 269"

Phrase: ":"

Phrase: "26132621,"

Phrase: "2002."

Phrase: "[Abstract/Free FullText"

Phrase: "] Van Beek J,"

Phrase: "Guan H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Julan L,"

Phrase: "and"

Phrase: "Yang K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.414: Glucocorticoid stimulates the expression of 11 beta-hydroxysteroid dehydrogenase type 2 in cultured human placental trophoblast cells. 

Phrase: "Glucocorticoid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017710:Glucocorticoid [Hormone,Steroid]

Phrase: "stimulates"

Phrase: "the expression of 11 beta-hydroxysteroid dehydrogenase type 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   716   C0608861:11-beta-Hydroxysteroid Dehydrogenase Type 2 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in cultured human placental trophoblast cells."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   897   C0007600:cultured cells [Cell]
   897   C0007635:Cultured Cells [Cell]
   897   C3282338:Cells, Cultured [Cell]
   875   C0427861:Human cells [Laboratory or Test Result]
   823   C1519658:Trophoblast cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.415: J Clin Endocrinol Metab 89: 56145621, 2004.[Abstract/Free FullText] Van Tilbeurgh H, Bezzine S, Cambillau C, Verger R, and Carriere F. 

Phrase: "J Clin Endocrinol Metab 89"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "56145621,"

Phrase: "2004."

Phrase: "[Abstract/Free FullText"

Phrase: "] Van Tilbeurgh H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "Bezzine S,"

Phrase: "Cambillau C,"

Phrase: "Verger R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Carriere F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.416: Colipase: structure and interaction with pancreatic lipase. 

Phrase: "Colipase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009304:colipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "interaction with pancreatic lipase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.417: Biochim Biophys Acta 1441: 173184, 1999.[ISI][Medline] Watanabe Y, Shibata K, Kikkawa F, Kajiyama H, Ino K, Hattori A, Tsujimoto M, and Mizutani S. 

Phrase: "Biochim Biophys Acta 1441"

Phrase: ":"

Phrase: "173184,"

Phrase: "1999."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Watanabe Y,"

Phrase: "Shibata K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kikkawa F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Kajiyama H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Ino K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Hattori A,"

Phrase: "Tsujimoto M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Mizutani S."
Processing 00000000.tx.418: Adipocyte-derived leucine aminopeptidase suppresses angiogenesis in human endometrial carcinoma via renin-ANG system. 

Phrase: "Adipocyte-derived leucine aminopeptidase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1847414:ADIPOCYTE-DERIVED LEUCINE AMINOPEPTIDASE [Gene or Genome]
   861   C0023402:Leucine Aminopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0002570:Aminopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "angiogenesis in human endometrial carcinoma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0302600:Angiogenesis [Organ or Tissue Function]
   760   C1519670:angiogenesis [Neoplastic Process]

Phrase: "via renin-ANG system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.419: Clin Cancer Res 9: 64976503, 2003.[Abstract/Free FullText] Weinstock PH, Bisgaier CL, Aalto-Setala K, Radner H, Ramakrishnan R, Levak-Frank S, Essenburg AD, Zechner R, and Breslow JL. 

Phrase: "Clin Cancer Res 9"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0006826:Cancer [Neoplastic Process]
   812   C0998265:Cancer [Eukaryote]
   812   C1306459:Cancer [Finding]
   812   C1315013:CLIN [Intellectual Product]
   812   C2347379:RES [Finding]

Phrase: ":"

Phrase: "64976503,"

Phrase: "2003."

Phrase: "[Abstract/Free FullText"

Phrase: "] Weinstock PH,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "Bisgaier CL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "Aalto-Setala K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: "Radner H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Ramakrishnan R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Levak-Frank S,"

Phrase: "Essenburg AD,"

Phrase: "Zechner R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Breslow JL."
Processing 00000000.tx.420: Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. 

Phrase: "Severe hypertriglyceridemia,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020557:Hypertriglyceridaemia [Finding]
   861   C1522137:Hypertriglyceridemia [Finding]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "high density lipoprotein,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0023821:High density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   827   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0178587:density [Quantitative Concept]
   827   C0205250:High [Qualitative Concept]
   827   C1299351:High [Qualitative Concept]
   827   C2700149:HIGH [Intellectual Product]
   755 E C0439794:Dense [Qualitative Concept]

Phrase: "and"

Phrase: "neonatal death in lipoprotein lipase knockout mice."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0410916:Neonatal death [Pathologic Function]
   748   C0011065:Death [Organism Function]
   748   C1306577:Death, NOS [Finding]
   748   C1552240:Neonatal [Professional or Occupational Group]
   748   C1552264:Neonatal [Professional or Occupational Group]
   748   C2939425:Neonatal [Temporal Concept]
Processing 00000000.tx.421: Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes. 

Phrase: "Mild hypertriglyceridemia with impaired very low density lipoprotein clearance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1867531:Mild hypertriglyceridemia [Finding]
   742   C0020557:Hypertriglyceridaemia [Finding]
   742   C1522137:Hypertriglyceridemia [Finding]

Phrase: "in heterozygotes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygotes [Organism Attribute]
Processing 00000000.tx.422: J Clin Invest 96: 25552568, 1995.[ISI][Medline] Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, and Ferrante AW Jr. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "96"

Phrase: ":"

Phrase: "25552568,"

Phrase: "1995."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Weisberg SP,"

Phrase: "McCann D,"

Phrase: "Desai M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Rosenbaum M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Leibel RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "and"

Phrase: "Ferrante AW Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.423: Obesity is associated with macrophage accumulation in adipose tissue. 

Phrase: "Obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "is"

Phrase: "associated with macrophage accumulation"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0024432:macrophage [Cell]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in adipose tissue."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001527:Adipose tissue [Tissue]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
   789   C0028754:Adiposity [Disease or Syndrome]
   789   C1563743:adiposity [Organism Attribute]
Processing 00000000.tx.424: J Clin Invest 112: 17961808, 2003.[Abstract/Free FullText] Wewer UM, Iba K, Durkin ME, Nielsen FC, Loechel F, Gilpin BJ, Kuang W, Engvall E, and Albrechtsen R. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "112"

Phrase: ":"

Phrase: "17961808,"

Phrase: "2003."

Phrase: "[Abstract/Free FullText"

Phrase: "] Wewer UM,"

Phrase: "Iba K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Durkin"

Phrase: "ME,"

Phrase: "Nielsen FC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2983605:FC [Activity]

Phrase: "Loechel F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Gilpin BJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005005:BJ [Geographic Area]

Phrase: "Kuang W,"

Phrase: "Engvall E,"

Phrase: "and"

Phrase: "Albrechtsen R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.425: Tetranectin is a novel marker for myogenesis during embryonic development, muscle regeneration, and muscle cell differentiation in vitro. 

Phrase: "Tetranectin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0076317:tetranectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1539092:TETRANECTIN [Gene or Genome]

Phrase: "is"

Phrase: "a novel marker for myogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0005516:Marker [Clinical Attribute]

Phrase: "during embryonic development,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0013936:Embryonic Development [Organ or Tissue Function]
  1000   C0243100:embryonic development [Functional Concept]
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "muscle regeneration,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0034964:muscle regeneration [Cell]
   861   C0026845:Muscle [Tissue]
   861   C0034963:Regeneration [Organ or Tissue Function]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "and"

Phrase: "muscle cell differentiation"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C1326080:muscle cell differentiation [Cell Function]
   901   C0007589:Cell Differentiation [Cell Function]
           Differentiation
   827   C1511938:Differentiation [Clinical Attribute]
   827   C2945687:Differentiation [Functional Concept]
   755 E C0205615:Differentiated [Qualitative Concept]
   734   C0596981:Muscle cell [Cell]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.426: Dev Biol 200: 247259, 1998.[CrossRef][ISI][Medline] Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, and Chen H. 

Phrase: "Dev Biol 200"

Phrase: ":"

Phrase: "247259,"

Phrase: "1998."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Xu H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Barnes GT,"

Phrase: "Yang"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "Q,"

Phrase: "Tan G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Yang"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Chou CJ,"

Phrase: "Sole J,"

Phrase: "Nichols A,"

Phrase: "Ross JS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "Tartaglia LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "Chen H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.427: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. 

Phrase: "Chronic inflammation in fat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0021376:Chronic inflammation [Pathologic Function]
   770   C0021368:Inflammation [Pathologic Function]
   770   C0205191:chronic [Temporal Concept]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a crucial role in the development of obesity-related insulin resistance."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0035820:Role [Social Behavior]
   738   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.428: J Clin Invest 112: 18211830, 2003.[Abstract/Free FullText]

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "112"

Phrase: ":"

Phrase: "18211830,"

Phrase: "2003."

Phrase: "[Abstract/Free FullText"

Phrase: "]"

